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1 Introduction 
For thousands of years, natural products have been continuously applied for 
human use. Also in pharmaceutical industries, natural products play an important 
role due to their chemical diversity and various bioactivities against diseases. Addi-
tionally, crude natural products have become an important source of drugs in devel-
oping countries due to their low cost and ready availability. According to the World 
Health Organization, about 80% of the world’s population rely on traditional medi-
cines for their health care.
[1,
 
2]
 
A number of drug classes derived from natural products plays an important role 
in therapeutic areas of oncology, immunosuppression, infectious and metabolic dis-
eases.
[3]
 The development of resistance in infectious microorganisms to the available 
pharmaceuticals and the increase in diseases such as Ebola, SARS, and AIDS need 
the discovery and development of new drugs.
[4]
 
Recently, seas and oceans have drawn attention as potential natural resources of 
many bioactive compounds.
[5]
 As the habitats for marine organisms considerably 
differ from terrestrial ones, it can be expected that their secondary metabolites will 
be different.
[5,
 
6]
 Microorganisms have continued to be a productive and successful 
spotlight for marine natural products study.
[7]
 
The study on natural products chemistry derived from marine microorganisms 
has increased remarkably in recent years. The demand of compounds with potential 
pharmaceutical and economic applications as cosmetics, drugs, personal-care prod-
ucts and fine chemicals is the reasons for this.
[8]
 Until now, from the many species 
which have been assayed for their activities, a treasure of bioactive molecules having 
unique structural features has been isolated.
[4, 6]
 
1.1 Natural products in modern therapeutic use 
Despite successes in controlling some previously thought incurable diseases, re-
cent increase in epidemic viral infections such as AIDS, hepatitis, Ebola, SARS have 
been reported in developing countries (Asia, Africa).
[9]
 Therefore, the intention to 
search for new resources of bioactive metabolites still gains worldwide attention, as 
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most medicinal plants (~97%) have been investigated. As a result, many other natu-
ral sources have already been taken into consideration, especially those located in 
marine habitats, e.g. soft corals, sponges, jellyfishes, algae, and microorganisms.
[10]
 
Microorganisms which are living in different biological ecosystems represent a huge 
source of diverse bioactive secondary metabolites.
[11,12]
 The discovery of penicillin 
(1) from microorganisms had initiated the pharmaceutical research in screening new 
antibiotic source, and a massive screening of microorganism started after Second 
World War.
[13]
 The antibiotic activity of penicillin (1) is due to the -lactam ring. 
Cephalosporin C (2) is another example of -lactam antibiotics derived from micro-
organisms.
[14]
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Mycophenolic acid (MPA) (3) is a natural product-based medicine used in hu-
man-organ transplantation as an immunosuppressant. Mycophenolic acid (3) was 
first isolated by Italian physician Bortolomeo Gosio as early as 1893. In addition, it 
is the first purified antibiotic from microorganism.
[15]
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Daunorubicin (DNR) (4) and doxorubicin (DOX) (5) were the first effective an-
titumor drugs developed in pharmaceutical industry in the 1960s. They were isolated 
from Streptomyces peucetius. DOX (5) and DNR (4) belong to the group of an-
thracyclines consisting of a tetracyclic ring system and sugar moieties. However, 
their use is limited by cardiotoxic side effects.
[16]
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By 1990, about 80% of drugs have been derived from microorganisms. Length-
ening life expectancy of world population to over 77 years today is one of the most 
significant impacts of natural product-based drugs. However, there was about 30% 
drop in natural product-based drugs in clinical studies between 2001 and 2008.
[13]
 
The increase of resistant pathogen indicates an urgent demand to continue antibiotics 
discovery and development.
[17]
 On the other hand, genetic sequencing and biosyn-
thetic pathway manipulation maybe a solution for the discovery of next generation 
pharmaceutical agents.
[13, 18]
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Figure 1:  The major groups of antibiotics between 1940 and 2010 (Ref.
[17]
 mod-
ified)
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Figure 2:  Numbers of drugs approved in the United States between 1981 and 
2007 (according to
[13]
)
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1.2 Secondary metabolites from bacteria 
The history of natural products from bacteria started about 60 years ago. In 
1943, Selman Waksman and co-workers first reported the production of streptomycin 
(6) from Streptomyces griseus.
[19]
 This antibiotic had been used successfully in the 
treatment of tuberculosis.
[20]
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The genus of Streptomyces is the largest source of novel antibiotics from bacte-
ria since the first report of streptomycin (6) was published in 1942. Currently, many 
microbial-derived antibiotics are reported from species of this genus, and this has 
increased exponentially for the last two decades.
[21,22]
 In 2001, about 70% of all 
known antibiotics had been isolated from streptomycetes, and 4% of them were used 
clinically as human drugs.
[23]
 
Erythromycin A (7) is a macrolide antibiotic derived from marine Streptomyces, 
and widely used as antimicrobial agent. The structure of erythromycin A (7) consists 
of a glycosidic 14-membered ring macrolide. Macrolides are one group of secondary 
metabolites produced by Streptomyces. Woodward firstly introduced the term "mac-
rolide" for macrocyclic lactone antibiotics. The size of monolactone macrolides can 
be up to 62-membered cyclic systems.
[24]
 Additionally, most macrolide antibiotics 
have been reported to exhibit strong anti-inflammatory activity.
[25]
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Neopeltolide (8 ) had been isolated from a deep-water organism Daedalopelta 
sp. in north Jamaican coast. It had been also reported to show antifungal activity 
against Candida albicans having MIC of 0.62 g/mL.[26] 
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Arenicolides A-C (9-11) are 26-membered ring macrolides isolated from marine 
bacteria Salinispora arenicola. Among these macrolides, arenicolide A (9) was re-
ported to exhibit moderate activity against the human colon adenocarcinoma cell line 
HCT-116.
[27]
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Pimaricin (12) belongs to the group of polyene macrolide with 26-membered 
ring possessing antifungal activity.
[28]
 The pimaricin analogue JBIR-13 (13) isolated 
from Streptomyces bicolor NBRC 12746 has been reported to show antifungal activi-
ty against Candida albicans with a minimum inhibitory concentration (MIC) value of 
3.13 g/mL.[29] 
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Fiedler and co-workers have recently reported three new atacamycins A (14), B 
(15), and C (16), 22-membered macrolatones, as bioactive metabolites from Strepto-
myces sp. C38. Moderate antitumor activity had been exhibited by atacamycins A 
(14) and B (15) against tumor cell lines.
[30]
  
Some antimicrobial agents have been reported as inhibitors of -ketoacyl-(acyl-
carrier-protein (ACP)-synthase I/II (FabF/B), which plays an important role in bacte-
rial fatty acid biosynthesis.
[31]
 Platensimycin (17) is an example of these inhibitors 
and was isolated independently in our group.
[32]
 Interestingly, it has been reported to 
demonstrate no cross-resistance to methicillin resistant Staphylococcus aureus 
(MRSA), vancomycin-resistant Enterococcus (VRE) and other tested antibiotic-
resistant strains.
[31, 33]
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Ionophore antibiotics are another type of antibiotics of bacterial origin, which 
can act as mobile ion carriers in complex form within cell membranes.
[34]
 Nonactin 
(18) is an example with antitumor activity: it was firstly isolated and reported from 
Streptomyces griseus; in addition to (-)-nonactic acid (19), the monomer of nonactin 
(18).
[35,
 
36]
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Alkaloids as another class of natural products are synthesized by both marine 
and terrestrial organisms in all evolutionary phases. Indole alkaloids in particular are 
present in a number of drugs which are currently on the market.
[37]
 -Hydroxy-N-
acetyltryptamine (20) and staurosporine (21) are two indole alkaloids isolated from 
Streptomyces staurosporeus.
[37,
 
38]
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A new catechol derivative, vanchrobactin (22), has been isolated from the bacte-
rial fish pathogen Vibrio anguillarum serotype O2. Vanchrobactin (22) belongs to 
the siderophore group produced by bacteria as iron chelator.
[39,
 
40]
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Vitamin B2 or riboflavine (23) is one of vitamins required in human nutrition 
and is found in both plants and bacteria. In bacteria, riboflavine (23) is used as an 
intercellular signalling agent to regulate the expression of genes in local populations. 
This feature is responsible for the coordination behaviour of gene or protein in motil-
ity, mating, stress responses and biofilm formation.
[41]
 Currently, it has been reported 
that a deficiency of riboflavine (23) may increase the risk of cancer and cardiovascu-
lar diseases.
[42] 
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Six new chromophenazines A (24), B (26), C (25), D (27), E (28) and F (29) 
were isolated recently in our group from the terrestrial Streptomyces sp. Ank 315. 
Phenazine derivatives have been reported to exhibit broad-range activities such as 
antioxidant, neuroprotectant, antimicrobial, antiviral, antiparacitic, antitumor and 
antimalaria. Among the six chromophenazines, only chromophenazine D (27) 
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showed moderate antimicrobial activity against Bacillus subtilis, Escherichia coli, 
and Mucor miehei (Tü 284).
[43]
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Three new angucycline antibiotics N05WA963A (30), B (31) and D (32) have 
been isolated from the culture broth of Streptomyces sp. N05WA963. In addition, 
they have been also reported to show potent antitumor activity against several cancer 
cell lines such as SW620, K-562, MDA-MB-231, YES-4, T-98 and U251SP.
[44]
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Recently, leinamycin (33), a new hybrid peptide-polyketide antibiotic with anti-
tumor activity, has been isolated from Streptomyces atroolivaceus S-140. The bio-
synthesis of leinamycin (33) is derived from the polyketide pathway. Microbial 
polyketides are a large group of natural products and many of them are in clinical use 
as drugs.
[45]
 Most microbial peptide antibiotics are biosynthetically formed as nonri-
bosomal metabolites produced in a multi-functional enzymatic process.
[46]
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Two cyclic octapeptides, thalassospiramides A (34) and B (35) were isolated re-
cently from a new marine-derived -proteobacterium of the Thalassospira genus. 
They exhibited immunosuppressive activity in an interleukin-5 production inhibition 
assay.
[47]
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Thiopeptides or thiazolylpeptides are natural bacterial antibiotics, which are 
produced by filamentous prokaryotic organisms. Philipimycin (36) is an example of 
this group isolated from Actinoplanes philippinensis MA7347, with strong antibacte-
rial activity against Gram-positive bacteria with MIC values ranging from 0.015 to 1 
g/mL.[48] 
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Val-geninthiocin (37) is another thiopeptide antibiotic, which was recently iso-
lated in our group from the terrestrial Streptomyces sp. RSF18.
[49]
 This type of anti-
biotics is also strongly active as antimalarial agent against Plasmodium falcipa-
rum.
[50]
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Kettapeptin (38), a new cyclic hexadepsipeptide antibiotic, had been isolated 
and characterized in our group from the terrestrial Streptomyces sp. GW 99/1572 by 
Maskey. It showed antibacterial and antitumor activities against Bacillus subtilis, 
Streptomyces viridochromogenes (Tü 57), Staphylococcus aureus, Escherichia coli 
and several human cancer cell lines.
[51]
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Azoxy compounds are another type of microbial-origin antibiotics exhibiting 
several biological activities: They are  e.g. antiviral, antitumor, antifungal and 
antinematodal.
[52]
 Valanimycin (39)
[53]
 and elaiomycin (40) are examples with anti-
cancer activity among the azoxy derivatives isolated from Streptomyces sp.
[52, 54]
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Maniwamycins A (41) and B (42) are further antifungal azoxy antibiotics.
[55]
 
They were isolated from the terrestrial Streptomyces prasinopilosus.
[56]
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Two new derivatives of elaiomycins B (43) and C (44) have been isolated re-
cently from Streptomyces sp. BK 190. They have been reported to show slight anti-
microbial activity against Staphylococcus lentus DSM 6672.
[57] 
Further azoxy antibi-
otics have been reported recently.
[58]
  
Nucleobase-containing natural products e.g. purine and adenosine analogues 
have been of interest due to their significant pharmacological properties.
[59,60]
 Sine-
fungin (45) is a natural nucleoside first reported from Streptomyces griseolus in 
1973. It demonstrated potent antifungal, antiviral, and antiparasitic activities.
[61]
 (-)-
Aristeromycin (46) is another example of natural nucleoside analogues and was first 
isolated from Streptomyces citricolor. It showed antiviral and inhibitory activities 
against cellular enzyme S-adenosyl-L-homocysteine hydrolase (SAH).
[60]
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Cyanobacteria are an alternative and also prolific microbial source of natural 
products.
[62]
 Recently, two credneramides A (47) and B (48) containing a vinyl chlo-
ride unit have been reported from a Papua New Guinea cyanobacterium, cf. Tricho-
desmium sp. nov. They were reported additionally as inhibitor of calcium oscillations 
in cerebrocortical neurons of mice.
[63]
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1.3 Natural products from fungi 
After the discovery of penicillin (1) from Penicillium notatum in 1928 by Alex-
ander Fleming, fungi have contributed a highly significant amount of drugs in the 
pharmaceutical industry for the treatment of human diseases. Currently, terrestrial 
and marine fungi were reported to produce many important and useful substances for 
medicines and plant protections.
[64, 65] 
 
 
Figure 3:  Percentages of new metabolites based on fungi sources until mid 
2010.
[65]
 
Enniatin B (49) and bassianolide (50) are examples of fungi-originated cy-
clodepsipeptides. Enniatins act as ionophores in biological membranes, inhibitors of 
the ABC-transporter Pdr5p and topical agent for the treatment of respiratory infec-
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tions. Bassianolide (50) was toxic to insect larvae and some cancer cell lines in 
vitro.
[66]
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Fusaristatins A (51) and B (52) are two new cyclic lipopeptides isolated in our 
group from the endophytic fungus Fusarium sp. YG-45 in rice medium. Both 
fusaristatins A (51) and B (52) were active as anticancer agent against lung cancer 
cells LU 65. Additionally, fusaristatin B (52) showed moderate activity against 
topoisomerases I and II, respectively.
[67]
  
Two known xanthones, sterigmatocystin (53) and secosterigmatocystin (54), 
were recently re-isolated in our group in a screening for insecticidal compounds from 
the endophytic fungus Podospora sp. Sterigmatocystin (53) revealed strong larvaci-
dal activity against Anopheles gambiae indicating potential insecticidal use in order 
to control the vectors of malaria, dengue fever, yellow fever, and several other dis-
eases caused by mosquitoes.
[68]
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Recently, four new pyridine and tetramic acid alkaloids namely torrobiellones A 
(55), B (56), C (57) and D (58) have been isolated from the fungus Torrobiella sp. 
BCC 2165. Torrobiellone A (55) has been reported to show antimalarial activity 
against Plasmodium falciparum.
[69]
 In addition, a unique tetramic acid derivative, 
cryptocin (59), has been isolated from the endophytic fungus Cryptosporiopsis 
quercina. It exhibited antifungal activity against the plant pathogenic fungus Pyricu-
laria oryzae.
[11]
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Humicolone (60) had been isolated from the terrestrial fungus Humicola grisea 
Traaen. It exhibited cytotoxicity against KB cell line with IC50 values ranging be-
tween 1 and 5 ppm.
[70]
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Two new cyclohexanone epoxide derivatives, jesterone (61) and hydroxy-
jesterone (62) were isolated from the endophytic fungus Pestalotiopsis jesteri found 
in Papua New Guinea. Jesterone (61) specifically showed antimycotic activity 
against oomyceteous plant pathogenic fungi Pythium ultimum, Aphanomyces sp., 
Phytophthora citrophthora, and Phytophthora cinnamomi.
[71,72]
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The marine endophytic fungus Gymnascella dankaliensis from the Japanese 
sponge Halichondria japonica produced an unusual steroid derivative, dankasterone 
(63). Dankasterone (63) displayed cytotoxic activity against human cancer lines.
[65,73]
 
O
O
O
 
63   
Recently, three new cerebroside derivatives, alternarosides A (64), B (65) and C 
(66), were reported from the marine fungus Alternaria raphani. They displayed weak 
antimicrobial activity against bacteria (Escherichia coli, Bacillus subtilis) and the 
fungus Candida albicans.
[74]
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Two new lactone derivatives, 1893 A (67 ) and B (68 ), have been reported from 
an unidentified endophytic fungus No. 1893. The fungus was isolated from an estua-
rine mangrove Kandelia candel.
[75]
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Recently, four new 10-membered lactones A (69), B (70), C (71) and D (72) 
have been reported from marine-derived endophytic fungus Curvularia sp. The fun-
gus was isolated from the marine red alga Acanthophora spicifera.
[76]
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The endophytic fungus Hormonema sp. (ATCC 74360) has been reported to 
produce a new antifungal triterpenoid glycoside, enfumafungin (73). Its activity 
against Aspergillus fumigatus is an interesting feature.
[75]
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Recently, Verma and coworkers have isolated piperine (74) from an endophytic 
fungus Periconia sp. Piperine (74) is the alkaloid and pungent principle of black 
pepper and used in traditional medicine as antioxidant, analgesic, antidepressant and 
antibacterial. In addition, piperine (74) has shown strong antimycobacterial activity 
against Mycobacterium tuberculosis and Mycobacterium smegmatis.
[77]
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Lin and co-workers have reported the isolation of a new alternariol derivative, 
2240B (75) from Chinese endophytic fungus No. 2240. Alternariol has been reported 
as a mycotoxin contaminating fruits and cereals. In addition, alternariol 2240B (75) 
showed weak activities against two tumor cell lines, KB and KBv200.
[78]
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Jang and co-workers have reported a new pentacyclic ring system, fusarisetin A 
(76), from Fusarium sp. FN080326. It had shown inhibitory activity against MDA-
MB-231 cells.
[79]
 
2 Scope of the present work 
The current development of antibiotic resistance has become a major problem in 
modern medical therapy. In responding to this challenge, there is an urgent need to 
search for new sources and leads. Especially microorganisms are still a potent source 
of bioactive compounds with wide-ranging applications as antibiotics, agrochemi-
cals, immunosuppressant, antiparasitic, and anticancer agents.
[75] 
Despite of the short period of research on marine and terrestrial natural products, 
more than 230,000 compounds have been published within 80 years.
[80]
 Moreover, 
many of them possess unique functional groups or rare skeletons as well as potent 
biological activities. It is noteworthy that presently published new compounds with 
novel or rare skeletons are almost exclusively found in marine organisms.
[81]
 Alt-
hough, soil has been a common source to isolate microorganisms, living plants, leaf 
litter and dung have been reported as other promising environment of organisms.
[82]
 
Accordingly, the main objective of the present investigation is concerned with 
the isolation and structure elucidation of biologically active and preferably new sec-
ondary metabolites from bacteria and endophytic fungi. This study was focussed 
mainly on the genus Streptomyces collected from terrestrial and marine sources, and 
terrestrial endophytic fungi. 
To achieve this goal, chemical and biological screenings should be applied in 
such a way that minimizes the time and gets a maximum of results. For this reason, a 
'horizontal screening' was selected to be applied: having few biological tests against 
Gram-positive and Gram-negative bacteria, fungi and yeasts, microalgae and brine 
shrimp, the antibacterial, antifungal, phytotoxic and cytotoxic activities are covered, 
and results can be used as a guide for further detailed investigations. 
Microorganisms such as bacteria and endophytic fungi have proven as bioactive 
metabolite producers. Therefore, there are logical approaches to investigate selected 
terrestrial and marine-derived bacteria and endophytic fungi. 
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 After selecting the strains based on the chemical and biological screenings, 
the fermentation on large scale is performed in order to isolate the metabo-
lites. 
 The crude extracts obtained from fermentation are then separated and purified 
via different chromatographic techniques i.e. silica gel, Sephadex LH-20, RP-
18 columns, HPLC, PTLC. 
 Pure components are identified spectroscopically e.g. by NMR and MS tech-
niques, and guided by dereplication database software such as AntiBase, 
Chemical Abstracts (SciFinder), and the Dictionary of Natural Products 
(Chapman & Hall). 
 Finally, the isolated pure metabolites are subjected to bioassays in order to 
characterize the biological activity against bacteria, fungi, algae, and brine 
shrimps (Artemia salina). 
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3 General techniques 
3.1 Collection of strains 
All the strains (bacteria and fungi) in this research project were obtained via co-
operations with various microbiological groups, summarized as follows:  
 The terrestrial Streptomyces spp. (code beginning with Ank) were ob-
tained from and taxonomically determined by Prof. Dr. H. Anke, Institute 
for Biotechnology and Drug Research, Kaiserslautern, Germany. The ter-
restrial Streptomyces spp. (code beginning with GT) were received from 
the Hans-Knöll-Institute, Germany. The terrestrial Streptomyces spp. 
(code beginning with GW) were obtained from the laboratory of Dr. Iris 
Grün-Wollny, Giessen, Germany. 
 The marine Streptomyces spp. (code beginning with B) were obtained 
from the collection of Dr. E. Helmke, Alfred-Wegener Institute for Polar 
and Marine Research, Bremerhaven, Germany. 
 Some endophytic fungal strains were isolated from medicinal plants col-
lected in the Botanical Garden in Göttingen, in Cameroon and in Kenya 
and will also be discussed here. 
3.2 Strategic procedure in evaluating the selected strains 
It was essential to perform a well-defined strategy for a better evaluation of the 
samples in order to select the most suitable one from a large number of strains. This 
purpose can be achieved via the combination of simple bioassays and chemical 
screening techniques. Then, the cultivation of the selected strains was scaled up fol-
lowed by the isolation of the metabolites. Finally, the activity tests for the pure com-
pounds were carried out after the structure elucidation was performed. 
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Bacterial collection 
Storage 
Small-scale fermentation 
Freez-drying 
Extraction by ethyl acetate 
Chemical screening Biological screening 
Large-scale fermentation 
AntiBase, SciFinder 
Crude extract 
Isolation, purification 
Structure elucidation 
(NMR, MS data) 
Bioassay of pure substance 
 
Figure 4: General screening steps for the selected strains.
[83]
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3.3 Pre-screening 
For identification of the most promising candidates among the available cultures 
for further investigation, two different approaches can be applied, namely the biolog-
ical screening and the chemical screening. 
At the university level, the biological screening is performed in a 'horizontal' 
way with tests of low selectivity, to target a broad range of indications and to get 
rapidly activity results. In our group, agar diffusion tests were used in the screening 
of the crude extracts against Gram-positive and Gram-negative bacteria, fungi, mi-
croalgae (plants representatives), and brine shrimps (Artemia salina), to cover mi-
croorganisms, plants and higher organisms. The bio-autography method on TLC 
plates gave simultaneously additional information of bioactive components in the 
crude extracts. In case of interesting and positive results, the samples were sent to 
industrial partners for a more comprehensive 'vertical' screening e.g. for cytotoxicity 
tests (Oncotest GmbH, Freiburg) and agricultural application (BASF AG, Ludwigs-
hafen).
[84]
 
 
Figure 5: Principles of screening for activities of bioactive metabolites on univer-
sity and industry levels.
[84]
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Pharmaceutical or medical industries, on the other hand, conduct a 'vertical' 
screening. Their biological screening is performed by selective tests using receptors 
or enzymes as sites of actions with a large number of samples. Mainly due to time 
and resources constraints, horizontal screening was conducted at university level in 
order to retrieve a quick results of biological activities in a sample using a limited 
number of tested-indicator organisms.
[84]
  
3.4 Biological screening 
The strains were sub-cultured on agar plates for 3-7 days and microscopically 
controlled for contaminations. Then, small pieces of the agar culture were inoculated 
into 1 L Erlenmeyer flasks containing 250 mL of a suitable medium followed by the 
incubation on a rotary shaker at 28 °C. The resulting culture broth was lyophilised 
and the dried residue was extracted with ethyl acetate, which was then evaporated 
under reduced pressure. The crude extract was used for biological, chemical, and 
pharmacological screenings. For the biological activity tests, the agar diffusion tech-
nique was used with microorganisms and microalgae. In parallel, the cytotoxicity 
was evaluated against brine shrimps (Artemia salina).  
Microorganisms used for biological activity tests 
Bacillus subtilis 
Staphylococcus aureus 
Streptomyces viridochromogenes (Tü 57) 
Escherichia coli 
bacteria 
Candida albicans 
Mucor miehei (Tü 284) 
fungi 
Chlorella vulgaris 
Chlorella sorokiniana 
Scenedesmus subspicatus 
algae 
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3.5 Chemical screening 
The isolation and structure elucidation of secondary metabolites from microor-
ganisms are time consuming, multiple-step and expensive processes. Therefore, iden-
tification of known metabolites at the earliest stage from crude extracts or partially 
purified-fractions became an important issue. To achieve this, chemical screening via 
thin layer chromatography is one of the simplest and cheapest methods applied for 
the detection of chemical constituents in the crude extracts. After developing the 
TLC of the crude extract in a suitable solvent system (usually CH2Cl2/MeOH), the 
UV-lamp and spray reagents were used to visualize and localize the interesting 
zones. In our group, we use regularly the following spray reagents: 
 Anisaldehyde/sulphuric acid gives different colour reactions with many structural 
features. 
 Ehrlich's reagent is used for the specific detection of indoles, which turn to pink, 
orange, blue, or violet. Other heterocycles and anthranilic acid may turn yellow. 
 Concentrated sulphuric acid is applied for polyenes. Short conjugated chains 
show a brown or black colour while carotenoids turn to blue or green. 
 Peri-hydroxy-quinones turn to red, blue, or violet with sodium hydroxide. Deep 
red prodigiosins stain to yellow with base. 
 Chlorine/o,o'-dianisidine is a universal reagent for the detection of peptides. 
3.6 Cultivation and scaling-up 
After pre-screening of the strains, cultivating and scaling up steps of selected 
strains were performed for further investigation. Under certain circumstances, the 
optimisation of the culture conditions was needed in order to improve the microbial 
production of interesting natural metabolites. 
Well-grown agar cultures were used to inoculate 100 of 1 L Erlenmeyer flasks 
containing 250 mL medium at pH 7.8. Then, the cultures were cultivated on a linear 
shaker at 28 °C for 4 or 5 days. After harvesting, the culture broth was mixed with 
Celite (diatomaceous earth) and filtered over the filter press to separate the water 
phase and the biomass. The water phase was passed through an Amberlite XAD-16 
resin column followed by extraction with methanol. The biomass was exhaustively 
Isolation and purification work-up  35 
  
  
extracted with ethyl acetate and acetone. The organic phases were dried under re-
duced pressure and the dried-residue was used for the next separation steps. 
3.7 Isolation and purification work-up 
The technique applied for isolation and purification was dependent on the prop-
erties of the bioactive metabolites of interest e.g. the polarity and the amount of 
crude extracts. In general, the crude extract was subjected to silica gel column chro-
matography with a gradient of dichloromethane/methanol. After fractionation by 
column chromatography, the separated fractions were further subjected to size exclu-
sion chromatography using Sephadex LH-20. High recovery rate and minimum de-
compositions of the chemical constituents are the advantages of Sephadex LH-20. 
The next isolation methods may include preparative thin layer chromatography 
(PTLC), and column chromatography e.g. on RP-18, or again Sephadex LH-20 and 
silica gel columns. 
3.8 Dereplication technique 
Dereplication has been originally defined as the analysis of natural products, a 
fraction, or an extract using bioassays, spectroscopic and structural information, and 
comparing the information with internal and/or commercial databases, ascertaining 
whether the present metabolites are new or known compounds. The importance of 
dereplication in drug discovery continues to rise and became essential in rapid identi-
fication of compounds due to more natural products being isolated from a wider 
range of sources.
[85]
 
Currently, it has been reported that over 230,000 natural products have been iso-
lated as metabolites from plants and microorganisms. Therefore, it is essential to 
develop a method to identify structures of isolated metabolites rapidly.
[86]
 Previously, 
biological activity and resistance patterns were used as the procedure of dereplication 
in searching for new bioactive natural product.
[87]
 Nowadays, there are a number of 
databases being developed for dereplication of natural products. ChemIDplus is one 
among them, which provides some important features such as the structure, molecu-
lar formula, physicochemical properties, names, synonyms, CAS Registry Numbers, 
classification and locator codes.
[86]
 In our group, AntiBase has been used intensively 
for the dereplication of microbial products and limited secondary metabolites from 
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plants. It offers fast structural identification of natural compounds based on sub-
structures, high-resolution mass spectra, chemical shifts of 
1
H and 
13
C NMR spectra 
in ISIS/Base and ChemFinder formats. Currently, it covers over 39,000 natural prod-
ucts from microorganisms and higher fungi, which is very useful in identifying relat-
ed structures of natural compounds.
[88]
 The Dictionary of Natural Products (Chapman 
& Hall) database is another comprehensive dereplication tool of natural products 
covering over 230,000 compounds.
[86]
 However, the difficult sub-structure search 
and limited spectral information are the disadvantages of the Dictionary of Natural 
Products compared with AntiBase. 
4 Investigation of selected bacterial strains 
4.1 Marine Streptomyces sp. B8289 
TLC of the crude extract of the marine Streptomyces sp. B8289 showed some 
UV absorbing bands, which became blue, brown and red with anisaldehyde/sulphuric 
acid. The bioassay revealed weak activity against bacteria and fungi. 
The sub-culture on agar plates showed colonies with a white aerial mycelium af-
ter incubation on M2
+
 agar medium for 3 days at 28 ºC. The strain was cultivated in 
100 of 1 L Erlenmeyer flasks each containing 250 mL M2
+
 medium. The culture was 
fermented on a linear shaker (110 rpm) for 5 days at 28 ºC and the well-grown cul-
ture broth was mixed with Celite and filtered through a pressure filter. The filtered 
culture broth was passed through Amberlite resin XAD-16. The resin was washed 
with demineralised water and then eluted with methanol, whereas the biomass was 
extracted with ethyl acetate and acetone. Then, the organic extracts were evaporated 
to dryness under vacuum. 
The brown crude extract was then subjected to silica gel column chromatog-
raphy using dichloromethane and methanol, which gave four fractions. 
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Fat
Fraction I Fraction II Fraction IVFraction III
2-[5-(2-Oxo-propyl)-tetra-
hydro-furan-2yl]-propionic acid 
2-[5-(2-Oxo-propyl)-tetra-
hydro-furan-2yl]-propionic
acid methyl ester
B-8289
(25 L shaker)
Biomass Filtrate
Mixing with Celite and filtered by filter press
Extract. with EtOAc, evap. XAD-16 (MeOH,H2O), EtOAc , evap.
CC using silica gel (CH2Cl2:MeOH, gradient elution )
Crude extraxt 
(3.4 g)
Sephadex LH-20
(MeOH)
Sephadex LH-20
(MeOH)
2) Sephadex LH-20
    (MeOH)
1) Silica gel column
    (CH2Cl2:MeOH)
Homononactic acid methyl ester
Homononactic acid  
 Figure 6: Work-up scheme for marine Streptomyces sp. B8289 
4.1.1 2-[5-(2-Oxo-propyl)-tetrahydrofuran-2-yl]-propionic acid 
2-[5-(2-Oxo-propyl)-tetrahydrofuran-2-yl]-propionic acid (77) was obtained 
from fraction III as a 2:1 mixture of two diastereomers in form of a yellowish oil. It 
did not show a UV absorbing band, but turned reddish violet with anisalde-
hyde/sulphuric acid. The ESI mass spectrum delivered the molecular weight of 200 
Dalton and the HRESI mass analysis deduced the molecular formula as C10H16O4. 
The 
1
H NMR spectrum of the major isomer displayed the signal of an acidic 
proton as broad singlet at  8.84. Two oxy-methine multiplets were observed at  
4.27 and 4.04, and two methyl groups resonated at  2.16 and 1.14 as singlet and 
doublet, respectively. The remaining multiplets in the region of  2.77~1.54 compris-
ing of seven protons corresponded to three methylene groups and one methine ( 
2.50). 
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Figure 7: 
1
H NMR spectrum (CDCl3, 300 MHz) of 2-[5-(2-oxo-propyl)-
tetrahydrofuran-2-yl]propionic acid (77) 
The 
13
C NMR spectrum displayed two sets of each ten carbon signals, two of 
which were assigned as carbonyl groups at C 207.4 (ketone) and 179.5 (carboxylic 
acid), respectively. In addition, two oxycarbons and three methylene carbon signals 
appeared at C 80.4, 75.6, 49.6, 30.9, 28.5, respectively. A sub-structure search in 
AntiBase based on these spectroscopic data resulted in 2-[5-(2-oxo-propyl)-
tetrahydrofuran-2-yl]propionic acid (77) as suggested structure, which was further 
confirmed by comparison with authentic spectra and the literature.
[89]
 Other than in 
the sample of Shaaban,
[89]
 the 
13
C NMR spectrum of the sample isolated here showed 
most signal in duplicate, and also the protons H-2,5 showed four multiplets instead of 
two as in the reference sample. Zhang and Yadav in our group had also isolated 
compound 77 from Streptomyces sp. as a similar mixture of epimers.
[90]
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Figure 8: 
13
C NMR spectrum (CDCl3, 125 MHz) of 2-[5-(2-oxo-propyl)-
tetrahydrofuran-2-yl]propionic acid (77) 
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Compound 77 had been isolated previously in our group by Shaaban from Strep-
tomyces sp. Act8970; the cis-configuration at the tetrahydrofurane ring of 77 had 
been established on the basis of NOESY experiments.
[89] 
2-[5-(2-Oxo-propyl)-
tetrahydrofuran-2-yl]-propionic acid (77) showed weak biological activity against 
bacteria and fungi.  
4.1.2 2-[5-(2-Oxo-propyl)-tetrahydrofuran-2-yl]propionic acid methyl ester 
Compound 78 was separated from fraction II as yellowish oil by using Sephadex 
LH-20 column chromatography. It showed no UV absorbing bands but stained to 
violet with anisaldehyde/sulphuric acid. The high-resolution ESI mass analysis de-
livered a molecular formula of C11H18O4, which corresponded to a molecular weight 
of 214 Dalton. 
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The 
1
H NMR spectrum of 78 exhibited similar signals as 2-[5-(2-oxo-propyl)-
tetrahydrofuran-2-yl]-propionic acid (77), except for an additional singlet at  3.65 
(3H), suggesting the presence of a methyl ester group. A methyl ester was further 
supported by the presence of a carbon signal at C 52.1 as well as by the difference of 
m = 14 amu between 77 and 78, given by the mass spectrum. In addition, the 13C 
NMR spectrum of compound 78 was very similar to compound 77, but the protons 
H-2,5 showed four multiplets instead of two as in Shaaban's sample, indicating a 1:1 
sample of two diastereomers. 
 
Figure 9: 
1
H NMR spectrum (CD3OD, 300 MHz) of 2-[5-(2-oxo-propyl)-
tetrahydrofuran-2-yl]-propionic acid methyl ester (78) 
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Figure 10: 
13
C NMR spectrum (CD3OD, 125 MHz) of 2-[5-(2-oxo-propyl)-
tetrahydrofuran-2-yl]-propionic acid methyl ester (78) 
According to the HMBC spectrum of 78, the position of the methoxy group (C 
52.1) was established by a 
3
J cross-coupling signal from H3-4'' ( 3.65) to C-1" (C 
177.1). The acetyl group was further confirmed by the 
2
J cross signal between H3-1' 
( 2.15) and C-2' (C 210.0). This acetyl is attached directly to the methylene carbon 
C-3' (C 50.5) shown by 
3
J coupling from H3-1' to C-3'. Furthermore, the signal of H-
3" ( 1.10) showed 2J and 3J couplings to the ester carbonyl (C-1", C 177.1), the 
methine (C-2", C 46.8), and the oxymethine (C-2, C 82.3).  
Trials to determine the relative configuration were only partially successful: Di-
agnostic couplings in the NOESY experiment were the contacts between H-2 and H-
5, which were seen for both isomers; additionally, there was a weak cross signal be-
tween 1'-methyl and the methoxy group, indicating a cis-disubstitution at the tetrahy-
drofurane ring in both isomers and therefore a mixture of C-2" epimers. This agrees 
well with the assumption of (-)-nonactic acid (19) as precursor, which also occurs in 
form of the 2"-epimer. 
2-[5-(2-Oxo-propyl)-tetrahydrofuran-2-yl]-propionic acid methyl ester (78) has 
been obtained previously by esterification of 2-[5-(2-oxo-propyl)-tetrahydrofuran-2-
yl]-propionic acid (77) with diazomethane;
[89]
 it is reported here as new natural de-
rivative of nonactic acid (19) from bacteria. 
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Figure 11: HMBC spectrum (CD3OD, 600 MHz) of 2-[5-(2-oxo-propyl)-
tetrahydrofuran-2-yl]-propionic acid methyl ester (78) 
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Figure 12: Selected 
1
H-
1
H COSY (▬) and HMBC ( ) correlations of 2-[5-
(2-oxo-propyl)-tetrahydrofuran-2-yl]-propionic acid methyl ester (78) 
Compound 78 is a nonactic acid derivative, which may be biosynthesized from 
acetate, propionate or succinate. Nonactic acid is a building block of macrotetro-
lides.
[91]
 
4.1.3 Homononactic acid 
Compound 79 was isolated as yellowish oil; the HRESI mass analysis gave the 
molecular formula C11H20O4, corresponding to a molecular weight of 216 Dalton. 
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The 
1
H NMR spectrum revealed no aromatic or olefinic signals. Three oxygenated 
methine signals were observed at  4.06, 3.91, 3.64. In the region of  2.39~1.36 
with integration of nine protons, a series of multiplets was present, which corre-
sponded to the protons of three methylene and one methine groups. Two methyl sig-
nals appeared at  1.01 and 0.79 as doublet and triplet, respectively. 
 
Figure 13: 
1
H NMR spectrum (CDCl3, 300 MHz) of homononactic acid (79) 
The 
13
C NMR spectrum displayed 13 carbon signals, and one signal at C 177.8 
suggested the presence of a carboxylic acid carbonyl. Three oxygenated carbon at-
oms showed resonances at C 80.1, 76.6, and 70.1. The remaining carbon signals 
appeared in the aliphatic region comprising of one methine, four methylene and two 
methyl groups between C 44.9-9.7. A sub-structure search in AntiBase and compari-
son with an authentic spectrum led to homononactic acid (79) as the confirmed struc-
ture.
[89]
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Figure 14: 
13
C NMR spectrum (CDCl3, 125 MHz) of homononactic acid (79) 
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79   
Homononactic acid (79) had been reported first time as a microbial natural 
product by Prikrylova and co-workers from Streptomyces griseus. Compound 79 was 
isolated in mixture with nonactic acid (19) from Streptomyces griseus.
[92]
  
4.1.4 Homononactic acid methyl ester 
Homononactic acid methyl ester (80) was obtained as light yellow and non-UV 
absorbing oil. It stained to brown with anisaldehyde/sulphuric acid. The molecular 
formula of 80 was deduced from the (+)-HRESI mass analysis as C12H22O4, corre-
sponding to a molecular weight of 230 Dalton. Compound 80 exhibited 
1
H and 
13
C 
NMR spectra similar to homononactic acid (79), with three oxygenated methine, one 
non-oxygenated methine, two methyl, and four methylene groups. The only major 
difference in the NMR spectra was the presence of an additional singlet at  3.60 (C 
51.5) assigned for a methoxy group. 
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Figure 15: 
1
H NMR spectrum (CDCl3, 300 MHz) of homononactic acid methyl 
ester (80) 
 
Figure 16: 
13
C NMR spectrum (CDCl3, 125 MHz) of homononactic acid methyl 
ester (80) 
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80   
Homononactic acid methyl ester (80) was synthesized from homononactic acid 
(79) by treating with diazomethane at 25 ºC.
[92]
 Compound 80 had also been isolated 
first time in our group as a natural product from the marine-derived Streptomyces sp. 
Act8970.
[89]
 
4.2 Terrestrial Streptomyces sp. Ank86  
The antimicrobial assay of Streptomyces sp. Ank86 showed moderate activity 
against Streptomyces viridochromogenes (Tü 57), Bacillus subtilis, and Staphylococ-
cus aureus. TLC of the crude extract showed UV absorbing bands in the middle 
polar region, which changed to blue and violet by spraying with anisaldehyde/sul-
phuric acid solution after heating. The TLC also exhibited orange polar zones, which 
changed to deep red by moistening with concentrated sulphuric acid hinting to the 
presence of an actinomycin. 
Well grown agar plates of the marine Streptomyces sp. Ank86 were used to in-
oculate a 25 L shaker culture on M2 medium. After 6 days at 28 °C, the culture was 
harvested and mixed with Celite prior to filtering using a filter press. The water 
phase was passed through Amberlite XAD-16 resin followed by elution with metha-
nol. The biomass and filtrate were extracted separately with ethyl acetate. The com-
bined organic phases were evaporated to afford 2.4 g of crude extract, which was 
then subjected to column chromatography on silica gel to give four fractions. The 
fractions were further purified by using different chromatographic methods to get the 
pure components. 
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Ank 86
(25 l shaker)
Mycelium Filtrate
Mixing with Celite and filtered by filter press
Extract. with EtOAc, evap. XAD-16 (MeOH,H2O), EtOAc , evap.
CC using silica gel (CH2Cl2:MeOH, gradient elution )
Fraction I Fraction II Fraction III Fraction IV
Tryptophol 
Crude extraxt 
(2.4 g)
Sephadex LH-20
(MeOH)
1) Sephadex LH-20 
(MeOH)
Actinomycin D
Sephadex LH-20
(MeOH)
2) RP-18
4-Hydroxy-2-methoxyacetanilide
 
Figure 17: Work-up scheme for terrestrial Streptomyces sp. Ank86 
4.2.1 4-Hydroxy-2-methoxyacetanilide 
4-Hydroxy-2-methoxyacetanilide (81) was separated from fraction II by using 
Sephadex LH-20 and RP-18 columns as white solid. It was UV absorbing at 254 nm 
and gave no reaction with anisaldehyde/sulphuric acid. 
The 
1
H NMR spectrum demonstrated three aromatic protons at  7.56, 7.52, and 
6.85. The ABX spin pattern showed two ortho-coupled 1H doublets at  7.56 and 
6.85, along with one meta-coupled proton at  7.52 (J = 1.96). Additionally, the 
spectrum displayed two methyl singlets at  3.90 and 2.53, corresponding to methoxy 
and acyl (CH3CO) groups, respectively. 
EIMS showed the molecular ion peak at m/z 181. Additionally, the spectrum 
displayed fragment ions at m/z 166 and 151 (base peak) due to the loss of two methyl 
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fragments. A sub-structure search in AntiBase based on 
1
H NMR and mass spectra 
gave structure 81. Comparison with authentic spectra from our spectra collection 
confirmed this assignment. 
 
Figure 18: 
1
H NMR spectrum (CD3OD, 300 MHz) of 4-hydroxy-2-
methoxyacetanilide (81) 
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Compound 81 had been reported previously as a fungal metabolite
[93]
 and was 
reported here as a bacterial product. A trivial compound, tryptophol, was also isolat-
ed from this strain; it was often isolated in our group from bacteria.  
4.2.2 Actinomycin D 
Actinomycin D (82) was separated from fraction IV as reddish-orange solid us-
ing Sephadex LH-20 column chromatography; it gave an orange colour after staining 
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with anisaldehyde/sulphuric acid and heating. It was UV absorbing and showed no 
colour change with sodium hydroxide, but turned red with concentrated sulphuric 
acid. Actinomycins belong to a family of chromopeptide antitumor antibiotics and 
were isolated from many streptomycetes. The natural actinomycins all share the 
same phenoxazinone chromophore, varying only in the amino acid content of their 
two depsipentapeptide moieties.
[94,95]
 
The 
1
H NMR spectrum showed two ortho protons at  7.21 and 7.42 of a 
1,2,3,4-tetrasubstituted aromatic ring, and two 3H singlets at 2.25 and 2.57 for me-
thyl groups attached to an aromatic system. This is characteristic of the phenoxazi-
none chromophore in actinomycins. In addition, it depicted the signals of 4 NH 
groups as doublets between δ 7.60-8.15. It also exhibited eight hydrogen signals of 
oxygenated methines or α-amino acid protons at δ 6.03 (d), 5.96 (d), 5.25-5.15 (m, 2 
H), 4.78 (d), 4.73 (d), 4.61 (dd) and 4.49 (dd). The signals between δ 4.01-3.48 ex-
hibited many methylene and methine groups. Six methyl singlets were observed be-
tween δ 2.98-2.20, four of them for N-methyl groups and two for methyl groups at-
tached to an aromatic ring. Methylene groups appeared between δ 1.80 - 2.24 as mul-
tiplets with intensity of 6H. Additionally, the spectrum showed 5 signals between  
0.75 and 1.41 for five methyl groups. At highest field, the doublet of a methyl group 
was observed at δ 0.75. 
The ESI mass spectrum revealed the molecular ion peak at m/z 1255 [M+H]
+
, 
which corresponded to the molecular weight of 1254 Dalton. A sub-structure search 
in AntiBase and comparison the spectroscopic data with the authentic spectrum con-
firmed the structure as actinomycin D (82).
[94] 
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Figure 19: 
1
H NMR spectrum (CDCl3, 300 MHz) of actinomycin D (82) 
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82 
Actinomycin D (82) had been first isolated from Streptomyces chrysomallus in 
1949 and was synthesized by Brockmann and Lackner.
[94] 
Actinomycin D (82) has 
been used in clinical application as anticancer agent in treatments of Wilm's tumor 
and soft tissue sarcoma in children, and has anti-HIV activity.
[96-98]
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4.3 Terrestrial Streptomyces sp. Ank68 
Pre-screening of the crude extract from Streptomyces sp. Ank68 revealed strong 
antibacterial activity against Bacillus subtilis, Staphylococcus aureus, and Strepto-
myces viridochromogenes (Tü 57), and moderate antifungal activity against Candida 
albicans and Mucor miehei (Tü 284). TLC of crude extract displayed UV absorbing 
zones at 254 and 366 nm, which changed to blue, red and black with anisalde-
hyde/sulphuric acid. 
The strain was cultivated on M2 medium in 25 L scale as shaker culture for five 
days at 28 ºC. The brown culture broth was mixed with Celite and filtered with the 
aid of a filter press. The water phase was passed through Amberlite XAD-16 column 
and eluted with methanol, while the mycelial residue was extracted with ethyl acetate 
and acetone. The crude extract was subjected to silica gel chromatography column 
using a dichloromethane/methanol gradient. 
Fat
Ank 68
(25 l shaker)
Mycelium Filtrate
Mixing with Celite and filtered by filter press
Extract. with EtOAc, evap. XAD-16 (MeOH,H2O), EtOAc , evap.
CC using silica gel (CH2Cl2:MeOH, gradient elution )
Fraction I Fraction II Fraction III
Fungichromin 
Crude extraxt 
(4.43 g)
1) Sephadex LH-20 (MeOH)
2) Sephadex LH-20 
(MeOH)
Actinomycin D
1) PTLC
2) RP-18
 
Figure 20: Work-up scheme for terrestrial Streptomyces sp. Ank68  
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4.3.1 Fungichromin 
Fraction III was worked up with Sephadex and RP-18 columns to isolate com-
pound 83 as yellow solid. It exhibited a highly polar blue UV fluorescent band (366 
nm), which turned green-blue with anisaldehyde/sulphuric acid. 
The 
1
H NMR spectrum revealed resonances of nine protons for five olefinic 
double bonds between  6.49-5.94 and eleven oxygenated methine groups between 
5.23-3.48, respectively. The multiplet of a methine proton attached to an sp
2
 carbon 
atom was observed at  2.45. In addition, the signals between  1.69-0.85 were as-
signed for methylene and three methyl groups. The 
13
C NMR spectrum revealed 35 
carbon signals, and one carbon atom signal at C 170.4 suggested the presence of a 
carbonyl group. The remaining carbon signals were one quaternary sp
2
 carbon at C 
138.7, nine sp
2 
methines, eleven sp
3
 methines, nine sp
3
 methylenes, and three methyl 
signals between C 134.9-11.6. 
 
Figure 21: 
1
H NMR spectrum (DMSO-d6, 300 MHz) of fungichromin (83) 
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Figure 22: 
13
C NMR spectrum (DMSO-d6, 125 MHz) of fungichromin (83) 
The ESI mass spectrum supplied a pseudo-molecular ion at m/z 671.4 [M+H]
+
 
and the high-resolution ESI mass analysis gave C35H59O12 as the molecular formula. 
The sub-structure search in AntiBase based on the 
1
H, 
13
C NMR and mass spectra 
afforded structure 83, which was confirmed by comparison with authentic spectra 
from our group and literature data.
[99]
 
OH OH OH OH OH OH
O O
OH
OH
OH
OH
1
2
512
14
16
18 22
26
28
29
1'
3'
6'
 
83   
Fungichromin (83) has been reported as one of several macrocyclic polyene an-
tibiotics, which showed antifungal, antiprotozoal and antinematodal activities.
[99]
 The 
biosynthesis of fungichromin (83) is derived from the polyketide pathway with 12 
acetate, one propionate and one intact octanoate units.
[100]
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4.4 Terrestrial Streptomyces sp. Ank248 
The chromatogram of the crude extract from Streptomyces sp. Ank248 showed 
several UV absorbing bands under the UV lamp, which turned blue, yellow, violet 
and red colours with anisaldehyde/sulphuric acid after heating. The biological activi-
ty test revealed activities against bacteria and Artemia salina, respectively. 
The well grown agar culture of the strain was fermented on LB-medium on a 10 
L scale for 4 days at 28 ºC and worked up to obtain 1.23 g of crude extract. 
Fat
N
H
O
OH
N
H
N
O
Ank 248
(10 L shaker)
Mycelium Filtrate
Mixing with Celite and filtered by filter press
Extract. with EtOAc & Acetone, evap. XAD-16 (MeOH,H2O), EtOAc , evap.
CC on  Sephadex LH-20 (CH2Cl2:MeOH, 6:4 )
Fraction I Fraction II Fraction III Fraction IV
Tryptophol 
Crude extraxt 
(1.23 g)
Sephadex LH-20
(MeOH)
1) Sephadex LH-20 
(MeOH)
Sephadex LH-20
(MeOH)
2) RP-18
 
Figure 23: Work-up scheme for terrestrial Streptomyces sp. Ank248  
4.4.1 1-Acetyl--carboline 
Compound 84 was isolated as brownish solid from fraction II, which turned yel-
low by staining with anisaldehyde/sulphuric acid. 
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The 
1
H NMR spectrum of 84 exhibited a broad signal at  10.28 (NH or OH), a 
doublet at  8.53 with a coupling constant of 4.9 Hz, which was less than ortho cou-
pling but bigger than the meta coupling of aromatic systems, suggesting a hete-
roaromatic ring. The resonances of a multiplet between  8.15-8.13 (2H), a doublet 
of doublet at  7.58 (2H), and a multiplet at  7.32 demonstrated a 1,2-disubstituted 
benzene ring. Furthermore, a 3H singlet at  2.88 indicated an acetyl group. 
 
Figure 24: 
1
H NMR spectrum (CDCl3, 300 MHz) of 1-acetyl--carboline (84)  
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84   
The sub-structure search in AntiBase with the 
1
H NMR data and comparing with 
the authentic spectra as well as literature data
[101,102]
 led to structure 84. This -
carboline alkaloid was previously reported as plant metabolite.
[103,104]
 Interestingly, 
bacteria and fungi produced also this type of compounds, which exhibited several 
pharmacological activities as enzyme inhibitors for monoamineoxidase and cAMP-
phosphodiesterase.
[105,106]
 -Carboline derivatives have also been reported to be used 
56  Investigation of selected bacterial strains 
 
 
as herbicides, fungicides and anti-tumor agents.
[107,108]
 In addition, 3-(hydroxy-
acetyl)-indole and tryptophol were also isolated from this strain. Ikeda and co-
workers had reported that 3-(hydroxyacetyl)-indole showed activities as antifungal 
and anticancer agent.
[108]
 
4.5 Terrestrial Streptomyces sp. Ank181 
In the primary screening, the thin layer chromatogram of the crude extract from 
Streptomyces sp. Ank181 showed UV absorbing bands at 254 nm, which stained to 
blue, deep green and violet in the less polar and middle regions, respectively, by 
spraying with anisaldehyde/sulphuric acid after heating. 
The antimicrobial assay exhibited a high activity against Candida albicans, 
moderate activity against E. coli, Streptomyces viridochromogenes (Tü 57), and Mu-
cor miehei (Tü 284). It showed a weak activity against Bacillus subtilis, and no activ-
ity against the Gram positive bacteria, Staphylococcus aureus and the algae, Chlorel-
la vulgaris, Chlorella sorokiniana and Scenedesmus subspicatus. 
A well grown agar culture of the strain was used to inoculate a 25 L jar fermen-
tor on M2 medium (pH 7.8). After 6 days at 28 °C, the culture broth was filtered. The 
resulting filtrate and mycelial residue were extracted separately using ethyl acetate 
and acetone giving a brown crude extract after evaporation under vacuum. The re-
sulting extracts showed a similar TLC pattern and were therefore combined. The 
crude extract was then chromatographed on silica gel (column) with a dichlorome-
thane/methanol gradient as shown in the work up scheme. 
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Figure 25: Work-up scheme for terrestrial Streptomyces sp. Ank181  
4.5.1 Reductiomycin 
Fraction II was subjected to a Sephadex LH-20 column to isolate reductiomycin 
(85) as yellow needle-shaped crystals. It showed a UV absorbing band and a deep 
green colour reaction by spraying with anisaldehyde/sulphuric acid. 
The 
1
H NMR spectrum showed a broad singlet of an H/D exchangeable proton 
at  13.76 and a further broad NH singlet at  7.68. The two doublets at  7.50 (3J = 
15.1 Hz) and  6.01 (3J = 15.1 Hz) each with intensity 1H were due of a trans-
disubstituted ,-unsaturated carbonyl derivative. The 3H singlet at  2.10 indicated 
a methyl group connected with an sp
2
 carbon atom. One of the two diastereotopic 
protons of a methylene group (H-3') showed doublets of a doublet at  3.05. The two 
methylene groups CH2-4, CH2-5 and one proton of CH2-3' showed a multiplet at  
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2.60. The 
1
H NMR spectrum also showed a singlet at  6.90 for the sp2 attached pro-
ton H-5' and doublets of a doublet at  6.70 for the anomeric proton H-2'. 
 
Figure 26: 
1
H NMR spectrum (CDCl3, 300 MHz) of reductiomycin (85) 
The ESI mass analysis delivered an odd molecular weight of 293 Dalton indicat-
ing the presence of nitrogen. The substructure search in AntiBase using these spectral 
data resulted in reductiomycin (85) which was further confirmed by comparing with 
authentic spectra as well as literature data.
[101]
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85   
Reductiomycin (85) is classified as antibiotic active against Gram-positive bac-
teria, fungi, the Newcastle disease virus and certain yeasts. Reductiomycin (85) 
showed a low acute toxicity (LD50) intraperitoneally in mice of about 80 mg/kg.
[109]
 
Chemically, reductiomycin (85) consists of two unique moieties, an unusual acet-
oxydihydrofuran and 2-amino-3-hydroxycyclopent-2-enone.
[110]
 The acetoxydihydro-
furanis also present in other compounds such as oudenone (an inhibitor for tyrosine 
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hydroxylase) and reductic acid (a reducing agent). The acetoxydihydrofuranmoiety 
seems to play an important role in their biological activities. The 2-amino-3-
hydroxycyclopent-2-enone moiety has shown to be present in various antitumor anti-
biotics including pyrrolo[1,4]benzodiazepine antibiotics, mitomycin, ansamitocin 
and naphthyridinomycin.
[111]
 In addition, 2,3-dihydroxybenzoic acid and indole-3-
carboxylic acid were also isolated from this strain. 
4.6 Ruminal bacterium Enterobacter amnigenus ZIA 
Ruminants such as cattles, sheep, buffaloes, deer, goats, and camels have a 
unique digestive system. They have a stomach with four compartments, and the 
rumen is one of them. The rumen contains microorganisms that are able to digest 
cellulose.
[112]
 Enterobacter is one genus among them, Gram-negative, facultatively 
anaerobic and rod-shaped bacteria.
[113]
 
Enterobacter amnigenus ZIA was isolated from the rumen of a Tunisian cow. 
Pre-screening of crude extract showed no biological activity against different micro-
organisms, but TLC of the crude extract showed UV absorbing bands at 254 nm, 
which stained to blue, red, brown and green with anisaldehyde/sulphuric acid. 
The strain was fermented on a 10 L scale in LB medium as shaker culture for 4 
days at 28 ºC. The culture broth was harvested and filtered to separate the cell mass, 
which was later extracted with ethyl acetate and acetone, respectively. The culture 
filtrate was then passed through Amberlite XAD-16 and eluted with 10 L methanol. 
The methanol extract was concentrated by using a rotary evaporator under reduced 
pressure. The organic phases were then mixed prior to monitoring by TLC to yield 
3.3 g of crude extract. TLC of the crude extract on a silica gel column using a 
CH2Cl2-MeOH gradient with increasing polarity resulted in four sub-fractions (I-IV), 
as monitored by TLC. 
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Crude
extraxt (3.3 g)
Butyl glycoside 
Enterobacter amnigenus
(10 L    shaker)
Mycelium Filtrate
Mixing with Celite and filtered by filter press
Extract. with EtOAc and
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XAD-16, MeOH , evap.
CC using silica gel (CH2Cl2:MeOH, gradient elution
)
Fraction I Fraction II Fraction III
Uracil 
Sephadex
LH-20 (MeOH)
Sephadex
LH-20  (MeOH)
Hypoxanthine
1) Sephadex LH-20
(MeOH)PHB
polymer
Tyrosol
2) RP-18 (10%
MeOH in H2O)
liquid
Indole-3-acetic acid
Fat
Sephadex
LH-20 (MeOH)
Sephadex
LH-20 (MeOH)
 
Figure 27: Work-up scheme for ruminal bacterium Enterobacter amnigenus ZIA  
4.6.1 Poly-(hydroxybutyric acid) (PHB) 
Compound 86 was obtained as white precipitate from sub-fraction II after being 
subjected to Sephadex chromatography. The 
1
H NMR spectrum showed three signals 
in the aliphatic region at  5.20 (m, 1H), 2.45 (dd, 2H) and 1.22 (d, 3H). A sub-
structure search in AntiBase and comparison with the authentic spectra
[114]
 as well as 
the literature data
[115]
 suggested poly-(hydroxybutyric acid) (86) as the structure. 
Poly-(hydroxybutiric acid) (86) has been isolated in our group from both terrestrial 
and marine-derived Streptomyces sp.
[115]
 The high-polymeric variety is used as bio-
logically degradable and environmentally safe plastic material from microorgan-
isms.
[115]
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Figure 28: 
1
H NMR spectrum (CDCl3, 300 MHz) of poly-(hydroxybutyric acid)  
(86) 
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86   
In addition, indole-3-acetic acid, uracil, tyrosol and hypoxanthine were isolated 
separately from different fractions during the work-up of the strain. They are often 
isolated as trivial metabolites from bacteria. 
4.6.2 Butyl glycoside 
Compound 87 showed no UV absorption and stained to green with anisalde-
hyde/sulphuric acid. It was isolated as oily compound from sub-fraction IV after pu-
rification by using Sephadex and RP-18 chromatography. The high-resolution ESI 
mass analysis delivered a quasi-molecular ion peak at m/z 259.11536 [M+Na]
+
 cal-
culated for C10H20O6Na as molecular formula. 
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The 
1
H NMR spectrum displayed resonances of a doublet of an anomeric proton 
at  4.72 (d, J = 1.5 Hz), and multiplets of five oxygenated methines and two oxy-
genated methylene groups between  3.81-3.39, which suggested the presence of a 
sugar moiety. In addition, it showed two multiplets and one triplet of two methylenes 
and a methyl group at  1.56, 1.41 and 0.93, respectively. 
 
Figure 29: 
1
H NMR spectrum (CD3OD, 300 MHz) of butyl glycoside (87) 
The 
13
C NMR spectrum revealed ten signals. Seven of them were due to oxy-
genated carbon atoms. The resonance at C 101.5 was characteristic of the acetal car-
bon in a sugar skeleton. The other oxygenated carbon signals were observed at C 
74.5 (CH-2'), 72.6 (CH-3'), 72.3 (CH-4'), 68.6 (CH-5'), 68.2 (CH2-1), and 62.9 (CH2-
6'), respectively. Additionally, three signals at C 32.7, 20.5, and 14.3 were assigned 
as two methylenes and one methyl group of an aliphatic chain. The sub-structure 
search in AntiBase and the Chemical Abstracts based on these spectroscopic data of 
87 resulted in no hits, so that the compound was identified as a new n-butyl hexopy-
ranoside. The sugar part was not determined due to limited amount of the compound, 
but an identical butyl glycoside (87) has been isolated in parallel from another rumi-
nal bacterium Enterobacter amnigenus ZIH and was fully characterised by 2D 
NMR.
[116]
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Figure 30: 
13
C NMR spectrum (CD3OD, 125 MHz) of butyl glycoside 87 
O
OH
OH
OH
OH
O CH
3
1 3
1'
3'
5'
6'
 
87   
Alkyl glycosides are present in nature as glycolipids with rhamnose, sophorose 
and trehalose as carbohydrate units. They show surfactant behaviour when the alkyl 
chain consists of at least four carbon atoms and are biodegradable and less toxic.
[117-
119]
   
4.7 Terrestrial Streptomyces sp. Ank75 
The terrestrial Streptomyces sp. Ank75 formed on M2 agar medium a white aeri-
al mycelium within 3 days at 28 ºC. The crude extract of the strain showed activities 
against Candida albicans, Mucor miehei (Tü 284), Chlorella vulgaris, Chlorella so-
rokiniana, but was inactive against bacteria and Artemia salina (brine shrimp test). 
The Ank75 strain was fermented in 25 L scale on M2 medium for 5 days at 28 
ºC. The culture broth was filtered over Celite and the water phase was adsorbed on 
Amberlite XAD-16 resin and eluted with methanol after washing with demineralised 
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water prior to the elution with methanol. The biomass was exhaustively extracted 
with ethyl acetate and acetone. The thin layer chromatograms of crude extract from 
both organic residues were identical, thus the extracts were combined for further 
work-up procedure. The crude extract was subjected to silica gel column chromatog-
raphy using a dichloromethane/methanol gradient to afford four fractions, which 
were further purified via different chromatography methods to obtain the pure me-
tabolites (see work-up scheme). 
Fat
Fraction I Fraction II Fraction IVFraction III
OH
O
OH
Benadrostin
Azoxy alkene Azoxy ketone
OH
OH
NHO
NH
2
O
OH
OH
NH
2
O
OH
OH
OHO
Fraction V
Ank75
(25 L shaker)
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(5.4 g)
Sephadex LH-20
(MeOH:CH2Cl2; 6:4)
Sephadex LH-20
(MeOH)
2) RP-18 (MeOH:H2O)
1) Sephadex LH-20
    (MeOH)
2) RP-18 (MeOH:H2O)
1) Sephadex LH-20
    (MeOH)
N6,N6-Dimethyladenosine
 
Figure 31: Work-up scheme for terrestrial Streptomyces sp. Ank75  
4.7.1 Benadrostin 
Compound 88 was isolated as white solid and showed an UV absorbing spot, 
which turned violet with anisaldehyde/sulphuric acid. The HRESI mass analysis de-
livered C8H5NO4 as the molecular formula. The 
1
H NMR spectrum displayed two 
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doublets of doublets and one triplet at  7.35 (J = 7.5 and 1.7 Hz), 7.24 (J = 7.9 and 
1.7 Hz), and 7.18 (J = 7.7 Hz). Furthermore, a broad singlet of an H/D exchangeable 
proton was observed at  11.17. The sub-structure search in AntiBase based on these 
data resulted in benadrostin (88) as the coincident structure to the spectroscopic data. 
This was further confirmed by comparison with authentic spectra and literature da-
ta.
[101, 120]
 
 
Figure 32: 
1
H NMR spectrum (DMSO-d6, 300 MHz) of benadrostin (88) 
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Benadrostin (88) had been reported as an inhibitor of poly(ADP-ribose)-
synthetase.
[121]
 This enzyme plays an importance role in the biosynthesis of the pro-
tein-bound homopolymer, poly(ADP-ribose) from nicotinamide adenine dinucleotide 
(NAD).
[121]
 Several nuclear proteins, i.e. histone and non-histone proteins, had been 
reported as the acceptors of these polymers.
[122-125]
 Hence, the biosynthesis of 
poly(ADP-ribose) has been suggested to be required for the efficient DNA repair.
[125]
 
Additionally, poly(ADP-ribose) synthetase had been also reported to play an im-
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portant role in some pathological conditions such as systemic lupus erythematodes, 
myasthenia gravis, and diabetes mellitus.
[126, 127]
 
4.7.2 2-O-Methylpyrogallol 
Compound 89 was isolated from fraction II as white solid, which stained to red 
with anisaldehyde/sulphuric acid. The HRESI mass analysis delivered a pseudomo-
lecular ion peak [M]
+
 (m/z 140.4730) corresponding to the molecular formula 
C7H8O3. The 
1
H NMR spectrum showed three proton signals in the aromatic region 
at  6.72 (t, 1H) and 6.37 (d, 2H) suggesting a 1,2,3-trisubstituted aromatic system, 
and one methoxy signal at  3.77. The 13C NMR spectrum exhibited four carbon sig-
nals at C 151.5, 124.5, 108.3 and 60.5, respectively. The sub-structure search in An-
tiBase based on the NMR and mass spectra did not give any appropriate structure, 
while the Chemical Abstracts suggested the synthetic 2-O-methylpyrogallol (89) as 
the most plausible candidate. The latter structure was confirmed indeed by compari-
son with the literature.
[128,129]
  
 
Figure 33: 
1
H NMR spectrum (acetone-d6, 300 MHz) of 2-O-methylpyrogallol 
(89) 
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Figure 34: 
13
C NMR spectrum (acetone-d6, 125 MHz) of 2-O-methylpyrogallol 
(89) 
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Compound 89 had been obtained by synthesis and had been also reported as a 
metabolite from gallic acid (90).
[129] 
It is for the first time isolated here from bacteria 
as natural product. 
4.7.3 N-Aminocarbonyl-2,3-dihydroxybenzamide 
Compound 91 was purified from fraction III by Sephadex LH-20 chromatog-
raphy using methanol as eluent. The 
1
H NMR spectrum exhibited ABC signals of a 
1,2,3-trisubstituted benzene ring at  7.45 (dd), 7.00 (dd) and 6.79 (t), respectively. 
The HRESI mass analysis delivered a pseudomolecular ion peak [M+H]
+
 (m/z 
197.05573) corresponding to the molecular formula C8H9N2O4. The sub-structure 
search in AntiBase based on the 
1
H NMR and mass spectra afforded N-
aminocarbonyl-2,3-dihydroxybenzamide (91) as the suggested structure. The struc-
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ture was then confirmed by comparing with authentic spectra and literature data.
[101]
 
Compound 91 had been isolated for the first time in our group from Streptomyces sp. 
Ank132.
[101]
 
 
Figure 35: 
1
H NMR spectrum (CD3OD, 300 MHz) of N-aminocarbonyl-2,3-
dihydroxybenzamide (91) 
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Compound 91 is a salicylurea derivative and has been used in food industry to 
preserve residues with high water content. The ability of acetylurea in preserving 
residues of grapes and apples can promote the growth of lactic bacteria and inhibit 
the growth of putrid bacteria.
[130]
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4.7.4 2,3-Dihydroxybenzamide 
Compound 92 was obtained as brownish UV active solid from fraction III after 
separation on Sephadex LH-20 using methanol. It showed no colour reaction with 
anisaldehyde/sulphuric acid. 
 
Figure 36: 
1
H NMR spectrum (CD3OD, 300 MHz) of 2,3-dihydroxybenzamide 
(92) 
 
Figure 37: 
13
C NMR spectrum (CD3OD, 125 MHz) of 2,3-dihydroxybenzamide 
(92) 
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Figure 38: HMBC spectrum (CD3OD, 600 MHz) of 2,3-dihydroxybenzamide 
(92) 
The 
1
H NMR spectrum displayed the ABC system of a 1,2,3-trisubstituted ben-
zene ring in the aromatic region. In the 
13
C NMR spectrum, it revealed seven signals, 
of four quaternary carbon atoms and three sp
2
 methines. One of the four quaternary 
carbon signals at C 174.8 was identified as carbonyl group, and two carbon signals 
in the aromatic region at C 151.6 and 146.8 were due to oxygenated quaternary sp
2
 
carbons. The remaining signals at C 121.9, 121.6, 119.2, and 116.0 were assigned as 
three sp
2
 methines and a quaternary sp
2
 carbon, respectively. According to HMBC 
correlations of 92, the positions of the carbonyl group were assigned through the 
3
J 
cross-signal between H-6 ( 7.33) and C-1' (C 174.8), and the 
3
J cross-signal be-
tween H-5 ( 6.64) and C-1 (C 116.0). The HRESI mass analysis delivered the mo-
lecular formula C7H7NO2. Based on the 
1
H NMR, 
13
C NMR, HMBC spectroscopic 
data and mass measurement, the isolated compound was assigned as 2,3-
dihydroxybenzamide (92), which was isolated here for the first time from a Strepto-
myces sp. 
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Figure 39: HMBC ( ) correlations of 2,3-dihydroxybenzamide (92) 
Similarly, compound 92 is also a salicylic acid derivative as well as compound 
91. It is known as sub-structure in various iron chelators of the catechol type.  
4.7.5 3-[(1Z)-1-Hexenyl-ONN-azoxyl]-1,2-butanediol 
Compound 93 was isolated as oil from fraction IV after purification on Se-
phadex LH-20 and RP-18 columns. It revealed UV absorption at 254 nm and stained 
to green with anisaldehyde/sulphuric acid. The molecular formula was deduced as 
C10H20N2O3 by high-resolution ESI MS of the pseudomolecular [M+Na]
+
 ion at m/z 
239.13680.  
The 
1
H NMR spectrum exhibited signals of olefinic protons at  6.78 and 5.78 
as doublet and multiplet, respectively. In the aliphatic region, the spectrum showed 
two multiplets of methine groups at  4.16 and 3.76, which may be attached to oxy-
gen or nitrogen. The remaining signals between  3.56-0.92 were assigned as four 
methylenes, and two methyl groups. The sub-structure search in AntiBase based on 
the 
1
H NMR and mass spectra resulted in 3-[(1Z)-1-hexenyl-ONN-azoxyl]-1,2-
butanediol (93). The structure was further confirmed by comparison with literature 
data.
[131]
 It has been reported that compound 93 was isolated from an "Actinomadu-
ra-like fungus" and showed antifungal activity,
[131]
 but it is for the first time here 
isolated from a terrestrial Streptomyces sp. It is the reduction product of LL-BH-
872a, and an isomer of 3-[(hex-1-enyl)-NNO-azoxy]-butane-1,2-diol. 
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Figure 40: 
1
H NMR spectrum (CD3OD, 300 MHz) of 3-[(1Z)-1-hexenyl-ONN-
azoxyl]-1,2-butanediol (93) 
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4.7.6 Bandamycin 
Working up fraction IV with Sephadex LH-20 and RP-18 columns afforded 
bandamycin (94) and additionally 3-[(1Z)-1-hexenyl-ONN-azoxyl]-1,2-butanediol 
(93) as yellow oils. It showed UV absorption at 254 nm and stained to green with 
anisaldehyde/sulphuric acid. 
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Figure 41: 
1
H NMR spectrum (DMSO-d6, 300 MHz) of bandamycin (94) 
Based on the 
1
H NMR spectra, both bandamycin (94) and 3-[(1Z)-1-hexenyl-
ONN-azoxyl]-1,2-butanediol (93) showed similar proton signals in the aliphatic re-
gion except of the olefinic protons. The 
1
H NMR spectrum of bandamycin (94) ex-
hibited two broad singlets at  4.73 and 4.48, which might be due to the presence of 
two hydroxyl groups. Two methylene and two methine groups bearing oxygen or 
nitrogen were observed at  4.10 (2H), 3.94 (1H), 3.55 (1H), and 3.34 (2H), respec-
tively. The remaining signals at  2.49, 2.40, 2.00, 1.01, and 0.92 were assigned for 
three methylene and two methyl groups. The carbon spectrum indicated the presence 
of ten carbon atoms: The carbon atom types were analysed by the HSQC spectrum 
implying the presence of four aliphatic carbons connected to heteroatoms, three ali-
phatic methylenes, and two methyls. 
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Figure 42: 
13
C NMR spectrum (DMSO-d6, 125 MHz) of bandamycin (94) 
In the HMBC spectrum, the position of the ketone carbonyl (C4', C 209.7) was 
assigned through correlations of 
2
J cross-signals between H-5' ( 2.40) and H-3' ( 
2.49) to C-4' (C 209.7), and 
3
J cross-signals between H2-2' ( 2.00) and H3-6' (0.92) 
to C-4' (C 209.7). The methyl doublet at  1.01 (C 11.6) correlated to C-3 (
2
J cou-
pling), and C-2 (
3
J coupling). In addition, 
2
J correlations of H-3 ( 3.94) and H2-1 ( 
3.34) to an oxygenated methine (C-2, C 73.0) were observed. Surprisingly, there 
was no COSY correlation between C-2,3, which indicated an orthogonal orientation 
due to steric hindrance or a hydrogen bridge. The HRESI mass analysis gave 
C10H20N2O4 as the molecular formula, which required two double bond equivalents. 
One of the double bond equivalents has been assigned to the keto carbonyl group and 
the other one could be due to an azoxy group. 
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Figure 43: HMBC spectrum (DMSO-d6, 600 MHz) of bandamycin (94) 
The presence of an azoxy group was further supported by an absorption band in 
the IR spectrum at 1500 cm
-1
, which is characteristic for the azoxy moiety.
[132]
 In 
addition, the absorption bands of carbonyl and hydroxyl groups appeared at 1710 and 
3420 cm
-1
, respectively.  
Two isomeric azoxy derivatives are possible: compound 94, or an isomer with 
the oxygen atom at the other nitrogen. According to shift calculations,
[133]
 the N
+
-O
-
 
unit causes a strong downfield shift both in the 
1
H and 
13
C spectra with respect to the 
other side. As this is the case for the compound investigated here, the structure 94 
shown in Figure 45 was the most plausible one for bandamycin. The cyclic oxa-
diaziridine isomers
[134, 135]
 of azoxybenzenes have been described, but are instable 
and can be excluded here. Bandamycin is a new antifungal agent from bacteria.  
According to AntiBase, there were about 20 compounds isolated from microor-
ganisms containing the azoxy unit.
[88]
 Helaly and co-workers reported the biosynthe-
sis of an aliphatic azoxy compound, elaiomycin (40), which is derived from n-
octylamine, L-serine, and acetate units.
[136]
 L-Serine and L-valine are the biosynthetic 
precursors of a related azoxy antibiotic, valanimycin (39).
[53, 136]
  
76  Investigation of selected bacterial strains 
 
 
 
Figure 44: IR spectrum (KBr disc) of bandamycin (94) 
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Figure 45: Selected 
1
H-
1
H COSY (▬) and HMBC ( ) correlations of 
bandamycin (94) 
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Figure 46: Formation of azoxybenzene by oxidation of aniline.
[137]
 
Terrestrial Streptomyces sp. Ank75  77 
  
  
The synthesis of azoxy compounds had been reported for the first time by Zinin 
in 1841. Zinin prepared azoxybenzene by the reduction of nitrobenzene under alka-
line conditions.
[138]
 Chang and Liu had synthesized azoxybenzenes via catalytic oxi-
dation of anilines with hydrogen peroxide.
[137]
 
4.7.7 N6, N6-Dimethyl-adenosine 
N
6
,N
6
-Dimethyl-adenosine (95) was obtained as pale yellow oil showing UV 
absorption at 254 nm. It stained to greenish yellow with anisaldehyde/sulphuric acid 
on the thin layer chromatogram. The 
1
H NMR spectrum revealed two singlets at  
8.18 and 8.16, one signal of an anomeric proton ( 5.94, d), four proton signals of 
three oxygenated methines and one oxymethylene group between  4.74 and 3.87, 
and one singlet at  3.34 with the intensity of six protons. The signals at  3.34 and 
3.47 were later assigned as two methyl groups attached to a nitrogen atom. The ESI 
mass spectrum delivered a pseudo-molecular ion peak at m/z 296 [M + H]
+
 corre-
sponding to C12H18N5O4 as the molecular formula from HRMS analysis. A search in 
AntiBase based on these spectroscopic data as well as by comparison with literature 
data resulted in N
6
,N
6
-dimethyl-adenosine (95) as the confirmed structure.
[139]
  
 
Figure 47: 
1
H NMR spectrum (CD3OD, 300 MHz) of N
6
,N
6
-dimethyl-adenosine 
(95) 
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Compound 95 was isolated in our group as microbial metabolite from both ter-
restrial and marine-derived Streptomyces sp. According to AntiBase
[88]
, there are at 
least 62 adenosine derivatives which have been isolated from microorganisms. 
4.8 Marine Streptomyces sp. B5798 
In the biological pre-screening, the crude extract of the marine Streptomyces sp. 
B5798 showed no activity against bacteria, fungi, and algae, but it was active against 
brine shrimps. The TLC of the crude extract revealed four UV absorbing bands at 
254 nm, which stained to violet, red, and deep brown with anisaldehyde/sulfuric ac-
id. 
The strain Streptomyces sp. B5798 formed white mycelial colonies after incuba-
tion on M2
+
 agar medium for 3 days at 28 ºC. This agar culture was then used to in-
oculate 25 L of M2
+
 medium with 50% artificial seawater. After 5 days, the culture 
broth was filtered over Celite to afford the water phase and the biomass. The water 
phase was passed through Amberlite XAD-16, which was then washed with water 
followed by elution with methanol. The biomass was extracted thoroughly with ethyl 
acetate and acetone. As the organic extracts of both water phase and biomass showed 
identical chromatograms, they were combined. This crude extract was fractionated 
on a silica gel column to obtain four fractions, which were further purified by various 
chromatographic techniques. 
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Fat
Macrolactin A
B5798
(25 l shaker)
Mycelium Filtrate
Mixing with Celite and filtered by filter press
Extract. with EtOAc, evap. XAD-16 (MeOH,H2O),
EtOAc , evap.
CC using silica gel (CH2Cl2:MeOH, gradient elution )
Fraction I Fraction II Fraction III Fraction IV
Crude extraxt 
(6.4 g)
Sephadex LH-20
(MeOH)
1) Sephadex LH-20
(MeOH)
Sephadex LH-20
(MeOH)
2) RP-18
p-Hydroxyphenylacetic acid
Indole-3-carboxylic acid
Indole-3-acetic acid
 
Figure 48: Work-up scheme for marine Streptomyces sp. B5798 
4.8.1 p-Hydroxyphenylacetic acid 
Working up fraction II by Sephadex column chromatography resulted in com-
pound 96 as white solid. It showed a UV absorbing zone at 254 nm and stained to 
pink with anisaldehyde/sulphuric acid. The 
1
H NMR spectrum exhibited two dou-
blets and one singlet with intensity of each two protons in the aromatic and aliphatic 
regions, respectively. The two doublets at  7.08 and 6.72 with a coupling constant 
8.6 Hz suggested a 1,4-disubstituted benzene system. The resonance at  3.47 (2H) 
was assumed to be due to a methylene group situated between benzene ring and car-
bonyl group. The sub-structure search in AntiBase using 
1
H NMR data gave p-
hydroxyphenylacetic acid (96). The structure was further confirmed by comparison 
with the authentic spectrum and the literature.
[140]
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Figure 49: 
1
H NMR spectrum (CD3OD, 300 MHz) of p-hydroxyphenylacetic 
acid (96) 
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p-Hydroxyphenylacetic acid (96) is an intermediate in the microbial degradation 
of phenylalanine and tyrosine. A degradation product of p-hydroxyphenylacetic acid 
(96) is 3,4-dihydroxybenzaldehyde, a precursor of the anti-Parkinson drug Levodo-
pa.
[141]
  
4.8.2 Macrolactin A 
Working up of sub-fraction IV on Sephadex LH-20 and RP18 columns delivered 
the oily compound 97, which showed a UV absorbing band at 254 nm and stained to 
black with anisaldehyde/sulphuric acid. The 
1
H NMR spectrum revealed twelve ole-
finic proton signals between  7.23- 5.53. In addition, four oxymethine signals were 
observed at  5.02, 4.48, 4.33, and 3.98. The remaining signals between  2.47-1.26 
were assigned to six methylenes and one methyl group, respectively. 
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Figure 50: 
1
H NMR spectrum (CDCl3, 300 MHz) of macrolactin A (97) 
The 
13
C NMR spectrum showed 24 carbon signals consisting of one lactone car-
bonyl at C 167.6, 12 olefinic carbons between C 144.4-117.6, four oxymethine car-
bon signals at C 71.8, 71.7, 69.5 and 68.9. The remaining signals were attributed to 
seven sp
3
 carbon atoms, which were six methylenes at C 42.4, 42.2, 32.5, 30.2, 25.1, 
20.1, and one methyl at C 17.40, respectively. The high-resolution ESI mass analy-
sis gave C24H34O5 as molecular formula. The sub-structure search in AntiBase using 
these spectroscopic data and comparison with authentic spectra in literature led to 
macrolactin A (97).
[83]
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Figure 51: 
13
C NMR spectrum (CD3OD/CDCl3, 125 MHz) of macrolactin A (97) 
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Macrolactin A (97) has been reported to exhibit antibacterial properties, anti-
cancer activity against B16-F-10 murine melanoma cells, antiviral activity against 
Herpes simplex and to inhibit the squalene synthase.
[142,143]
 Macrolactin A (97) had 
also been reported as one of the macrolide derivatives biosynthetically following the 
polyketide route.
[144, 145]
 Two trivial metabolites, indole-3-carboxylic acid and indole-
3-acetic acid, had been also isolated from this strain. 
4.9 Terrestrial Streptomyces sp. GT-2005/049 
In pre-screening, the crude extract of Streptomyces sp. GT-2005/049 afforded a 
strong activity against bacteria, fungi and brine shrimps, and showed UV absorbing 
bands at 254 nm. A 30 L culture in M2 medium and extraction with organic solvents 
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afforded a yellow oily crude extract. Fractionation and purification by different 
chromatographic methods delivered seven constituents, namely lumichrome (98), 1-
methyluracil, thymine, indole-3-carboxylic acid, 1-acetyl--carboline (84), uracil and 
hypoxanthine (Figure 60). 
Fat
Fraction I Fraction II Fraction IV
Lumichrome
Fraction III
GT-2005/49
(30 L shaker)
Mycelium Filtrate
Mixing with Celite and filtered by filter press
Extract. with EtOAc, evap. XAD-16 (MeOH,H2O), EtOAc , evap.
CC using silica gel (CH2Cl2:MeOH, gradient elution )
Crude extraxt 
(4.1 g)
Sephadex LH-20
(MeOH)
1) Sephadex LH-20 
(MeOH) Sephadex LH-20
(MeOH)
2) RP-18
Indole-3-carboxylic acid 
Hypoxanthine
acetyl--carboline
Thymine Methyluracil Uracil
 
Figure 52: Work-up scheme for terrestrial Streptomyces sp. GT-2005/049 
4.9.1 Lumichrome 
Lumichrome (98) was obtained as pale yellow and UV-fluorescence absorbing 
solid. It was isolated from fraction II by subjecting to Sephadex L-20 and RP-18 col-
umns. The 
1
H NMR spectrum exhibited two singlets in the aromatic region at  8.03 
(1H) and 7.85 (1H), and two 3H singlets at  2.33 and 2.27. 
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Figure 53: 
1
H NMR spectrum (pyridine-d5, 300 MHz) of lumichrome (98) 
The 
13
C NMR spectrum showed twelve carbon signals, eight of them were qua-
ternary carbons, two methines sp
2
, and two methyl groups. Two quaternary carbon 
signals at C 161.9 and 151.7 were assigned to carboxamides. The HRESI mass anal-
ysis showed a molecular ion peak at m/z 265.07014 ([M+Na]
+
) corresponding to the 
molecular formula C12H10N4O2Na. A sub-structure search in AntiBase by applying 
these spectroscopic data gave lumichrome (98). The structure was further confirmed 
via comparison with authentic spectra and literature data.
[89]
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Figure 54: 
13
C NMR spectrum (pyridine-d5, 125 MHz) of lumichrome (98) 
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Lumichrome (98) is considered as a metabolite of riboflavine (23) and competed 
with tetrachlorodibenzodioxin (99) for binding to the cytosolic TCCD receptor in 
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rodent tissues.
[146]
 Lumichrome (98) and two lumichrome analogs, namely 1-
methyllumichrome (100) and 1-(-ribofuranosyl)-lumichrome (101), were isolated 
from Micromonospora sp. Tü 6368 (actinomycetes).
[147]
  
4.10 Terrestrial Streptomyces sp. GW 4723 
 The terrestrial Streptomyces sp. GW 4723 grew on agar with a white aerial 
mycelium and dark green pigmented agar. The scale-up of this strain had been car-
ried out in M2 medium by Fotso Fondja Yao during her Ph.D study: The crude ex-
tract of this strain showed antibacterial, antialgal and antifungal activities against 
Bacillus subtilis, Staphylococcus aureus, Escherichia coli, Streptomyces viridochro-
mogenes (Tü 57), Chlorella vulgaris, Chlorella sorokiniana, Scenedesmus subspi-
catus, and Mucor miehei.
[148]
 Three new angucyclinones, celastramycin C, celastra-
mycin D, and celastramycin D had been previously isolated from this strain in M2 
medium. In the current investigation, the strain was re-fermented as 60-L shaker cul-
ture in LB
+
 medium for 10 days at 28 ºC. Chromatography of crude extract on differ-
ent stationary phases delivered celastramycin B (103) and four trivial compounds 
such as acetyl--carboline, uracil, tyrosol, and adenosine. Aim of this re-
fermentation was the structure re-assignment of celastramycin B (103). 
4.10.1 Celastramycin B 
In a previous study, Fondja had isolated three new angucyclinones along with a 
small amount of the known metabolite celastramycin B (103).
[148]
 The 
13
C NMR CO 
signals at C 181.6 and 192.3 were an indication of a double chelated and a non-
chelated quinone carbonyl, i.e. a 1,11-dihydroxylated tetracenequinone. However, as 
the other celastramycins described by Fondja were clearly angucyclinones, a respec-
tive skeleton was also plausible in the case of celastramycin B, i.e. a 1,4-benzo[a]an-
thracenequinone ring system should be present.
[149]
 Due to limited amount of the 
sample, the HMBC correlations of hydroxyl groups were not found by Fondja. 
Therefore, the intention of this re-isolation was to confirm the old structure 102 or to 
suggest a new one on the basis of improved measurements. 
In this study, we have refermented the Streptomyces sp. GW 4723 in LB
+
 medi-
um and pbtainewd 1.4 mg of celastramycin B, while the other three new quinones 
were not found. The 
1
H NMR spectrum exhibited two singlets of two chelated OH 
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protons at  12.23 (8-OH) and 12.18 (6-OH). In addition, the signals of aromatic, 
oxymethine, methine, methylene and methyl protons were also observed in the 
1
H 
NMR spectrum. The 
13
C NMR indicated 19 carbon signals, and three signals at C 
197.2, 192.3 and 181.5 suggested the presence of carbonyl groups. The (+)-ESI mass 
spectrum showed peak at m/z 767 ([2M+Na]
+
) and an isotope peak at m/z 769, indi-
cating the presence of a chlorine atom. The sub-structure search in AntiBase based 
on spectroscopic data and comparison with a reference sample confirmed celastra-
mycin B, a compound, which was first reported from Streptomyces MaB-QuH-8.
[150]
  
 
Figure 55: 
1
H NMR spectrum (CDCl3, 300 MHz) of celastramycin B (103) 
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Figure 56: 
13
C NMR spectrum (CDCl3, 125 MHz) of celastramycin B (103) 
According to the literature, the signals of non-chelated and one chelated quinone 
carbonyls appear in the region of C 1803, and 186; doubly chelated carbonyls 
show signals at C 190-192, and 195-200, respectively.
[149]
 Hence, the carbon signal 
at C 192.3 (C-7) was assigned to a double chelated quinone carbonyl, while the car-
bon signal at C 181.5 (C-12) should be a non-chelated C=O.  
Furthermore, the proton signal at  7.25 (H-11 in 102) appeared at an unusually 
high field for a peri-proton. A cross-coupling correlation of H-11 ( 7.25) with the 
phenolic carbon at C 164.0, which corresponded to a 
4
J coupling would be very un-
likely for structure 102. On the other hand, the singlet signal at  7.25 in structure 
103 showed the expected cross-signal in the HMBC spectrum with the carbonyl C-7 
but not with the carbonyl C-12. In addition, the hydroxyl singlet at  12.18 exhibited 
strong coupling with carbon at C 120.7, which was very unusual for a 
5
J correlation 
between 6-OH and C-11 in structure 102. To sum up, celastramycin B is not an an-
thracyclinone 102, but an angucyclinone 103.  
This was confirmed in the HMBC spectrum by weak correlations of H-5 to the 
carbonyl carbons at C 192.3 (C-7) and 197.2 (C-1). The proton signal of 8-OH ex-
hibited strong correlations to C-9 (C 129.1) and C-7a (C 115.7). Similarly, the pro-
ton signal of 6-OH exhibited strong correlations to C-5 (C 120.7), C-6 (C 164.0), C-
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6a (C 116.8) and weak correlation to C-4a (C 153.7), respectively. Based on these 
HMBC correlations and literature, structure 102 can be revised to an angular frame 
and the structure 103 is confirmed for celastramycin B.  
 
 
 
Figure 57: HMBC spectrum of celastramycin B (103). 
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Figure 58: Selected HMBC ( ) correlations of celastramycin B (103) 
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Table 1: 
1
H NMR (CDCl3, 300 MHz) and 
13
C NMR (CDCl3, 125 MHz) data of 
celastramycin B (103) 
Position C H (mult.; J in Hz) HMBC 
8 157.5 - - 
7a 115.7 - - 
9 129.1 - - 
10 137.5 7.77 (d, 8.1 Hz) 8, 9, 11, 11a 
11 120.1 7.63 (d, 8.1 Hz) 7a, 9, 10, 12, 7* 
11a 133.3 - - 
12 181.5 - - 
12a 136.8 - - 
13 128.8 - - 
4a 153.7 - - 
5 120.7 7.25 (d, 0.5 Hz) 13, 6, 6a, 7*, 1* 
6 164.0 - - 
6a 116.8 - - 
7 192.3 - - 
1 197.2 - - 
2 42.6 2.91 (dd, 6.9, 17.1 Hz) 13, 1, 3, 4, 14 
  2.73 (dd, 7.8, 17.1 Hz)  
3 34.5 2.54 (m) 2*, 4*, 14* 
4 71.5 4.73 (d, 2.8 Hz) 13, 4a, 5, 2, 14 
14 15.9 1.17 (d, 6.9 Hz) 2, 3, 4 
8-OH  12.23 8, 7a, 9 
6-OH  12.18 4a*, 5, 6, 6a 
* weak correlation 
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5 Metabolites from selected endophytic fungi 
5.1 Endophytic fungus LAF20  
The endophytic fungus LAF20 was isolated from the medicinal plant Laggera 
alata (Asteraceae), which was collected from the edges of the Mau forest in the Rift 
Valley Province of Kenya. Laggera alata is used as traditional medicine for the 
treatment of inflammatory diseases including hepatitis and as insecticide.
[68,151]
 Plant 
endophytic fungi have been defined as symbiotic microorganisms living within plant 
tissues for a mutual benefit, e.g. by exhibiting ecological effects such as insecticidal, 
anti-nematodal, antibacterial properties. They even help the host plant to be resistant 
against external biotic and abiotic stress. Phenols, lactones, steroids, terpenoids, and 
alkaloids have been reported as secondary metabolites from endophytic fungi. 
[152]
  
The fungus LAF20 was incubated on M2 agar medium at 28 ºC for 6 days. The 
pre-screening of the crude extract did not exhibit antimicrobial activities against dif-
ferent microorganisms, but TLC of crude extract showed blue, red, grey colour reac-
tions with anisaldehyde/sulphuric acid. 
The strain was cultivated on rice medium for one month at 25 ºC in resting cul-
ture. The fungal culture was then extracted with ethyl acetate and the solvent was 
evaporated under vacuum. The crude extract was subjected to column chromatog-
raphy on silica gel with CH2Cl2/MeOH. 
92  Metabolites from selected endophytic fungi 
 
 
OOH
OH
mixture of sterols
OOH
OH
OH
Extract. with EtOAc, evap.
CC using silica gel (CH2Cl2:MeOH, gradient elution)
Sephadex LH-20 (MeOH)
Fraction I Fraction II Fraction III Fraction IV
LAF-20
(Rice medium)
Fat
2) Sephadex LH-20
    (MeOH)
Crude extract
(10.7 g)
Sephadex LH-20 (MeOH)
1) Silica gel column
    CH2Cl2:MeOH
PHB
 
Figure 59: Work-up scheme for the fungus LAF-20 
5.1.1 Isosclerone 
Isoclerone 104 was isolated as white solid from a UV absorbing zone, which 
turned brown with anisaldehyde/sulphuric acid. The EI mass spectrum gave a molec-
ular weight of m/z 178 corresponding to a molecular formula C10H10O3. The 
1
H 
NMR spectrum revealed two doublets and one doublet of doublet at  7.00, 6.91 and 
7.48, respectively, with coupling constants of 7.7 and 8.2 Hz, suggesting a 1,2,3-
trisubstituted aromatic ring. A singlet at  12.4 indicated the presence of a chelated 
hydroxyl group. The resonance of an oxygenated methine was observed at  4.90, 
and signals of two methylenes appeared between  2.96 and 2.17. 
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Figure 60: 
1
H NMR spectrum (CDCl3, 300 MHz) of isosclerone (104) 
The 
13
C NMR spectrum showed 10 carbon signals, one carbonyl at  204.1, six 
sp
2
 carbons (three methines and three quaternary), one oxygenated sp
3
 carbon at  
67.7 and two methylene signals at  34.6 and 31.3, respectively. A sub-structure 
search in AntiBase based on the molecular formula delivered 25 hits. Further sub-
structure searches in AntiBase based on the 
1
H and 
13
C NMR spectroscopic data led 
to isosclerone as the suggested structure for 104. The naphthalenone derivative 
isosclerone
[153]
 (104) was further confirmed by comparison of the spectroscopic data 
with the literature.
[154]
  
 
Figure 61: 
13
C NMR spectrum (CDCl3, 125 MHz) of isosclerone (104) 
 
94  Metabolites from selected endophytic fungi 
 
 
OH
OH
O
1 2
34
5
6
7
8
4a
8a
 
104   
Isosclerone (104) is a phytotoxic phenol, previously isolated from the fungus 
Discula sp.
[155]
 It has been reported as nematocidal agent against Bursaphelenchus 
xylophilus.
[156]
  
5.1.2 4, 6, 8-Trihydroxy-1-tetralone 
Compound 105 was isolated as brownish solid; the molecular formula was de-
duced as C10H10O4 from the HRESI mass analysis. The 
1
H NMR spectrum depicted 
two doublets at  6.52 and 6.15 with a coupling constant of 2.3 Hz, suggesting meta 
coupling of protons within an aromatic ring. In addition, signals of one oxygenated 
methine and multiplets for two diastereotopic CH2 groups were revealed at  4.71 
and between 2.75 and 2.03. 
 
Figure 62: 
1
H NMR spectrum (CD3OD, 300 MHz) of 4,6,8-trihydroxy-1-
tetralone (105) 
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The 
13
C NMR spectrum exhibited the signals of a ketone carbonyl at  203.5, 
two sp
2
 methine signals at  107.6 and 102.5, and four quaternary carbons at  167.3, 
166.7, 150.9, and 110.0 suggesting a tetrasubstituted aromatic system. In the aliphat-
ic region, the 
13
C NMR spectrum showed signals of one oxymethine and two meth-
ylene groups at  68.5, 35.7, and 32.6, respectively. A sub-structure search in Anti-
Base based on the molecular formula delivered 44 hits. After filtering with the 
1
H 
and 
13
C NMR data, only 3,4-dihydro-4,6,8-trihydroxy-1(2H)-naphthalenone and 6-
hydroxyisosclerone were left. The structure 4,6,8-trihydroxy-1-tetralone (105) was 
finally confirmed by comparison with authentic spectra and the literature data.
[156]
  
 
Figure 63: 
13
C NMR spectrum (CD3OD, 125 MHz) of 4,6,8-trihydroxy-1-
tetralone (105) 
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4,6,8-Trihydroxy-1-tetralone (105) was active against the nematode Bursaphe-
lenchus xylophilus.
[156]
 It had also been reported as one of the phytotoxic phenols 
isolated from the fungus Tubakia dryina (Sacc.) Sutton.
[155]
  
5.2 Endophytic fungus NP32-A 
The fungal strain NP32-A was isolated from the leaves of Campyloneurum phyl-
litidis, which was collected in the Botanical Garden, Germany of the University of 
Göttingen. It formed white fluffy cotton-like mycelial colonies after incubation on 
M2 agar medium for 5 days at 28 °C. This strain was selected for chemical investiga-
tion considering its biological activities against E. coli, B. subtilis, Streptomyces viri-
dochromogenes Tü 57, Staphylococcus aureus, and Rhizoctonia solani. On thin layer 
chromatography, it showed several UV active zones and blue, red, yellow, or violet 
colour reactions with anisaldehyde/sulphuric acid after heating. 
Fat
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Figure 64: Work-up scheme for endophytic fungus NP32-A 
5.2.1 Cerevisterol 
Cerevisterol (106) was obtained as white solid from subfraction II and was not 
UV-active. The 
1
H NMR spectrum exhibited signals of three sp
2 
and two oxygenated 
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sp
3
 methines. In the aliphatic region between  3.37 and 0.55, the spectrum revealed 
the resonances of protons for seven methylene, five methine, and six methyl groups.  
 
Figure 65: 
1
H NMR spectrum (DMSO-d6, 300 MHz) of cerevisterol (106) 
The HRESI mass analysis delivered C28H46O3 as the molecular formula, and the 
13
C NMR spectrum showed signals of 28 carbon atoms; four of them were due to sp
2
 
carbon atoms, and three to oxygenated sp
3
 carbons. A sub-structure search in Anti-
Base based on the molecular formula delivered 11 hits. After filtering with the 
1
H 
and 
13
C NMR data, six structures were left. The structure 106 was finally assigned as 
cerevisterol and confirmed by comparison with authentic spectra and the literature 
data.
[157,158]
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Figure 66: 
13
C NMR spectrum (DMSO-d6, 125 MHz) of cerevisterol (106) 
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Cerevisterol (106) is an ergosterol derivative and was for the first time isolated 
as a natural secondary metabolite from yeast in 1932.
[159]
 Cerevisterol (106) was not 
active against HeLa cells,
[160]
 however, Mizushina and co-workers have reported a 
selective inhibition of eukaryotic DNA polymerase.
[161]
  
5.2.2 Fusaproliferin 
Fusaproliferin (107) was isolated as a UV absorbing white solid. The HRESI 
mass analysis delivered a pseudo-molecular ion at m/z 467.27680 ([M+Na]
+
) corre-
sponding to a molecular formula of C27H40O5Na. The 
1
H NMR spectrum revealed 
signals of three sp
2 
methines, one oxygenated methylene, one oxygenated sp
3
 me-
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thine, and six methyl groups between  5.38~0.96. The remaining signals between  
2.45-1.71 were assigned to two sp
3
 methines and six sp
3
 methylene groups. 
 
Figure 67: 
1
H NMR spectrum (CD3OD, 300 MHz) of fusaproliferin (107) 
The 
13
C NMR spectrum exhibited resonances of two carbonyl groups at C 
209.0 and 172.7, eight sp
2
 carbons (three methines and five quaternary carbons) be-
tween C 149.9 and 123.0 and two oxygenated carbon sp
3
 atoms at C 77.1 and 67.1. 
A sub-structure search in AntiBase based on the molecular formula resulted in 6 hits. 
After filtering with the 
1
H and 
13
C NMR data, the structure 107 was finally con-
firmed as fusaproliferin by comparison with authentic spectra and the literature da-
ta.
[162]
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Figure 68: 
13
C NMR spectrum (CD3OD, 125 MHz) of fusaproliferin (107) 
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Fusaproliferin (107) was for the first time isolated from the fungus Fusarium 
proliferatum Nirenberg, which is worldwide reported to infect plants and a number 
of agricultural products.
[163] 
Fusaproliferin (107) is therefore one of the mycotoxins 
found in food such as maize.
[164,165]
  Fusaproliferin (107) showed also toxicity against 
Artemia salina and a lepidopteran cell line.
[165]
   
5.2.3 Beauvericin 
Beauvericin (108) was obtained as white solid from subfraction IV and showed 
UV absorption at 254 nm. The 
1
H NMR spectrum demonstrated resonances of five 
aromatic protons at  7.25, three aliphatic methines, one methylene between  3.41 
and 3.36, and three methyl groups at  3.14, 0.84 and 0.24. 
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Figure 69: 
1
H NMR spectrum (CD3OD, 300 MHz) of beauvericin (108) 
The 
13
C NMR spectrum indicated 13 signals assigned to two carbonyls and a 
mono-substituted aromatic benzene. The remaining signals represented one oxygen-
ated (77.2) and six aliphatic carbons between  58-17. The HRESI mass analysis 
gave a pseudo-molecular ion peak at m/z 806.39831 ([M+Na]
+
) as calculated for 
C45H57N3O9Na. The blue colour reaction in the chlorine/dianisidine test indicated 
that the compound 108 was a peptide. A search in AntiBase using the molecular for-
mula, C45H57N3O9, delivered only one hit, which was beauvericin. The structure of 
beauvericin (108) was further confirmed by comparing 
1
H and 
13
C NMR spectral 
data with literature data.
[166,167]
 The simplicity of 
1
H and 
13
C NMR spectra of beau-
vericin (108) is explained by the symmetry in its molecule: It is a cyclotrimeric ester 
of N-methylphenylalanine (NMePhe) and 2-hydroxyisovaleric acid (Hiv).
[168] 
Beau-
vericin (108) had been reported for the first time as a fungal cyclohexadepsipeptide 
antibiotic from fungus Beauveria bassiana.
[169]
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Figure 70: 
13
C NMR spectrum (CD3OD, 125 MHz) of beauvericin (108) 
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In our biological tests, beauvericin (108) showed strong activity against brine 
shrimps. It exhibited also toxicity against mosquito larvae with an LC50 value of 26 
ppm.
[166]
 It has also been reported that beauvericin  (108 was cytotoxic against two 
human cell lines, namely hepatocellular carcinoma (Hep G2) and fibroblast-like fetal 
lung cells (MRC5). It has been further reported as an acyl-CoA inhibitor.
[170]
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5.2.4 Trichosetin 
Trichosetin (109) was obtained as a UV absorbing white solid from sub-fraction 
V. It stained to yellow on heating after spraying with anisaldehyde/sulphuric acid. 
The HRESI mass analysis resulted in a pseudo-molecular ion peak at m/z 382.19880 
([M+Na]
+
) calculated for C21H29NO4Na. The 
1
H NMR spectrum showed signals of 
four olefinic protons between  5.36 and 5.18, four methylene, five sp3 methines and 
three methyl groups. 
 
Figure 71: 
1
H NMR spectrum (CD3OD, 300 MHz) of trichosetin (109) 
The 
13
C NMR spectrum revealed 21 carbon signals: two carbonyls at C 192.7 
(ketone) and 180.3 (amide), four sp
2
 methines, two quaternary carbons (C 203.6 and 
104.9), one quaternary sp
3
 (C 52.7), four methylene, five sp
3
 methine, and three me-
thyl groups. In the HMBC spectrum (Figure 72), the methyl doublet ( 1.19) dis-
played a 
3
J coupling to methylene carbon C-7 ( 41.1) and the methyl doublet ( 
1.49) showed 
2
J and 
3
J couplings to two methine carbons C-13 ( 134.9) and C-14 ( 
129.7). The methyl singlet ( 1.34) exhibited 2J and 3J couplings to a methine carbon 
C-11 ( 43.2) and  two quaternary carbons at  52.7 (C-2) and 203.6 (C-1). In addi-
tion, the methine proton at  5.36 showed cross couplings to two methine carbons at 
 44.9 (C-3) and 43.2 (C-11). A search in AntiBase based on the molecular formula, 
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C21H29NO4, resulted in 4 hits. After filtering with the HMBC and COSY NMR corre-
lations (Figure 72) as well as the 
1
H and 
13
C NMR spectra, trichosetin was assigned 
as the best fit for compound 109, and the structure was further confirmed by compar-
ison with the literature data.
[171,172]
 Trichosetin (109) showed biological activities as 
phytotoxin and anti-HIV agent.
[172] 
In addition, it has been reported to show antimi-
crobial activity against Gram-positive bacteria.
[172]
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Figure 72: Selected 
1
H-
1
H COSY (▬) and HMBC ( ) correlations of 109  
 
Figure 73: 
13
C NMR spectrum (CD3OD, 125 MHz) of trichosetin (109) 
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Trichosetin (109) is a member of the tetramic acid derivatives, which consist of 
two unique structural features, namely a 2,4-pyrrolidinedione and a bicyclic hydro-
carbon unit. The biosynthesis of trichosetin (109) seems to occur via the cyclisation 
of a linear polyketide, of which acetate, serine and methionine were the precur-
sors.
[172]
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Figure 74: Proposed biosynthesis pathway of trichosetin (109).
[172]
 
5.2.5 Cerebroside B 
Compound 110 was isolated as white UV-inactive compound and stained to red 
on heating with anisaldehyde/sulphuric acid. The 
1
H NMR spectrum exhibited reso-
nances of three vinylic protons at  5.72, 5.45 and 5.10, one anomeric proton at  
4.24 with a coupling constant of J = 7.8 Hz, suggesting a sugar moiety in the mole-
cule. The triplet and singlet at  1.56 and 0.86 were assigned to methyl groups. A 
high broadened singlet at  1.25 indicated a long aliphatic hydrocarbon chain. 
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Figure 75: 
1
H NMR spectrum (CD3OD/CDCl3, 300 MHz) of cerebroside B (110) 
The 
13
C NMR spectrum exhibited four olefinic carbon signals at C 136.5, 
134.6, 130.3, 124.3, and an amide carbonyl signal at C 176.7. The ESI mass spec-
trum supplied a pseudo-molecular ion peak at m/z 750 ([M+Na]
+
) corresponding to 
the molecular weight of 727 Dalton. The HRESI mass analysis revealed the molecu-
lar formula C41H77NO9, which indicated that a third double bond equivalent was con-
tributed by a sugar ring. The anomeric carbon signal of the sugar unit appeared at C 
104.1. A sub-structure search in AntiBase based on the molecular formula, 
C41H77NO9, delivered 4 hits. Among them, cerebroside B (110) was proposed on the 
basis of the NMR data. The structure was further confirmed by comparing the spec-
troscopic data with the literature values.
[173]
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Figure 76: 
13
C NMR spectrum (CD3OD/CDCl3, 125 MHz) of cerebroside B 
(110) 
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Cerebrosides are glycosphingolipids and were found in many phytopathogens as 
elicitors inducing e.g. the disease resistance in rice.
[174]
 Cerebroside B (110) has been 
reported as antifungal agent against Candida albicans.
[175]
 The sugar unit of 
cerebroside B (110) had been previously reported as -D-glucose.[175]  
5.3 Endophytic fungus FT44  
The endophytic fungus FT44 was isolated from the Cameroonian medicinal 
plant Endodesmia calophylloides (Clusiaceae) collected from Balmayo in the Centre 
Province; the plant has also been found in Nigeria, Gabon and Angola.
[176]
 E. 
calophylloides belongs to the family of Guttiferae or Clusiaceae and this family has 
been reported to produced a wide range of natural products including xanthones, bi-
flavonoids, and triterpens.  
The strain was cultivated in rice medium for one month at 28 ºC in resting cul-
ture. The fungal culture was then extracted with ethyl acetate and the solvent was 
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evaporated under vacuum. TLC of crude extract showed blue, red and green colour 
reactions with anisaldehyde/sulphuric acid. The crude extract was subjected to col-
umn chromatography on silica gel. This fungus produced two major bioactive com-
pounds namely, 1233-A (111) and ergosterol peroxide (112), and a mixture of other 
sterols, which was not further separated. 
5.3.1 1233-A 
Compound 111 was isolated as a UV absorbing colourless oil. The 
1
H NMR 
spectrum exhibited two singlets of olefinic protons at  5.73 and 5.68. The resonanc-
es at  4.59, 3.41 and 1.62 were assigned as three methine groups, and signals of an 
ABX system were observed at  4.05/3.88 and 2.09. The remaining signals of five 
methylene and three methyl groups appeared between  2.24-0.84. 
 
Figure 77: 
1
H NMR spectrum (CDCl3, 300 MHz) of 1233-A (111) 
The 
13
C NMR spectrum exhibited 18 carbon signals: Two of them at  171.6 
and 169.9 were due to acid carbonyls. Four olefinic carbon signals appeared at 156.8 
(Cq), 141.9 (Cq), 129.4 (CH), and 116.7 (CH). The remaining carbon signals were 
assigned to three methine, six methylene and three methyl groups. The ESI mass 
spectrum delivered the molecular weight of 324 Dalton calculating for C18H28O5. A 
sub-structure search in AntiBase based on the molecular formula delivered 13 hits. 
After filtering with the 
1
H and 
13
C NMR data, only one structure was left. The struc-
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ture was finally confirmed as 1233-A (111) by comparison with authentic spectra 
and the literature data.
[177]
  
 
Figure 78: 
13
C NMR spectrum (CDCl3, 125 MHz) of 1233-A (111) 
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Compound 111 has been reported as one of 43 -lactone antibiotics from na-
ture.
[88]
 The -lactone 1233-A (111) was isolated first time from the fungus Cephalo-
sporium sp. ACC 1233.
[178]
 It exhibited activity as inhibitor of 3-hydroxy-3-
methylglutaryl coenzyme A synthase and cholesterol biosynthesis.
[177, 178]
 Recently, 
Pascale and co-worker have reported that -lactone derivatives are potent inactiva-
tors of homoserine transacetylase (HTA) in searching new antimicrobial agents.
[179]
 
The biosynthesis of 1233-A (111) proceeds on the polyketide pathway via condensa-
tion of seven acetate units.
[180]
  
5.3.2 Ergosterol peroxide 
Ergosterol peroxide (112) was obtained as a UV active white solid, which turned 
blue on heating with anisaldehyde/sulphuric acid. It was isolated from the middle 
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polar fraction and its molecular formula was established as C28H44O3Na by HRESI 
MS. In the 
1
H NMR spectrum, four mutually coupled olefinic protons were assigned 
to H-6, H-7, H-22 and H-23, respectively. The multiplet at  3.97 was characteristic 
for the oxygenated methine H-3 of ergosterol derivatives. 
 
Figure 79: 
1
H NMR spectrum (CDCl3, 300 MHz) of ergosterol peroxide (112) 
Twenty eight signals were observed in the 
13
C NMR spectrum consisting of four 
olefinic carbons, two oxygenated quaternary, and one oxygenated methine (C 66.5). 
The remaining signals between  56.2 and 12.9, were assigned to seven methylene, 
six methine, six methyl and two quaternary carbon atoms. A search in AntiBase on 
the basis of the molecular formula, C28H44O3, delivered 15 hits. After filtering with 
the 
1
H and 
13
C NMR data, three structures were left. The structure was finally con-
firmed as ergosterol peroxide (112) by comparison with authentic spectra and the 
literature data.
[181]
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Figure 80: 
13
C NMR spectrum (CDCl3, 125 MHz) of ergosterol peroxide (112) 
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Ergosterol peroxide (112) has been reported to show cytotoxic activity against 
several human tumor cell lines and antibacterial activity against Mycobacterium tu-
berculosis.
[182,183]
 In addition, ergosterol peroxide (112) has been reported as a syn-
thetic product by oxidation of ergosterol in the presence of ultraviolet light (Figure 
81).
[184]
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Figure 81: Proposed reaction for synthesis of ergosterol peroxide (112)  
5.4 Endophytic fungus FTM1 
The endophytic fungus strain FTM1 was isolated from the Cameroonian medic-
inal plant Endodesmia calophylloides (Clusiaceae) collected from Balmayo in the 
Centre Province.  
The strain was cultivated in rice medium for one month at 28 ºC in resting cul-
ture. The fungal culture was then extracted with ethyl acetate and the solvent was 
evaporated under vacuum. TLC of the crude extract revealed UV absorbing bands, 
which turned blue, grey and violet with anisaldehyde/sulphuric acid. The crude ex-
tract was subjected to column chromatography on silica gel. Three compounds were 
isolated and purified by different chromatographic methods, namely 8-hydroxy-6,7-
dimethoxy-3-methylisocoumarin (113), 5-methylochracin (114) and alternariol 
monomethyl ether (115), respectively. 
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Figure 82: Work-up scheme for the endophytic fungus FTM1 
5.4.1 8-Hydroxy-6,7-dimethoxy-3-methylisocoumarin 
 8-Hydroxy-6,7-dimethoxy-3-methylisocoumarin (113) was isolated as white 
solid, which showed a UV absorbing band at 254 nm on TLC. The 
1
H NMR spec-
trum exhibited five singlets at  6.33, 6.19, 3.95, 3.91 and 2.27. Three singlets ob-
served in the aliphatic region at  3.95, 3.91 and 2.27 were assigned for two methoxy 
and one methyl groups. In addition, an H/D exchangeable broad singlet of a hydroxyl 
group appeared at  11.07. The 13C NMR spectrum displayed two methoxy groups, 
one methyl, eight sp
2
 carbons, and a carbonyl function. The high-resolution (+)-ESI 
mass analysis showed a pseudomolecular ion at m/z 259.05780 ([M + Na]
+
), indica-
tive of a molecular formula C12H12O5Na. A search in AntiBase based solely on the 
molecular formula delivered 20 hits. After filtering with the 
1
H and 
13
C NMR data, 
only 8-hydroxy-6,7-dimethoxy-3-methylisocoumarin and 8-O-methylreticulol were 
left. The structure was finally confirmed as 8-hydroxy-6,7-dimethoxy-3-methyl-
isocoumarin (113) by comparison with authentic spectra and literature data.
[185]
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Figure 83: 
1
H NMR spectrum (CDCl3, 300 MHz) of 8-hydroxy-6,7-dimethoxy-3-
methylisocoumarin (113) 
 
Figure 84: 
13
C NMR spectrum (CDCl3, 125 MHz) of 8-hydroxy-6,7-dimethoxy-
3-methylisocoumarin (113) 
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8-Hydroxy-6,7-dimethoxy-3-methylisocoumarin (113) has been isolated 
previously from Streptomyces mobaraensis.
[186]
 Recently, Boonlarppradab and co-
workers have reported that 8-hydroxy-6,7-dimethoxy-3-methylisocoumarin (113) 
showed cytotoxic activities against MCF-7, KB and NCI-H187 cell lines.
[187]
 8-
Hydroxy-6,7-dimethoxy-3-methylisocoumarin (113) has been reported also as inhibi-
tor of phosphodiesterase and topoisomerase I.
[188]
  
5.4.2 5-Methylochracin 
 Compound 114 was isolated as white solid, which showed a UV absorbing 
zone at 254 nm and stained to grey on heating with anisaldehyde/sulphuric acid. The 
(+)-HRESI mass analysis showed a pseudo-molecular ion at m/z 215.2010 ([M + 
Na]
+
), indicating a molecular formula of C11H12O3Na.  
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Figure 85: 
1
H NMR spectrum (CDCl3, 300 MHz) of 5-methylochracin (114) 
In the 
1
H NMR spectrum, two AB-type aromatic signals appeared at  7.24 (d, 
1H, 
3
J = 8.5 Hz, H-6) and 6.76 (d, 1H, 
3
J = 8.5 Hz, H-7), suggesting a 1,2,3,4-
tetrasubstituted benzene. In addition, signals of two methyls at  2.16 and 1.51, one 
methylene at  2.91 and 2.67, and one methine at  4.64 were observed. The 13C 
NMR spectrum exhibited six signals for aromatic carbons including a phenolic one, 
the presence of an oxymethine and a methylene carbon at  75.4 and 31.9, two me-
thyl groups at  20.9 and 18.1, and a carbonyl group at  170.1, respectively. A sub-
structure search in AntiBase based on the molecular formula delivered 30 hits. After 
filtering with the 
1
H and 
13
C NMR data, only 5- and 7-methylmellein were left. The 
structure 5-methylochracin (5-methylmellein, 114) was finally confirmed by compar-
ison with authentic spectra and the literature data.
[189]
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Figure 86: 
13
C NMR spectrum (CDCl3, 125 MHz) of 5-methylochracin (114)  
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5-Methylochracin (114) has been isolated first time from a plant pathogenic 
fungus Fusicoccum amygdali Del.
[190,191]
 It showed selective antiparasitic activity 
against Leishmania donovani
[192]
 and antifeedant activity against the cotton leafworm 
Spodoptera littoralis,
[193]
 but it showed no phytotoxicity in vitro.
[192]
  
5.4.3 Alternariol 5-methyl ether (AME) 
 Fraction IV was subjected to column chromatography on Sephadex LH-20 to 
obtain compound 115 as reddish-white solid. It revealed a UV absorbing band at 254 
nm, which turned violet with anisaldehyde/sulphuric acid. The HRESI mass analysis 
exhibited a peak at m/z 271.06120 [M - H]
-
, indicating a molecular formula of 
C15H11O5. 
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Figure 87: 
1
H NMR spectrum (DMSO-d6, 300 MHz) of alternariol-5-methyl ether 
(115). 
The 
1
H NMR spectrum showed two pairs of meta-positioned aromatic protons at 
 7.19 and 6.59 (d, J = 2.0 Hz),  6.72 and 6.63 (d, J = 2.5 Hz), a signal of a chelated 
hydroxyl group at  11.80 (s), and two singlet signals of methoxy and methyl groups 
at  3.90 and 2.72. The 13C NMR spectrum displayed 15 carbon atom signals, includ-
ing a carbonyl group, twelve aromatic carbons, one methoxy, and one methyl group. 
A search in AntiBase based on the molecular formula delivered 28 hits. After filter-
ing with the 
1
H and 
13
C NMR spectroscopic data, alternariol-monomethyl ether (115) 
was suggested. The structure 115 was finally confirmed by comparing with authentic 
spectra and literature data.
[194]
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Figure 88: 
13
C NMR spectrum (DMSO-d6, 75 MHz) of alternariol-5-methyl ether 
(115). 
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Alternariol-5-methyl ether (115) had been reported to show cytotoxic activity 
against KB, KBv200 and L5178Y mouse lymphoma cells.
[194, 195]
 The compound 
showed also inhibitory activity against several protein kinases.
[195]
 
6 Plant metabolites 
Samples from plants were received from our research collaborators, Prof. S. Ga-
napaty (India) and Prof. Aye Aye Tun (Myanmar). Among others, five compounds 
were isolated from three different plants from Myanmar, namely Adansonia agitate, 
Dillenia pentagyna, Kaempferia parviflora; six further samples were isolated from 
an Indian plant. 
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6.1 Adansonia digitata 
Adansonia digitata belongs to the genus Adansonia in the family of Malva-
ceae.
[196]
 The genus Adansonia comprises eight species and is distributed in Austral-
ia, Africa and Asia.
[197]
 Adansonia digitata has been widely used as medicinal plant 
and alternative source of food in Africa, Asia and Australia.
[197,198]
 Flavonoids, tan-
nins, steroids, lipids, vitamins, amino acids, carbohydrates and terpenoids have been 
reported as chemical constituents.
[196,197]
  
In the current investigation, three compounds were isolated from this plant and 
identified by using spectroscopic methods, i.e. garcinon D (116), rubraxanthone 
(117), and acetyl aleuritolic acid (118). 
6.1.1 Garcinon D 
Compound 116 was obtained as yellow powder and revealed a molecular ion 
peak at m/z 451.17272 [M+Na]
+
 in HRESIMS, which corresponds to the sodiated 
molecular formula C24H28O7Na. The 
1
H NMR spectrum displayed two singlets of 
aromatic signals at  6.78 and 6.34 and showed the presence of a methoxy group at  
3.75. In the aliphatic region, the spectrum exhibited two multiplets at  3.32 (16-H) 
and 1.57 (15-H). The spectrum showed additionally four methyl groups at  1.73, 
1.62 and 1.22, respectively. Furthermore, the signals at  5.18 (3J = 7.1 Hz, 1H) and 
3.21 (
3
J = 7.1 Hz, 2H) demonstrated the presence of sp
2
 protons adjacent to a meth-
ylene group, which indicated an isoprene unit. 
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Figure 89: 
1
H NMR spectrum (DMSO-d6, 300 MHz) of garcinon D (116) 
The 
13
C NMR spectrum showed 23 carbon signals which comprised of an -
unsaturated ketone at  181.9, six quaternary sp2 carbons between  162~143.0 most 
likely attached to heteroatoms, four quaternary sp
2
 carbons between  139~101, three 
sp
2
 methine carbons at  122.2, 101.3, 92.0 and nine sp3 carbon atoms between  
69.0~17.6.  
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Figure 90: 
13
C NMR spectrum (DMSO-d6, 125 MHz) of garcinon D (116) 
The structure was elucidated based on 2D NMR correlations. The HMBC spec-
trum revealed two correlations of protons at  6.78 and 6.34 with the carbonyl carbon 
at C 181.9. The sp
2
 proton signal at  6.78 showed further a strong 3J correlation 
with the quaternary sp
2
 carbon at C 109.8 (Cq-8a); the methyl protons at  1.22 (C 
28.7) exhibited strong 
2
J and 
3
J correlations with the quaternary sp
3
 carbon at C 69.0 
(Cq-17) and a methylene carbon at C 44.7 (CH2-16). In addition, the sp
2
 methine and 
methylene protons at  6.34 and 3.21 correlated strongly with the quaternary sp2 car-
bon at C 109.3 (Cq-2). The position of a methoxy group was assigned through the 
correlation of the proton signal at  3.75 with the quaternary sp2 carbon at C 143.1 
(Cq-7). A search in AntiBase based on its molecular formula, C24H28O7, delivered 
two hits, however, the spectroscopic data did not match these structures. A search in 
The Dictionary of Natural Product
[80]
 with the molecular formula delivered garcinon 
D (116) as a structure , which and was further confirmed by comparing the spectro-
scopic values with the literature data.
[199] 
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Figure 91: Selected 
1
H-
1
H COSY (▬) and HMBC ( ) correlations of garci-
non D (116) 
Garcinon D (116) is a member of xanthone-related compounds isolated from 
Garcinia mangostana.
[200]
 It showed cytotoxic activity against the HT-29 human 
colon cancer, epidermoid carcinoma (KB), and breast cancer (BC-1) cell lines.
[199]
  
6.1.2 Rubraxanthone 
Rubraxanthone (117) was obtained as yellow compound with a pseudo-
molecular ion peak at m/z 433.162196 [M+Na]
+
 in HRESIMS, which corresponds to 
the sodiated molecular formula C24H26O6Na. In the aromatic region of the 
1
H NMR 
spectrum, it showed two meta-coupled aromatic protons at  6.03 and 6.09 (J = 2.2 
Hz) for H-2 and H-4, and a singlet at  6.60 for H-5. A resonance of a methoxy 
group appeared at  3.73. Three singlets at  1.49, 1.52 and 1.78 corresponded to 
three methyl groups of a geranyl moiety. The presence of the geranyl skeleton was 
shown by the deshielded resonance of a methylene group (CH2-10) at  4.00, which 
is in a peri position to a carbonyl group. HMBC correlations (Figure 94) showed that 
the methoxy protons at  3.73 gave a strong correlation to the quaternary sp2 carbon 
at C 144.7 (C-7). In addition, the methylene protons at  4.00 revealed two 
3
J corre-
lations with two quaternary sp
2
 carbons at 112.1 (C-8a) and 144.7 (C-7). Finally, the 
structure was assigned as rubraxanthone (117) on the basis of spectroscopic and mass 
analysis data and was further confirmed by comparing with literature values.
[201]
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Figure 92: 
1
H NMR spectrum (CD3OD, 300 MHz) of rubraxanthone (117) 
 
Figure 93: 
13
C NMR spectrum (CD3OD, 300 MHz) of rubraxanthone (117) 
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Figure 94: Selected 
1
H-
1
H COSY (▬) and HMBC ( ) correlations of ru-
braxanthone (117). 
Rubraxanthone
[201]
 (117) has been isolated firstly from Garcinia rubra.
[202]
; it 
reported to show cytotoxicity against HL-60 cells.
[203]
 In addition, Jantan and co-
workers have reported that rubraxanthone (117) exhibited inhibitory effects on plate-
let-activating factor binding to rabbit platelets.
[204]
  
6.1.3 Acetylaleuritolic acid 
Acetyl aleuritolic acid (118) was isolated as white powder; the HRESI mass 
analysis gave an ion at m/z 521.36066 ([M+Na]
+
), calculating for C32H50O4Na. The 
1
H NMR spectrum showed an olefinic proton at  5.20 (15-H). A multiplet at  4.50 
was assigned to the proton signal of the oxygenated position at C-3 in a steroid skele-
ton; this was additionally supported by a 
13
C NMR resonance at C 80.8 (CH-3). A 
series of methylene and methyl signals was observed between  2.80-0.70. 
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Figure 95: 
1
H NMR spectrum (CDCl3, 300 MHz) of acetylaleuritolic acid (118)  
 
Figure 96: 
13
C NMR spectrum (CDCl3, 125 MHz) of acetylaleuritolic acid (118) 
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In addition, the 
13
C NMR spectrum revealed two olefinic and two carbonyl car-
bons at  143.5 (Cq-14), 122.4 (CH-15), 170.8 (Cq-ester) and 184.1 (Cq-28), respec-
tively. A search in AntiBase based on its molecular formula, C32H50O4, delivered 9 
hits. The 
1
H and 
13
C NMR spectroscopic data suggested acetyl aleuritolic acid as the 
proposed structure for 118. In addition, all the spectral values were then compared 
with the authentic spectra in our group and found to be identical with acetyl-
aleuritolic acid (118). The structure was finally confirmed by comparing the experi-
mental data with the literature data.
[205] 
Acetyl aleuritolic acid (118) has been reported first time from the plant Aleurites 
montana (Euphorbiaceae) and belongs to a group of pentacyclic triterpene.
[206,207]
 
Ramos and co-workers have reported that acetylaleuritolic acid (118) exhibited anal-
getic activity.
[208]
 In addition, 118 has shown trypanocidal activity against protozoan 
Trypanosoma cruzi.
[209]
  
6.2 Dillenia pentagyna 
Dillenia pentagyna belongs to the family of Dilleniaceae, including about 120 
species.
[210]
 Many Dillenia species are native to southern Asia, Australia, and India 
and were used as medicinal plants.
[210,211]
 Terpenoids and flavonoids were reported 
as the major constituents.
[ 211,212]
 
6.2.1 Betulinic acid 
Betulinic acid (119) was obtained as white solid. The 
1
H NMR spectrum showed 
many overlapping proton signals in the upfield region. Two olefinic protons ap-
128  Plant metabolites 
 
 
peared at  4.70 and 4.56 and one methyl group at  1.65 suggested the presence of 
an exomethylene group. The proton signals at  0.93, 0.87, 0.77, 0.65 were assigned 
to five tertiary methyl groups. 
 
Figure 97: 
1
H NMR spectrum (DMSO-d6, 300 MHz) of betulinic acid (119) 
The 
13
C NMR spectrum showed three sp
2
 carbon signals at  176.9, 150.1, 
109.4, and an oxygenated sp
3
 carbon at  76.7, respectively. The other carbon signals 
in the region of 55.3-14.4 were due to sp
3
 carbons. The HRESI mass analysis of 
compound 119 showed a pseudo-molecular ion peak at m/z 455.35309 ([M-H]
-
), 
which was in agreement with the molecular formula C30H48O3. A search in AntiBase 
based on its molecular formula, C15H10O2, delivered 21 hits. A sub-structure search 
on the basis of the 
1
H and 
13
C NMR spectroscopic data suggested betulinic acid as 
the structure for 119. In addition, all the spectral values were then compared with the 
authentic spectra in our group and found to be identical with betulinic acid (119).
[213]
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Figure 98: 
13
C NMR spectrum (DMSO-d6, 125 MHz) of betulinic acid (119) 
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The pentacyclic triterpene betulinic acid
[214]
 (119) has antiinflammatory proper-
ties and show antiviral activity against HIV as well as cytotoxic properties.
[212, 215]
  
6.2.2 Betulin  
Betulin (120) was obtained as white solid. The 
1
H NMR spectrum had similar 
proton resonances as betulinic acid (119), except that the two doublets at δ 3.53 and 
3.78 were assigned as two protons at position 28. The structure of 120 was confirmed 
by comparing the 
1
H NMR spectrum with the authentic spectrum in our group 
through AntiBase.  
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Figure 99: 
1
H NMR spectrum (CDCl3, 300 MHz) of betulin (120) 
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Both betulin (120) and betulinic acid (119) consist of a lupane skeleton.
[216]
 In 
addition, they have been reported to exhibit promising biological activities such as 
anti-HIV, anti-inflammatory, antiviral, and anticancer properties.
[216, 217]
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6.3 Kaempferia parviflora 
Kaempferia parviflora belongs to the family of Zingiberaceae and is used as 
folk medicin and food ingredient in southern Asia. Flavonoids have been reported as 
the major bioactive compounds from the Kaempferia genus.
[218,219]
 In addition, diter-
penes, monoterpenes, cyclohexane oxides and cinnamates have been reported as phy-
tochemicals of Kaempferia species.
[220,221]
 
 
6.3.1 5,7-Dimethoxyapigenin 
5,7-Dimethoxyapigenin (121) was obtained as white powder: The ESI mass 
spectrum indicated the pseudo-molecular ion peak at m/z 297 ([M-H]
-
), which fixed 
the molecular weight to 298 Dalton. The HRESI mass analysis of m/z 299.09140 
[M+H]
+
 corresponded to the molecular formula C17H15O5. In the aromatic region, the 
1
H NMR spectrum indicated seven protons. Two doublets of an A2B2 system at  
7.87 and 6.90 (J = 8.8 Hz), and two meta-coupled proton signals at  6.82 and 6.49 
suggested a para- and a 1,2,3,5-tetrasubstituted benzene ring. A singlet at  6.56 is 
characteristic of the 3-H position of flavones. 
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Figure 100: 
1
H NMR spectrum (DMSO-d6, 300 MHz) of 5,7-dimethoxyapigenin 
(121)  
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Figure 101: Selected 
1
H-
1
H COSY (▬) and HMBC ( ) correlations of 5,7- 
dimethoxyapigenin (121) 
A sub-structure search in AntiBase with the molecular formula, C17H14O5, de-
livered 19 hits. The structure of compound 121 was confirmed by 1D and 2D NMR 
data as 5,7-dimethoxyapigenin and all spectral data were in agreement with the lit-
erature values.
[222]
 5,7-Dimethoxyapigenin (121) is a flavone derivative and has been 
reported to show antimutagenic activity.
[223]
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6.3.2 Ganschisandrine 
Compound 122 was obtained as white powder and revealed a molecular ion 
peak at m/z 395.18283 [M+Na]
+
 in HRESIMS analysis corresponding to the sodiated 
molecular formula C22H28O5Na. In the aromatic region of the 
1
H NMR spectrum, it 
showed a typical pattern of o/m-coupled protons in 1,2,4-position with two doublets 
at  6.94, 6.83 and one doublet of doublet at  6.95. Furthermore, the 1H NMR spec-
trum revealed a methyl, two methine and two methoxy groups. 
 
Figure 102: 
1
H NMR spectrum (CDCl3, 300 MHz) of ganschisandrine (122) 
The 
13
C NMR spectrum showed only eleven carbon signals whereas the HRESI 
mass analysis has shown the presence of 22 carbon atoms in the molecule. It was 
assumed therefore that compound 122 had a symmetrical structure. The 
13
C NMR 
spectrum exhibited five oxygenated carbon atoms at C 148.8, 148.3, 87.2, 55.9 and 
55.8, respectively. A search in AntiBase based on its molecular formula delivered 
eight hits. The HMBC spectrum exhibited cross coupling signals from H-6 ( 6.95) 
and proton of 8-CH3 ( 1.02) towards the methine carbon C-7 (C 87.2). A sub-
structure search in AntiBase based on these HMBC correlations suggested ganschi-
sandrine (122) as the structure for this compound, which was further confirmed by 
comparison with literature data.
[224, 225]
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Figure 103: 
13
C NMR spectrum(CDCl3, 125 MHz) of ganschisandrine (122) 
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Figure 104: Selected 
1
H-
1
H COSY (▬, ) and HMBC ( ) correlations 
of ganschisandrine (122)  
Ganschisandrine (122) has been isolated previously from a Chinese medicinal 
plant Schisandra sphenanthera.
[225] 
It belongs to a group of tetrahydrofuran lignans 
and has been reported to demonstrate potent activities as antitumor, antiviral, anti-
hepatotoxic, antioxidant and trypanocidal agent.
[224,226]
 Four natural stereoisomers of 
tetrahydrofuran lignans (structures II to V) have been reported so far from plants 
(Figure 105).
[227]
 Since the experimental analysis data were in agreement with the 
literature data, form IV was proposed as the relative configuration of the isolated 
ganschisandrine (122).   
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Figure 105: The six natural stereoisomers of tetrahydrofuran lignans.
[227]
  
6.3.3 Stigmasterol glucoside 
Stigmasterol glucoside (123) was obtained as white powder. The 
1
H NMR spec-
trum showed the typical pattern of a steroid with many overlapping proton signals in 
the upfield region. An olefinic proton appeared at δ 5.33, six methyl groups were 
observed between δ 0.93-0.69, in addition to seven methine protons between δ 2.15-
0.65. Six oxymethines of a sugar moiety appeared between δ 4.27-3.11 along with an 
oxymethylene at δ 3.49 and 11 methylene protons. 
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Figure 106: 
1
H NMR spectrum (DMSO-d6, 300 MHz) of stigmasterol glucoside 
(123) 
The 
13
C NMR spectrum exhibited 35 carbon signals constituted by three quater-
nary and three olefinic carbons, seven oxygenated carbons, 9 methylene, seven me-
thine and six methyl carbons. The signal at δC 100.7 was assigned to an anomeric 
carbon (C-1’). The four methine resonances at δC 76.8, 76.7, 76.6, 73.3 and one 
methylene resonance at δC 61.0 were assigned to C-5’, C-3’, C-2’, C-4’ and C-6’, 
respectively, of a sugar unit.  
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Figure 107: 
13
C NMR spectrum (DMSO-d6, 125 MHz) of stigmasterol glucoside 
(123) 
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The ESI mass spectrum delivered the pseudomolecular ion peak at 597 
([M+Na]
+
, which gave a molecular weight of 574 Dalton. The HRESI mass analysis 
gave the molecular formula C35H58O6. The structure of 123 was confirmed by com-
paring the NMR spectra with authentic spectra in AntiBase and was also in agree-
ment with the literature data.
[228]
 
6.3.4 Oleanolic acid 
Oleanolic acid (124) was obtained as pale yellow solid. Its ESI mass spectrum 
showed the molecular weight of 456 Dalton and the HRESI MS analysis gave the 
molecular formula C30H48O3. The 
1
H NMR spectrum exhibited one olefinic proton 
138  Plant metabolites 
 
 
and one proton of an oxygenated methine at δ 5.23 and 3.14 of triterpenoid deriva-
tives. In addition, protons of methine, methylene and seven methyl groups appeared 
between δ 2.82-0.77.  
 
Figure 108: 
1
H NMR spectrum (CDCl3, 300 MHz) of oleanolic acid (124) 
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A sub-structure search in AntiBase delivered oleanolic acid (124) as the sug-
gested structure, which was also confirmed by comparing the spectra with the litera-
ture data.
[229]
 Oleanolic acid (124) and its glycoside derivatives have been reported to 
show antitumor, antifungal, antiviral, anti-inflammatory, and anti-hyperlipidemic 
activities.
[229, 230]
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6.3.5 2-Methylanthraquinone 
The 
1
H NMR spectrum of a yellow compound (125) revealed five resonances of 
aromatic protons and one aromatic-bound methyl singlet at δ 2.52. The multiplets at 
δH 8.28 and 7.77 were assigned to an o-disubstituted benzene ring, and the signals at 
δH 8.18 (d), 8.08 (d) and 7.58 (dd) suggested a second 1,2,4-trisubstituted benzene 
ring. HRESI mass analysis gave a pseudo-molecular ion at m/z 245.05735 
([M+Na]
+
), which was consistent with a molecular formula of C15H10O2Na.  
 
Figure 109: 
1
H NMR spectrum (CDCl3, 300 MHz) of 2-methylanthraquinone 
(125) 
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A search in AntiBase based on its molecular formula, C15H10O2, delivered only 
one hit, which was 2-methylanthraquinone. The structure of 2-methylanthraquinone 
(125) was further confirmed by comparing the spectroscopic data with the literature 
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values.
[231, 232]
 2-Methylanthraquinone (125) has been reported as one of the anthra-
quinones found in the family of Rubiaceae; it exhibited cytotoxicity against the LAC 
cell line.
[233]
  
6.3.6 Scopoletin 
Compound 126 was isolated as yellow solid in mixture with betulinic acid (119). 
High-resolution electrospray mass analysis (HRESIMS) showed an ion peak at m/z 
215.03147 ([M+Na]
+
), which indicated a molecular formula of C10H8O4Na. The 
1
H 
NMR spectrum exhibited a methoxy singlet at δ 3.93. The two doublets exhibited at 
δ 7.58 and 6.25 with J = 9.5 Hz, suggesting cis-protons of a double bond, and two 
singlet signals at δ 6.89 and 6.82 attributed to an electron rich 1,2,4,5-tetrasubstituted 
benzene ring.  
 
Figure 110: 
1
H NMR spectrum (CDCl3, 300 MHz) of scopoletin (126) 
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A sub-structure search in AntiBase delivered scopoletin (126) as the suggested 
structure, which was confirmed by comparison with literature data.
[231]
 Scopoletin 
(126) is a coumarin derivative and has been reported to have anticancer activity.
[234]
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7 Summary 
The demand for the development of new drugs for the pharmaceutical market is 
still growing. Drug-resistant infectious diseases and disorders are the major reasons 
for natural product scientists to search in sponges, tunicates, and soft corals as alter-
native sources for bioactive metabolites.
[235]
 Additionally, microorganisms are still in 
the focus of interest.
[236]
 They are favoured over plants and animals due to the possi-
bility to cultivate them in any quantity and at any time.
[235]
 
In continuing our search for new and biologically active compounds, we are per-
forming the screening of extracts from terrestrial and marine-derived microorgan-
isms. In the present work, seven terrestrial and two marine Streptomyces spp., one 
ruminal bacterium, and four endophytic fungi were selected according to the results 
of chemical and biological screenings. Fermentation, extraction and purification were 
performed under standard procedures. The database AntiBase 
[88]
 was used for derep-
lication of known metabolites, and NMR and MS measurements were carried out for 
structure elucidations. Additionally, antibacterial, antifungal and cytotoxicity assays 
were conducted with the pure compounds. 
The marine-derived Streptomyces sp. B8289 was found to inhibit the growth of 
Staphylococcus aureus, Streptomyces viridochromogenes Tü 57, Escherichia coli, 
the fungus Mucor miehei Tü 284, and the microalgae Chlorella vulgaris, Chlorella 
sorokiniana, and Scenedesmus subspicatus in the agar diffusion test. From a 25 L 
shaker culture, four major constituents were isolated: 2-[5-(2-oxopropyl)-tetrahydro-
furan-2-yl]-propionic acid (77), the new 2-[5-(2-oxopropyl)-tetrahydrofuran-2-yl]-
propionic acid methyl ester (78), homononactic acid (79), and homononactic acid 
methyl ester (80).  
Homononactic acid (79), 2-[5-(2-oxopropyl)-tetrahydrofuran-2-yl]-propionic ac-
id (77), 2-[5-(2-oxopropyl)-tetrahydrofuran-2-yl]-propionic acid methyl ester (78), 
and homononactic acid methyl ester (80) are nonactic acid derivatives. 2-[5-(2-
Oxopropyl)-tetrahydrofuran-2-yl]-propionic acid (77) had been isolated previously in 
our group from Streptomyces sp. Act8970, and its relative stereochemistry was estab-
lished partially on the basis of NOESY experiments by Shaaban.
[89]
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The terrestrial Streptomyces sp. Ank86 exhibited moderate activity against Ba-
cillus subtilis, Staphylococcus aureus, and Streptomyces viridochromogenes (Tü 57). 
From this strain, actinomycin D (82), tryptophol and 4-hydroxy-2-methoxyacet-
anilide (81) were obtained.  
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The terrestrial Streptomyces sp. Ank68 exhibited strong activity against bacteria, 
fungi and brine shrimps, due to the content of actinomycin D (82) and fungichromin 
(83). Both these compounds are well-known antibiotics.
[98-102]
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1-Acetyl--carboline (84) and 3-(hydroxyacetyl)-indole were isolated from the 
terrestrial Streptomyces sp. Ank248. Both compounds have been reported to exhibit 
weak antimicrobial and anticancer activities.
[108]
 
The terrestrial Streptomyces sp. Ank181 delivered three known compounds, 
namely reductiomycin (85), 2,3-dihydroxybenzoic acid, and indole-3-carboxylic ac-
id. Additionally, the antimicrobial assay exhibited a high activity against Candida 
albicans, moderate activity against E. coli, Streptomyces viridochromogenes (Tü 57), 
and Mucor miehei (Tü 284). It showed a weak activity against Bacillus subtilis. The 
activity of this strain was due to reductiomycin (85). 
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The terrestrial Streptomyces sp. Ank75 was selected due to its inhibition zones 
in the agar diffusion test against the fungi Candida albicans and Mucor miehei (Tü 
284), and the algae Chlorella vulgaris and Chlorella sorokiniana. Seven constituents 
were isolated from this strain and three of them were new compounds, namely 2-O-
methylpyrogallol (89), 2,3-dihydroxybenzamide (92), and bandamycin (94). 
Bandamycin (94) exhibited antifungal activity against Candida albicans and Mucor 
miehei (Tü 284). The other four known compounds were benadrostin (88), N-amino-
carbonyl-2,3-dihydroxybenzamide (91), 3-[(1Z)-1-hexenyl-ONN]-1,2-butanediol 
(93), and N
6
,N
6
-dimethyl-adenosine (95).  
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The crude extract of the terrestrial Streptomyces sp. GT-2005/049 exhibited 
strong activity against bacteria, fungi, and Artemia salina. From this strain, seven 
known compounds have been isolated. They were lumichrome (98), thymine, 1-
methyluracil, uracil, indole-3-carboxylic acid 1-acetyl--carboline (84), and hypo-
xanthine. Lumichrome (98) has been reported as the first endogenous substance in 
rats demonstrating affinity for the TCCD receptor.
[89,146]
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The marine Streptomyces sp. B5798 showed strong activity in the brine shrimp 
test. This strain produced macrolactin A (97), indole-3-carboxylic acid, indole-3-
acetic acid, and p-hydroxyphenylacetic acid (96). Among these compounds, macro-
lactin A (97) has been reported as an antibiotic, anticancer and antiviral agent.
[142, 143]
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The Streptomyces sp. GW 4723 had been fermented previously in M2 medium, 
and three new angucyclinone derivatives along with celastramycin B had been isolat-
ed,
[148]
 for which the anthracyclinone structure 102 has been reported.
[150]
 As other 
by-products of celastramycin B found by Fondja had an angucyclinone skeleton, it 
was assumed that the celastramycin B structure may be wrong. Due to limited 
amount of the sample in the previous study, the HMBC correlations of hydroxyl 
groups were not found in the structure of celastramycin B. To finally answer the re-
maining questions, the strain GW 4723 was refermented in LB
+
 medium to deliver 
five compounds, one of which was celastramycin B.  
The structure 102 has been reported previously for celastramycin B. The 
13
C 
NMR spectrum would show similar signals at C ~186 for two monochelated qui-
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none carbonyls
[149]
 in structure 102. However, the 
13
C NMR spectrum exhibited sig-
nals at C 181.5 and 192.3 indicating a non-chelated and a double chelated quinone 
carbonyl, which matched better for structure 103. A cross-coupling correlation of H-
11 ( 7.25) in 102 with the phenolic carbon at C 164.0, which corresponded to a 
4
J 
coupling would be very unlikely for structure 102. On the other hand, the singlet at  
7.25 in structure 103 showed the expected cross-signal in HMBC the spectrum with 
the carbonyl C-7 but not with the carbonyl C-12. In addition, the hydroxyl singlet at 
 12.18 exhibited strong coupling with carbon at C 120.7, which was very unusual 
for a 
5
J correlation between 6-OH and C-11 in structure 102. Finally, the  structure of 
celastramycin B was revised into 103.  
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The strain of Enterobacter amnigenus ZIA was isolated from the rumen of a 
Tunisian cow. In the biological test, the crude extract of E. amnigenus ZIA showed 
no activity against the tested microorganisms. Six compounds were isolated from this 
strain, namely poly-(hydroxybutyric acid) (PHB) (86), indole-3-acetic acid, uracil, 
tyrosol, hypoxanthine, and a new butyl glycoside (87). 
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The endophytic fungus LAF20 showed no biological activity against bacteria, 
fungi, algae and Artemia salina, but TLC of crude extract showed UV absorbing 
bands and different colour reactions with anisaldehyde/sulphuric acid. This strain 
delivered three known chemical constituents, namely poly-(hydroxybutyric acid) 
(PHB) (86), isosclerone (104), 4,6,8-trihydroxy-1-tetralone (105), and a mixture of 
sterol derivatives. 
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The endophytic fungus NP32-A exhibited interesting results in the bioassay 
against Bacillus subtilis, Escherichia coli, Candida albicans, Mucor miehei (Tü 284), 
Rhizoctonia solani and Artemia salina. Fusaproliferin (107) and beauvericin (108), 
isolated from the strain, demonstrated strong activity against Artemia salina, while 
trichosetin (109) exhibited moderate activity against Mucor miehei (Tü 284) and Rhi-
zoctonia solani. In addition, beauvericin (108) also showed weak activities against 
Bacillus subtilis, Escherichia coli, and Candida albicans. In contrast, cerevisterol 
(106) and cerebroside B (110) had no biological activities against bacteria, fungi, 
algae or in the brine shrimp test. 
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TLC analysis of endophytic fungus FT44 showed UV absorbing bands and dif-
ferent colour reactions with anisaldehyde/sulphuric acid. Ergosterol peroxide (112) 
and 1233-A (111) were isolated. Both compounds have been reported as inhibitors of 
3-hydroxy-3-methylglutaryl coenzyme A synthase.
[177, 178]
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The fermentation of an endophytic fungus Alternaria sp. FTM1 in rice medium 
afforded 8-hydroxy-6,7-dimethoxy-3-methylisocoumarin (113), 5-methylochracin 
(114), and alternariol 5-methyl ether (115).  
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In continuing research on plant-derived secondary metabolites, Prof. S. Ga-
napaty's group in India and Prof. Aye Aye Tun's group in Myanmar contributed elev-
en pure compounds. Their structures were elucidated as: garcinon D (116), rubraxan-
thone (117), acetyl aleuritolic acid (118), betulinic acid (119), 5,7-
dimethoxyapigenin (121), ganschisandrine (122), stigmasterol glucoside (123), 
oleanolic acid (124 ), betulin (120), 2-methylanthraquinone (125), scopoletin (126). 
Garcinon D (116), rubraxanthone (117), acetyl aleuritolic acid (118), betulinic acid 
(119) and 5,7-dimethoxyapigenin (121) were isolated from Myanmar medicinal 
plants, whereas stigmasterol glucoside (123), oleanolic acid (124), betulin (120), 2-
methylanthraquinone (125) and scopoletin (126) were isolated from Indian medicinal 
plant. In addition, all these plant secondary metabolites were reported in the literature 
to show a multitude of different biological activities.  
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Table 2: Total number of isolated compounds from microorganisms and plants in 
this thesis. 
Strains/Plants 
No. of 
strains/plants 
Total no. of 
compounds 
No. of new com-
pounds 
Marine Streptomyces sp. 2 8 1 
Terrestrial Streptomyces sp. 7 21 3 
Ruminal bacterium 1 6 1 
Endophytic fungi 4 13 - 
Medicinal plants 4 11 - 
 
Based on this study, natural sources such as microorganisms (bacteria and endo-
phytic fungi), plants and animals are still of interest as producers of bioactive com-
pounds in the field of natural product chemistry. Since nature does not produce sec-
ondary metabolites without reason, there is a demand to test the isolated products 
from microorganisms or plants against other biological systems and to determine the 
biological uses of the isolated compounds. 
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8 Materials and methods 
8.1 General  
IR spectra: Perkin-Elmer 1600 Series FT–IR; Perkin-Elmer 297 infrared spec-
tro-photometer; Beckman DU-640; Shimadzu FT-IR; (KBr tablet and film). - 
UV/VIS spectra: Perkin-Elmer Lambda 15 UV/VIS spectrometer. - Optical rota-
tions: Polarimeter (Perkin-Elmer, model 243). – 1H NMR spectra: Varian Unity 
300 (300.145 MHz), Bruker AMX 300 (300.135 MHz), Varian Inova 500 (499.8 
MHz), Varian Inova 600 (600 MHz). Coupling constants (J) in Hz. Abbreviations: s 
= singlet, ddoublet, dd doublet of doublet, t = triplet, q = quartet, m = multiplet, 
br = broad. – 13C NMR spectra: Varian Unity 300 (75.5 MHz), Varian Inova 500 
(125.7 MHz), Varian Inova 600 (150.7 MHz). Chemical shifts were measured rela-
tively to tetramethylsilane as internal standard. Abbreviations: APT (Attached Proton 
Test): CH/CH3 up and Cq/CH2 down. - 2D NMR spectra: H, H COSY (
1
H,
1
H-
Correlated Spectroscopy), HMBC (Heteronuclear Multiple Bond Connectivity), 
HMQC (Heteronuclear Multiple Quantum Coherence) and NOESY (Nuclear Over-
hauser Effect Spectroscopy). - Mass spectra: a) EIMS (70 eV) were recorded on a 
Finnigan MAT 95 or Jeol AccuTOF GC II spectrometer with perfluorokerosene as 
reference substance for EI HRMS. b) DCI-MS: Finnigan MAT 95, 200 eV, reactant 
gas NH3. c) ESIMS, HRESIMS, HPLC-MS and ESI-MS/MS were recorded on a 
Finnigan LCQ with quaternary pump Rheos 4000 (Flux Instrument). High-resolution 
mass spectra (HRMS) were recorded by ESI MS on an Apex IV 7 Tesla Fourier-
Transform Ion Cyclotron Resonance Mass Spectrometer (Bruker Daltonics, Billerica, 
MA, USA). HPLC-MS using a Phenomenex Synergi Max-RP 150  2.00 mm 4 
 RP-C12 column, solvent A: MeOH + 0.05% HCOOH, solvent B: H2O + 
0.05% HCOOH, flow rate 300 μL/min, gradient: start 10% or 20% of A, 0-20 min 
from 10% or 20% to 100% of A, 20-30 min at 100% A, UV/VIS-Diode-Array-
Detector (200-800 nm ever 5 nm). ESI MS/MS was performed with normalized col-
lision energy of 35%. d) GC-CI-MS were recorded by Thermo Finnigan TRACE GC 
Ultra with Varian FactorFour Capillary Column (VF-5ms 30 m  0.25mm + 5 m EZ-
Guard, layer 0.25 µm) and DSQ detector. Isobutan was used as reactant gas. GC-EI-
MS were recorded by Thermo Finnigan TRACE with Varian GC Capillary Column 
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(wcot fused silica coated CP-SIL 8CB for amines; 30 m  0.25 mm, layer 0.25 µm). 
– Filter press: Schenk Niro 212 B40. 
8.2 Materials  
Thin layer chromatography (TLC): DC-Folien Polygram SIL G/UV254 (Ma-
cherey-Nagel & Co.). – Glass plates for chemical screening: Merck silica gel 60 
F254, (10  20 cm). – Preparative thin layer chromatography (PTLC): 55 g Sili-
ca gel P/UV254 (Macherey-Nagel & Co., Düren, Germany) is added to 120 ml of de-
mineralised water and the suspension stirred for 60 minutes. Sixty ml of the homog-
enous suspension is poured on a horizontal held 20  20 cm glass plate and the un-
filled spaces are covered by evenly distributing the suspension. The plates are air 
dried for 24 hours and activated by heating for 3 hours at 130 C. – Column chro-
matography (CC): MN silica gel 60: 0.05-0.2 mm, 70-270 mesh (Macherey-Nagel 
& Co); size exclusion chromatography was done on Sephadex LH-20 (Lipophilic 
Sephadex, Amersham Biosciences Ltd; purchased from Sigma-Aldrich Chemie, 
Steinheim, Germany). Amberlite XAD-16 resin was obtained from Rohm and Haas, 
France. 
8.3 Spray reagents 
Anisaldehyde/sulphuric acid: 1 ml anisaldehyde was added to 100 ml of a 
stock solution containing 85 ml methanol, 14 ml acetic acid and 1 ml sulphuric acid. 
Ehrlich’s reagent: 1 g 4-dimethylaminobenzaldehyde was dissolved in a mixture of 
25 ml hydrochloric acid (37%) and 75 ml methanol; it gives red colouration with 
indole and yellow for other N-heterocycles on heating. Chlorine/o-dianisidin reac-
tion: The reagent was prepared from 100 ml (0.032%) o-dianisidin in 1 N acetic ac-
id, 1.5 g Na2WO4
.
 2 H2O in 10 ml water, 115 ml acetone and 450 mg KI. The mois-
tened TLC plate was kept ca. 30 min in a chlorine atmosphere (from 0.5 g KClO3 + 2 
ml conc. HCl) and then subjected to drying for ca. 1 h, till the excess of chlorine was 
evaporated and then dipped into the reagent. The reagent is specific for peptides as 
universal spraying reagent: Peptides turn blue or bluish green; a brown colour indi-
cates excess chlorine. NaOH or KOH: 2 N NaOH or KOH solutions are used to 
identify peri-hydroxyquinones by deepening of the colour from orange to violet or 
blue. 
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8.4 Microbiological materials  
Fermenter: The 50 L fermenter type U20 (Biostat) consisted of a 70 L metallic 
container (50 L working volume), propeller stirrer, and culture container covered 
with thermostat for autoclaving, cooling and thermostating (Braun Melsungen, Ger-
many). – Storage of strains: Deep-freeze storage in a Dewar vessel, 1’Air liquid 
type BT 37 A. - Capillaries for deep-freeze storage: diameter 1.75 mm, length 80 
mm, Hirschmann Laborgeräte Eberstadt. – Soil for soil culture: Luvos Heilerde LU-
VOS JUST GmbH  Co. Friedrichshof (from the health shop). – Ultraturrax: Janke 
 Munkel KG. – Shaker: Infors AG (CH 4103 Einbach) type ITE. – Laboratory 
shaker: IKA-shaker type S50 (max. 6000 Upm). – Autoclave: Albert Dargatz Auto-
clave, volume 119 L, working temperature 121 C, working pressure 1.2 kg/cm2. - 
Antibiotic assay discs: 9 mm diameter, Schleicher  Schüll No. 321 261. – Culture 
media: glucose (Carl Roth GmbH & Co. KG), agar (C. L. T. Intertrade Co., LTD), 
peptone (Fluka), yeast extract (Hartge Ingredients GmbH & Co. KG), malt extract 
(Aspera Brauerei Reise GmbH), tryptone (Fluka). – Antifoam solution: Niax PPG 
2025; Union Carbide Belgium N. V. (Zwiijndrecht). – Petri dishes: 94 mm diame-
ter, 16 mm height, Fa. Greiner Labortechnik, Nürtingen, Germany. – Celite (diato-
maceous earth): Celite France S. A., Rueil-Malmaison Cedex, France. – Sterile fil-
ters: Midisart 2000, 0.2 m, PTFE-Filter, Sartorius, Göttingen. – Laminar-Flow-
Box: Kojar KR-125, Reinraumtechnik GmbH, Rielasingen-Worblingen 1. – Brine 
shrimp eggs (Artemia salina): SERA Artemia Salinenkrebseier, SERA Heinsberg 
(brine shrimp eggs and food can be obtained from aquaristic shops).  
8.5 Recipes  
All cultures were autoclaved at 1.2 bar and 120 C. Sterilisation time for 1 L 
shaker culture: 33 min, 2 L concentrated medium for fermenter: 50 min and ferment-
er containing 16 L water: 80 min.  
Artificial seawater 
Iron citrate 2 g (powder) 
NaCl 389 g 
MgCl2 · 6H2O 176 g 
Na2SO4  68.8 g 
CaCl2 36.0 g 
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Na2HPO4 0.16 g 
SiO2 0.30 g 
trace element stock soln.  20 mL 
stock soln. 200 mL 
tap water add 20 L 
Trace element stock solution  
H3BO3 0.611 g 
MnCl2 0.389 g 
CuSO4 0.056 g 
ZnSO4 · 7 H2O 0.056 g 
Al2(SO4)3 · 18 H2O 0.056 g 
NiSO4 · 6 H2O 0.056 g 
CO(NO3)3 · 6 H2O 0.056 g 
TiO2 0.056 g 
(NH4)6Mo7O24 · 4 H2O 0.056 g 
LiCl 0.028 g 
SnCl2 0.028 g 
KI 0.028 g 
Tap water ad 1 L 
Stock solution 
KCl 110 g 
NaHCO3 32 g 
KBr 16 g 
SrCl2 · 6H2O 6.8 g (dissolved separately) 
H3BO3 4.4 g 
NaF 0.48 g 
NH4NO3 0.32 g 
Tap water add 2 L 
8.5.1 Nutrients 
M2 medium (without seawater) 
Malt extract 10 g 
Glucose 4 g 
Yeast extract 4 g 
Tap water ad 1 L 
The pH was adjusted to 7.8 using 2N NaOH. Solid medium was prepared by 
adding 18 g of agar. 
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M2
+
 medium (M2 medium with seawater) 
Malt extract 10 g 
Glucose 4 g 
Yeast extract 4 g 
artificial sea water 500 mL 
Tap water 500 mL 
The pH was adjusted to 7.8 using 2N NaOH. Solid medium was prepared by 
adding 18 g of agar. 
Luria-Bertani Medium (LB) 
Trypton 10 g 
Yeast extract 5 g 
NaCl 10 g 
Tap water 1000 mL 
The pH was adjusted to 7.8 using 2N NaOH. Solid medium was prepared by 
adding 18 g of agar. 
LB
+
 Medium (Luria-Bertani medium with glucose)  
Tryptone 10 g 
Yeast 5 g 
Glucose 5 g 
NaCl 10 g 
Tap water 1000 mL 
The pH was adjusted to 7.8 using 2N NaOH. Solid medium was prepared by 
adding 18 g of agar. 
Rice Medium 
rice 100 g 
distilled water 75 mL 
The rice was kept in water overnight before autoclaving. 
Recipes  159 
  
  
M Test Agar (for test organisms Escherichia coli, Bacillus subtilis (ATCC 6051), 
Staphylococcus aureus, Mucor miehei (Tü 284): 
Malt extract 10 g 
Yeast extract 4 g 
Glucose 4 g 
Agar 20 g 
Demineralised water 1000 mL 
The pH was adjusted to 7.8 using 2N NaOH. 
Sabouraud-Agar 
(for test organism Candida albicans) 
Glucose 40 g 
Bacto peptone 10 g 
Agar  20 g 
Demineralised water 1000 mL 
The pH was adjusted to 7.8 using 2N NaOH. 
Nutritional solution A 
Soybean meal (defatted) 30 g 
Glycerol 30 g 
CaCO3 2 g 
Artificial sea water 750 ml 
Demineralised water 250 ml 
Nutritional solution B 
Starch 10 g 
NZ-amine 5 g 
Soybean meal 2g 
Yeast extract 5 g 
KNO3 3 g 
Algal extract 2.5 mL 
Artificial sea water 750 mL 
Demineralised water 250 mL 
 
 
160  Materials and methods 
 
 
8.6 Stock solutions and media for cultivation of algae 
Fe-EDTA  
0.7 g of FeSO4
.
7 H2O and 0.93 g EDTA (Titriplex III) are dissolved in 80 ml of 
demineralised water at 60 C and then diluted to 100 ml.  
Trace element Solution II:  
Solution A: 
MnSO4 · H2O 16.9 mg 
Na2MoO4 · 2H2O 13.0 mg 
Co(NO3)2 · 6H2O 10.0 mg 
Salts are dissolved in 10 ml of demineralised water.  
Solution B: 
CuSO4 · 5H2O 5.0 mg 
H3BO3 10.0 mg 
ZnSO4 · 7H2O 10.0 mg 
Salts are dissolved each in 10 ml of demineralised water. Solutions A is added to 
B and diluted to 100 ml with demineralised water. 
 
Bold’s Basal medium (BBM): (for algae Chlorella vulgaris, Chlorella sorokiniana 
and Scenedesmus subspicatus.  
NaNO3 0.250 g 
KH2PO4 0.175 g 
K2HPO4 0.075 g 
MgSO4 · 7H2O 0.075 g 
NaCl 0.025 g 
CaCl2 · 2H2O 0.025 g 
Fe-EDTA 1.0 mL 
Trace element solution II  0.1 mL 
 
Salts are dissolved in 10 ml of demineralised water and added to Fe-EDTA and 
trace element solution II. The mixture is filled up to one litre with demineralised wa-
ter. Solid medium was prepared by adding 18 g of agar. 
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8.7 Microbiological and analytical methods  
8.7.1  Storage of strains 
All bacteria strains were stored in liquid nitrogen for long time. The strains were 
used to inoculate agar plates with the suitable media at room temperature.  
8.7.2  Pre-screening 
The microbial isolates (obtained from culture collections) were cultured in a 1 L 
scale in 1 L-Erlenmeyer flasks each containing 200250 ml of M2 or (for marine 
strains) M2
+
 medium. The flasks were shaken for 3-5 days at 28 C, after which the 
entire fermentation broth was freeze-dried and the residue extracted with ethyl 
acetate. The extracts were evaporated to dryness and used for the antimicrobial tests 
at 400 g/paper disk.  
8.7.3  Biological screening 
The crude extract was dissolved in CHCl3/10% MeOH (400 g/paper disk), in 
which the paper disks were dipped, dried under sterile conditions (flow box) and put 
on an agar plates inoculated with the Gram-positive bacteria Bacillus subtilis 
(ATCC6051), Staphylococcus aureus and Streptomyces viridochromogenes (Tü 57), 
the Gram-negative Escherichia coli, the yeast, Candida albicans, and the fungi Mu-
cor miehei (Tü 284) along with the three microalgae, Chlorella vulgaris, Chlorella 
sorokiniana, and Scenedesmus subspicatus.  
The plates were incubated at 37 °C for bacteria (12 hours), 27 °C for fungi (24 
hours), and 24-26 °C under daylight for micro-algae (96 hours). The diameters of the 
inhibition zones were measured by ruler. 
8.7.4 Chemical and pharmacological screening 
Samples of the extracts were separated on silica gel glass plates (10  20 cm) 
with two solvent systems CHCl3/5% MeOH and CHCl3/10% MeOH. After drying, 
the plates were photographed under UV light at 254 nm and marked at 366 nm, and 
subsequently stained by anisaldehyde and Ehrlich’s reagent. Finally, the plates were 
scanned for documentation. For the pharmacological investigations, approximately 
25 mg of the crude extract was sent to industrial partners. 
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8.7.5  Brine shrimp microwell cytotoxicity assay 
To a 500 ml separating funnel, filled with 400 ml of artificial seawater, 1 g of 
dried eggs of Artemia salina L. The suspension was aerated by bubbling air into the 
funnel and kept for 24 to 48 hours at room temperature. After aeration had been re-
moved, the suspension was kept for 1 h undisturbed, whereby the remaining un-
hatched eggs dropped. In order to get a higher density of larvae, one side of the sepa-
rating funnel was covered with aluminium foil and the other illuminated with a lamp, 
whereby the phototropic larvae were gathering at the illuminated side and could be 
collected by pipette. 30 to 40 shrimp larvae were transferred to a deep-well microtiter 
plate (wells diameter 1.8 cm, depth 2 cm) filled with 0.2 ml of salt water and the 
dead larvae counted (number N). A solution of 20 g of the crude extract in 5 to 10 
l DMSO was added and the plate kept at room temperature in the dark. After 24 h, 
the dead larvae were counted in each well under the microscope (number A). The 
still living larvae were killed by addition of ca. 0.5 ml methanol so that subsequently 
the total number of the animals could be determined (number G). The mortality rate 
M was calculated in %. Each test row was accompanied by a blind sample with pure 
DMSO (number B) and a control sample with 1 g/test actinomycin D. The mortality 
rate M was calculated using the following formula: 
 
 
100








NG
NBA
M   
with  
M = percent of the dead larvae after 24 h.  
A = number of the dead larvae after 24 h.  
B = average number of the dead larvae in the blind samples after 24 h 
N = number of the dead larvae before starting of the test.  
G = total number of brine shrimps 
The mortality rate with actinomycin D must be 100 %. 
8.7.6 Primary screening results 
Antibiotic screening (disk diffusion test): The test is performed using paper 
discs with a diameter of 8 mm under standardized conditions (see above). If the inhi-
bition zone is ranging from 11 to 20 mm, the compound is considered to be weakly 
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active (+), from 21 to 30 mm designated as active (++) and over 30 mm is highly 
active (+++). - Chemical screening: evaluation of the separated bands by the number, 
intensity and colour reactions with different staining reagents on TLC. - Toxicity 
test: By counting survivors after 24 hrs, the mortality of the extracts was calculated 
(see above). The extracts, fractions or isolated compounds were considered inactive 
when the mortality rate was lower than 10% (-), from 10 to 59% as weakly active 
(+), from 60 to 95% as active (++) and over 95% as strongly active (+++). 
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9 Metabolites from selected bacterial strains 
9.1 Marine Streptomyces sp. B8289 
Culture of the marine Streptomyces sp. B8289 showed a white mycelium on 
agar plates (using M2
+
 agar medium and incubation at 28 °C for four days). Fermen-
tation of the strain as 1 L scale at 28 °C using M2
+
 for three days afforded a brown 
culture broth. After extraction of the filtrate and biomass separately with ethyl ace-
tate (3 times for each of filtrate and biomass), brown extracts were obtained. 
The extracts were tested antimicrobially (see Table 3). The chemical screening 
on TLC showed four middle polar bands after spraying with anisaldehyde/sulphuric 
acid, which turned blue, red and brown. 
Table 3: Antimicrobial activities of the crude extract of marine Streptomyces sp. 
B8289 
Tested microorganisms 
Inhibition zone  [mm] 
Bacillus subtilis  0 
Staphylococcus aureus 13 
Streptomyces viridochromogenes (Tü 57) 11 
Escherichia coli 10 
Candida albicans 0 
Mucor miehei (Tü 284) 12 
Chlorella vulgaris 13 
Chlorella sorokiniana 12 
Scenedesmus subspicatus 11 
9.1.1 Fermentation and Isolation 
The marine Streptomyces sp. isolate B8289 was inoculated from its soil culture 
on three M2
+
 agar plates prepared with tap water. After incubation for 72 hours at 28 
°C, the well-developed colonies were used for up-scaling culture. The up-scaling 
fermentation was carried out in 25 L of M2
+
 medium. The cultures were cultivated at 
110 rpm for 5 days at 28 °C. After 5 days, the cultures were harvested and the broth 
was mixed with ca. 1 kg Celite and filtered by means of a filter press. The biomass 
was extracted with ethyl acetate and acetone until the filtrate was colourless. The 
water phase was adsorbed on XAD-16 resin column and followed by elution with 
methanol. The acetone extract was concentrated to a small volume in vacuo and then 
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extracted with EtOAc. As TLC of both extracts showed similar compositions, they 
were combined and evaporated under vacuum, to yield 3.4 g of brown crude extract.  
The extract was subjected to column chromatography (3  60 cm, 150 g silica 
gel), the column being eluted with CH2Cl2-MeOH gradient (0 to 10% MeOH) and 
separated under TLC control into four fractions. The first fraction contained only 
fatty acids and was not further analysed. The second fraction afforded 2-[5-(2-oxo-
propyl)tetrahydrofuran-2-yl]-propionic acid methyl ester (78, 6.1 mg) after purifica-
tion on Sephadex LH-20 column. The third fraction yielded 2-[5-(2-oxo-propyl)-
tetrahydrofuran-2-yl]-propionic acid (77, 6.3 mg) after purification on Sephadex LH-
20 column. The last fraction was subjected to silica gel column chromatography and 
followed by Sephadex LH-20 column to obtain homononactic acid (79, 100.5 mg) 
and homononactic acid methyl ester (80, 30.1 mg), respectively. 
2-[5-(2-Oxo-propyl)-tetrahydrofuran-2-yl]-
propionic acid (mixture of epimers, 77): Colourless 
oil, non UV absorbing band, turned brown with 
anisaldehyde/sulphuric acid. – Rf = 0.15 (CH2Cl2/5% 
CH3OH). – 
1
H NMR (CDCl3, 300 MHz, minor epimer I/major epimer II 1:2):  = 
8.84 (br s, 1H, COOH), 4.36/4.27 (m, 1H, H-5), 4.13/4.04 (m, 1H, H-2), 2.80 (dd, J 
= 15.9, 6.5 Hz, 1H, HA-3'), 2.55 (dd, J = 15.8, 6.4 Hz, 1H, HB-3'), 2.50 (q, J = 7.0 
Hz, 1H, H-2"), 2.17 (s, 3H, H3-1'), 2.08 (m, 1H, HA-4), 2.00 (m, 1H, HA-3), 1.63 (m, 
1H, HB-3), 1.54 (m, 1H, HB-4), 1.14/1.13 (d, J = 7.0 Hz, 3H, H3-3"). – 
13
C NMR 
(CDCl3, 125 MHz, minor epimer I/major epimer II):  = 207.4/207.3 (Cq-2'), 
179.5 (Cq-1"), 80.4/79.8 (CH-2), 75.6/75.3 (CH-5), 49.6/49.3 (CH2-3'), 45.2/44.7 
(CH-2"), 32.0/30.9 (CH2-4), 30.8/30.6 (CH3-1'), 29.7/28.5 (CH2-3), 13.3/13.0 (CH3-
3"). – (+)-ESI MS: m/z (%) = 223 ([M+Na]+, 60), 423 ([2M+Na]+, 100). – (-)-ESI 
MS: m/z (%) = 199 ([M-H]
-
, 47), 399 ([2M-H]
-
, 100). – (+)-HRESI MS: m/z = 
223.09510 [M+Na]
+
 (calcd. 223.09410 for C10H16O4Na). 
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2-[5-(2-Oxo-propyl)-tetrahydrofuran-2-
yl]-propionic acid methyl ester (mixture of ep-
imers, 78): Colourless oil, non UV absorbing 
band, stained to brown with anisalde-
hyde/sulphuric acid. – Rf = 0.33 (CH2Cl2/5% CH3OH). – 
1
H NMR (CD3OD, 300 
MHz, epimer I/epimer II):  = 4.32/4.21 (m, 1H, H-5), 4.09/3.97 (m, 1H, H-2), 
3.65 (s, 3H, OMe), 2.67 (m, 1H, HA-3'), 2.58 (m, 1H, HB-3'), 2.50 (m, 1H, H-2"), 
2.15 (s, 3H, H3-1'), 2.09 (m, 1H, HA-4), 2.00 (m, 1H, HA-3), 1.65 (m, 1H, HB-3), 1.54 
(m, 1H, HB-4), 1.10/1.08 (d, J = 7.0 Hz, 3H, H3-3"). – 
13
C NMR (CD3OD, 125 
MHz, epimer I/epimer II 1:1):  = 210.02/209.95 (Cq-2'), 177.1/177.0 (Cq-1"), 
82.3/81.7 (CH-2), 76.9/76.6 (CH-5), 52.10/50.08 (CH3-4"), 50.5/50.2 (CH2-3'), 
46.8/46.5 (CH-2"), 33.0/31.9 (CH2-4), 30.7/30.5 (CH3-1'), 30.4/29.4 (CH2-3), 
14.0/13.7 (CH3-3"). – (+)-ESI MS: m/z (%) = 237 ([M+Na]
+
, 36), 451 ([2M+Na]
+
, 
100). – (+)-HRESI MS: m/z = 237.11100 [M+Na]+ (calcd. 237.10970 for 
C11H18O4Na). 
Homononactic acid (79): Colourless oil, non 
UV absorbing band, stained to yellow with anisal-
dehyde/sulphuric acid. – Rf = 0.19 (CH2Cl2/5% 
CH3OH). – 
1
H NMR (CDCl3, 300 MHz):  = 4.06 
(m, 1H, H-2), 3.91 (m, 1H, H-5), 3.64 (m, 1H, H-3'), 2.39 (m, 1H, H-2"), 1.89 (m, 
2H, H-3), 1.54-1.36 (m, 6H, H-4,2',4'), 1.01 (d, J = 7.0 Hz, 3H, 4"-CH3), 0.79 (t, J = 
7.5 Hz, 3H, H-1'). – 13C NMR (CDCl3, 125 MHz):  = 177.8 (Cq-1"), 80.1 (CH-5), 
76.7 (CH-2), 70.1 (CH-3'), 44.9 (CH2-4), 40.8 (CH2-4'), 30.5 (CH-2"), 29.6 (CH2-2'), 
28.4 (CH2-3), 13.3 (CH3-4"), 9.7 (CH3-1). – (+)-ESI MS: m/z (%) = 239 ([M+Na]
+
, 
36), 455 ([2M+Na]
+
, 100). – (+)-HRESI MS: m/z = 239.12620 [M+Na]+ (calcd. 
239.12540 for C11H20O4Na). 
Homononactic acid methyl ester (80): Col-
ourless oil, UV non-absorbing band, turned yellow 
with anisaldehyde/sulphuric acid. – Rf = 0.34 
(CH2Cl2/5% CH3OH). – 
1
H NMR (CDCl3, 300 
MHz):  = 4.06 (m, 1H, H-2), 3.91 (m, 1H, H-5), 3.64 (m, 1H, H-3'), 3.60 (s, 3H, 1"-
COOCH3), 2.44 (dq, 1H, J = 8.2, 7.0 Hz, H-2"), 1.91 (m, 2H, H-3), 1.62-1.37 (m, 
O
CH
3
CH
3
OO
O
CH
3
1
2 5
1"
2"
3"
1'
3'
4"
OH
O
O
OH
1
2 5
2'
3'
1" 2"
O
O
O
OH
1
2 5
2'
3'
1" 2"
Terrestrial Streptomyces sp. Ank86  167 
  
  
6H, H-4,2',4'), 1.04 (d, 3H, J = 7.0 Hz, H-3"), 0.85 (t, 3H, J = 7.4 Hz, H-1). – (+)-
ESI MS: m/z (%) = 253 ([M+Na]
+
, 36), 483 ([2M+Na]
+
, 100). – (+)-HRESI MS: 
m/z = 253.14210 [M+Na]
+
 (calcd. 253.14100 for C12H22O4Na). 
9.2 Terrestrial Streptomyces sp. Ank86 
The terrestrial Streptomyces sp. Ank86 was grown on M2 agar. After incubation 
at 28 ºC for four days, colonies with a white aerial mycelium were formed. This cul-
ture was used for 1 L fermentation in M2 medium at 28 ºC for five days on the round 
shaker. The extract was used for the biological and chemical screening analysis. 
On TLC, it showed several UV absorbing zones, which changed to violet, red, 
and blue with anisaldehyde/sulphuric acid. 
Table 4: Antimicrobial activities of the crude extract of terrestrial Streptomyces 
sp. Ank86 
Tested microorganisms 
Inhibition zone  [mm] 
Bacillus subtilis  13 
Staphylococcus aureus 11 
Streptomyces viridochromogenes (Tü 57) 13 
9.2.1 Fermentation and isolation 
Well-grown plates were inoculated in a 25 L shaker culture on M2 medium and 
grown at 28 ºC on linear shaker. After 6 days, the culture was harvested and the wa-
ter phase and biomass were separated with the aid of a filter press. The water phase 
was subjected to XAD-16 resin column, followed by washing with demineralised 
water. Then, the XAD-16 resin was eluted with methanol. The biomass was extracted 
with ethyl acetate and acetone. The organic extracts were combined based on similar 
compositions of the extracts on TLC. 
The crude extract (2.4 g) was chromatographed on a silica gel column (3  60 
cm, 150 g) using gradient solvent system of dichloromethane and methanol (0 to 
15% MeOH) to afford four fractions. Fraction I contained fats and was not further 
investigated. The purification of fraction II with Sephadex LH-20 (MeOH as eluent) 
and RP-18 columns delivered 4-hydroxy-2-methoxyacetanilide (81, 2.10 mg). The 
purification of fraction III with Sephadex LH-20 using methanol as solvent system 
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afforded tryptophol. And finally, the fourth fraction was subjected to Sephadex LH-
20 (MeOH as eluent) to isolate actinomycin D (82, 30.4 mg). 
4-Hydroxy-2-methoxyacetanilide (81): Colourless solid, 
UV absorbing at 254 nm, no colour reaction with anisalde-
hyde/sulphuric acid. – Rf = 0.5 (CH2Cl2/5% MeOH). – 
1
H NMR 
(CD3OD, 300 MHz):  = 7.56 (dd, 
3
J = 8.2 Hz, 
4
J = 1.9 Hz, 1H, 
2-H), 7.52 (d, 
4
J = 1.9 Hz, 1H, 5-H), 6.85 (d, 
3
J = 8.2 Hz, 1H, 3-
H), 3.89 (s, 3H, 9-H), 2.53 (s, 3H, 8-H). – (+)-ESI MS: m/z (%) 
= 182 ([M+H]
+
, 32), 204 ([M+Na]
+
, 100). – (+)-HRESI MS: m/z = 182.08125 
([M+H]
+
), 204.06321 ([M+Na]
+
) (calc. 204.06311 for C9H11NO3Na). 
Actinomycin D (82): Reddish-orange solid, 
UV absorbing zone at 254 nm, and red with anisal-
dehyde/sulphuric acid, no colour change with 2 N 
NaOH, deep red colour reaction with conc. H2SO4. 
– Rf = 0.37 (CHCl3/MeOH 95:5). – 
1
H NMR 
(CDCl3, 300 MHZ):  = 8.13 (d br, 
3
J = 6.4 Hz, 1 
H, NH-Valα), 7.97 (d br, 
3
J = 6.4 Hz, 1 H, NH-
Valβ), 7.81 (d br, 
3
J = 6.4 Hz, 1 H, NH-Thrβ), 7.67 
(d, 
3
J = 7.9 Hz, 1 H, H-8), 7.39 (d, 
3
J = 7.9 Hz, 1 H, 
7-H), 7.21 (d br, 
3
J = 6.4 Hz, 1 H, NH-Thrα), 6.03 
(d, 
3
J = 9.1 Hz, 1 H, H-2, Proα), 5.96 (d, 
3
J = 9.1 Hz, 1 H, H-2 Proβ), 5.25-5.15 (m, 2 
H, H-3, Thrα,β), 4.81 (d, 
3
J = 18.1 Hz, 1 H, Ha-2, Sarα), 4.73 (d, 
3
J = 18.8 Hz, 1 H, 
Ha-2, Sarβ), 4.61 (dd, 
3
J = 6.4 Hz, 
3
J = 2.3 Hz, 1 H, H-2, Thrα), 4.49 (dd, 
3
J = 6.4, 
3
J 
= 2.3 Hz, 1 H, H-2, Thrβ), 4.03-3.40 (m, 8 H, Hb-2 Sarα,β, H-2, Valα,β, H2-5, Proα,β), 
2.93, 2.90, 2.88 (3 s, 3 H + 3 H + 6 H, NCH3 Me- Valα,β, NCH3, Sarα,β), 2.67, 2.57 (m 
+ s, 6 + 3, Ha-3, Proα,β, H-2,3, MeValα,β, CH3-6), 2.38-1.76 + 2.23 (m + s, 8 + 3 H, 
Hb-3, H2-4, Proα,β H-3, Valα,β CH3-4), 1.28 (m, 6 H, CH3, Thrα,β), 1.17-1.07 (m, 6 H, 
CH3, Valα,β), 0.99-0.82 (m, 12 H, CH3 Valα,β, CH3, Valα,β), 0.75 (d, 
3
J = 4.9 Hz, 6 H, 
CH3, Valα,β). – (+)-ESI MS: m/z (%) = 1277 ([M+Na]
+
, 100), 1255 ([M + H]+, 6). – 
(-)-ESI MS: m/z (%) = 1254 ([M-H]
-
). 
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9.3 Terrestrial Streptomyces sp. Ank68 
The bioassay of the crude extract, of 1 L fermentation in M2 medium at 28 ºC 
for three days, from strain Ank68 exhibited strong activities against bacteria, fungi, 
algae, and Artemia salina (brine shrimp).It showed strong UV absorbing zones at 
254 and 366 nm, strong red and black colour reactions with anisaldehyde/sulphuric 
acid. 
Table 5: Antimicrobial activities of the crude extract of terrestrial Streptomyces 
sp. Ank68 
Tested microorganisms 
Inhibition zone  [mm] 
Bacillus subtilis  40 
Staphylococcus aureus 29 
Streptomyces viridochromogenes (Tü 57) 24 
Escherichia coli 0 
Candida albicans 20 
Mucor miehei (Tü 284) 22 
Chlorella vulgaris 19 
Chlorella sorokiniana 19 
Scenedesmus subspicatus 18 
Artemia salina 100% 
9.3.1 Fermentation and isolation 
The terrestrial Streptomyces sp. Ank68 was grown on agar of M2 medium. After 
incubation at 28 ºC for four days, white mycelium colonies were formed. These well-
grown plates of Streptomyces sp. Ank68 were inoculated and grown in a 25 L shaker 
culture of M2 medium at 28 ºC on linear shaker. After 5 days, the cultures were har-
vested and mixed with Celite to separate water phase and biomass by using the filter 
press. The water phase was subjected to XAD-16 column, and followed by washing 
with demineralised water. After that, the XAD resin was eluted with methanol. The 
biomass was extracted with ethyl acetate and acetone. On the basis of TLC, these 
three organic extracts were combined. 
The crude extract (4.43 g) was then chromatographed on a silica gel column (3  
75 cm, 150 g) using a gradient solvent systems of dichloromethane and methanol 
(100% CH2Cl2 to 20% methanol in dichloromethane) to afford three fractions. From 
fraction II, actinomycin D (82, 20. 30 mg) was isolated after purification steps with 
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preparative thin layer chromatography (PTLC) and Sephadex LH-20 column 
(MeOH). Fraction III was subjected subsequently to Sephadex LH-20 (MeOH) and 
RP-18 (MeOH/H2O) columns to obtain fungichromin (83, 4.15 mg). Fraction I con-
tained fats and revealed blue spots after staining with anisaldehyde/sulphuric acid; it 
was not further investigated. 
Fungichromin (83): 
Highly polar yellow solid, UV 
fluorescent band at 366 nm, 
black with anisalde-
hyde/sulphuric acid. – Rf = 
0.17 (CH2Cl2/10% MeOH). – 
1
H NMR (DMSO-d6, 300 MHz):  = 6.49-6.23 (m, 7H, 18,19,20,21,22,23,24-H), 
5.94 (d, 
3
J = 10.9 Hz, 2H, 17,25-H), 5.23-3.48 (m, 11H, 1',3,5,7,9,11,13,14,15,26,27-
H), 2.45 (m, 1H, 2-H), 1.69 (s, 3H, 29-H), 1.40-1.07 (m, 21H, 2',3',4,4',5',6,8,10,12, 
28-H), 0.85 (m, 3H, 6'-H). – 13C NMR (DMSO-d6, 300 MHz):  = 170.4 (C-1), 
138.7 (C-16), 134.9 (CH-19), 133.21 (CH-21), 133.20 (CH-25), 133.0 (CH-23), 
132.9 (CH-20), 132.8 (CH-22), 129.1 (CH-24), 127.1 (CH-17), 127.0 (CH-18), 78.1 
(CH-15), 76.5 (CH-14), 73.1 (CH-27), 71.2 (CH-9), 71.1 (CH-5), 70.4 (CH-7), 70.3 
(CH-3), 70.0 (CH-26), 69.7 (CH-1'), 69.6 (CH-11), 69.2 (CH-13), 58.7 (CH-2), 43.9 
(CH2-8), 43.8 (CH2-6), 42.9 (CH2-10), 40.1 (CH2-4), 38.6 (CH2-12), 34.2 (CH2-2'), 
31.2 (CH2-4'), 24.5 (CH2-3'), 22.0 (CH2-5'), 17.7 (CH3-29), 13.8 (CH3-6'), 11.6 (CH3-
28). – (+)-ESI MS: m/z (%) = 671 ([M+H]+, 63), 693 ([M+Na]+, 100), 1363 
([2M+Na]
+
, 90). – (–)-ESI MS: m/z (%) = 669 ([M-H]-, 38), 1339 ([3M-H]-, 96). – 
(+)-HRESI MS: m/z = 671.40010 ([M+H]
+
) (calc. 671.39984 for C35H59O12). 
9.4 Terrestrial Streptomyces sp. Ank248 
The well-grown agar plate of the terrestrial Streptomyces sp. Ank248 isolate was 
used for inoculation in 1 L M2 medium and the culture was incubated for 3 days at 28 
ºC on linear shaker (95 rpm). The culture broth was then extracted with ethyl acetate 
to afford the crude extract for pre-screening. 
The biological activity assay resulted in weak antimicrobial activity against bac-
teria, but it showed strong activity against Artemia salina.  
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Table 6: Antimicrobial activities of the crude extract of terrestrial Streptomyces 
sp. Ank248 
Tested microorganisms 
Inhibition zone  [mm] 
Bacillus subtilis  15 
Staphylococcus aureus 11 
Streptomyces viridochromogenes (Tü 57) 12 
Escherichia coli 11 
Artemia salina 100% 
9.4.1 Fermentation and isolation 
Well-developed colonies on agar plates were used for inoculation of 10 L of LB 
medium. The culture was incubated at 28 ºC on linear shaker (95 rpm) for 4 days. 
The resulting brown culture broth was mixed with Celite and pressed through a filter 
press to afford the aqueous filtrate and the mycelial residue. The aqueous phase was 
extracted by Amberlite XAD-16 resin using methanol as the eluent. The biomass was 
extracted with ethyl acetate and acetone separately. Then, all three organic extracts 
were evaporated to dryness under reduced pressure. On TLC, all three crude extracts 
showed the same spot pattern and accordingly they were combined to obtain 1.23 g 
of brown crude extract. This extract was then dissolved in methanol and subjected to 
Sephadex LH-20 column using MeOH/CH2Cl2 (4:6) solvent system to afford four 
fractions. Fraction II was purified on Sephadex LH-20 column using methanol as 
eluent and followed by RP-18 column using MeOH/H2O as eluent system to isolate 
1-acetyl--carboline (84, 11.3 mg). Fraction III and fraction IV were subjected to 
Sephadex LH-20 columns with methanol as eluent to obtain tryptophol and 3-
hydroxy-acetylindole. 
1-Acetyl--carboline (84): Brownish powder, UV ab-
sorbing band at 254 nm, pale yellow with anisalde-
hyde/sulphuric acid. – Rf = 0.31 (CH2Cl2/5% MeOH). – 
1
H 
NMR (CDCl3, 300 MHz):  = 10.28 (br s, NH), 8.53 (d, 
3
J 
= 4.9 Hz, 1H, 4-H), 8.15-8.13 (m, 2H, 3,5-H), 7.58 (dd, 
4
J = 1.1 Hz, 
3
J = 6.7 Hz, 2H, 
7,8-H), 7.32 (m, 1H, 6-H), 2.88 (s, 3H, COCH3). 
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9.5 Terrestrial Streptomyces sp. Ank181 
The marine Streptomyces sp. Ank 181 grew as white aerial mycelium colonies 
when cultivated on M2
+
 medium agar plates at 28 °C for 3 days. The chemical 
screening showed UV absorbing zones as colourless and strongly blue florescent 
(365 nm) bands in the non polar region and absorbing zones (254 nm) in the middle 
polar region, which turned dark green, violet and red with anisaldehyde/sulphuric 
acid. 
Table 7: Antimicrobial activities of the crude extract of terrestrial Streptomyces 
sp. Ank181 
Tested microorganisms 
Inhibition zone  [mm] 
Bacillus subtilis  0 
Staphylococcus aureus 0 
Streptomyces viridochromogenes (Tü 57) 0 
Escherichia coli 0 
Candida albicans 0 
Mucor miehei (Tü 284) 0 
Chlorella vulgaris 0 
Chlorella sorokiniana 0 
Scenedesmus subspicatus 0 
Artemia salina 100% 
9.5.1 Fermentation and isolation 
Well-grown agar plates of the terrestrial Streptomyces sp. Ank 181 were used to 
inoculate a shaker culture on M2
 
medium, which was cultivated for 6 days at 28 °C 
affording a faint yellow broth. The resulting culture was harvested and filtered over 
Celite using a filter press. The filtrate was extracted by XAD-16, and the absorbed 
metabolites were eluted with methanol. The methanol phase was evaporated and the 
resulting water residue was extracted by ethyl acetate. The biomass was extracted 
with acetone and the water residue obtained after concentration was extracted with 
ethyl acetate. The combined organic phases were evaporated under vacuum to afford 
a yellow-brown crude extract (3.10 g). 
TLC of the strain extract showed mostly middle polar UV absorbing bands at 
254 nm, which stained to green, red and violet with anisaldehyde/sulphuric acid and 
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heating. Additionally, a fast moving band was found, which turned dark green by 
spraying with anisaldehyde/sulphuric acid and heating. 
The crude extract (3.10 g) was subjected to column chromatography on silica 
gel and was eluted with a CH2Cl2/MeOH gradient system (100% CH2Cl2, CH2Cl2/ 
3% MeOH, CH2Cl2/ 5% MeOH, CH2Cl2/10% MeOH, CH2Cl2/ 20% MeOH, 
CH2Cl2/40% MeOH) to give four fractions, which were monitored by TLC. Fraction 
I contained fats and was not further continued for investigation. Fractions II, III, and 
IV were subjected to Sephadex LH-20 columns using methanol as the solvent system 
to obtain reductiomycin (85, 20.1 mg), 2,3-dihydroxybenzoic acid and indole-3-
carboxylic acid, respectively. 
Reductiomycin (85): Middle polar yel-
low solid, UV absorbing band at 254 nm, 
and green with anisaldehyde/sulphuric acid. 
– Rf = 0.30 (CH2Cl2/5% MeOH). – 
1
H 
NMR (CDCl3, 300 MHz):  = 13.76 (br s, 1 H, 3-OH), 7.68 (br s, 1 H, 2-NH), 7.50 
(d, 
3
J = 15.1 Hz, 1 H, H-3''), 6.90 (s, 1 H, H-5'), 6.70 (dd, 
3
J = 7.5, 2.3 Hz, 1 H, H-2'), 
5.81 (d, 
3
J = 15.1 Hz, 1 H, H-2''), 3.05 (m, 1 H, HA-3'), 2.60 (m, 5 H, 4/5-CH2, HB-
3'). – (–)-ESI MS: m/z (%) = 607 ([2M-H+Na]-, 100), 292 ([M-H]-, 77). 
9.6 Ruminal Bacterium Enterobacter amnigenus ZIA 
The strain of Enterobacter amnigenus ZIA was isolated and identified by Imene 
Zendah from rumen cow in Tunisia. The strain was cultivated on LB agar medium at 
37 ºC for 24 hours. In the biological screening, the crude extract of the ruminal bac-
terium Enterobacter amnigenus ZIA did not give biological activity against tested-
microorganisms. 
9.6.1 Fermentation and isolation 
Pieces of well-gown agar plates were used to inoculate in 40 of 1 L Erlenmeyer 
flasks, each containing 250 mL of sterilized LB medium. The fermentation was car-
ried out on linear shaker (180 rpm) at 28 ºC for 4 days. The culture broth was har-
vested and mixed with Celite. The Celite-mixture of the culture broth was then fil-
tered with a filter press to obtain the water phase and biomass. The biomass was ex-
tracted with ethyl acetate (3 times) and acetone (2 times), respectively. The filtrate 
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was passed on the XAD-16 resin column, washed with 15 L demineralised water, 
and then eluted with 15 L methanol. After evaporating the solvents, all the organic 
phases were combined together based on thin layer chromatogram. 
The crude extract (3.3 g) was then chromatographed on silica gel (column 3  
60 cm, 150 g) using a CH2Cl2/MeOH gradient (1.5 L CH2Cl2, 1.0 L CH2Cl2/2% 
MeOH), 1.0 L CH2Cl2/3% MeOH, 1.0 L CH2Cl2/5% MeOH, 0.5 L CH2Cl2/10% 
MeOH, CH2Cl2/20% MeOH, 0.5 L CH2Cl2/50% MeOH, and 0.5 L MeOH), which 
afforded four main fractions. The purification of fraction II with Sephadex LH-20 
delivered poly-(hydroxybutyric acid) (PHB) (86, 8.8 mg) and indole-3-acetic acid. 
From fraction III, uracil and tyrosol were isolated through Sephadex LH-20 chroma-
tography (methanol as eluent). Hypoxanthine and butyl glycoside (87, 1.0 mg) were 
purified from fraction IV by Sephadex LH-20 (MeOH) and RP-18 (MeOH:H2O) 
chromatography columns, respectively. 
Poly-(hydroxybutyric acid) (PHB) (86): White 
solid, no UV absorbing band, and pink with anisalde-
hyde/sulphuric acid. – Rf = 0.57 (CH2Cl2/10% MeOH). 
– 1H NMR (CDCl3, 300 MHz):  = 5.20 (m, 1H, CH), 
2.45 (dd, 1H, 
3
J = 7.4 Hz, 
2
J = 15.5 Hz, CH2), 1.22 (d, 
3
J = 6.3 Hz, CH3). 
Butyl glycoside (87): Pale yellow oil, no 
UV absorbing band, green with anisalde-
hyde/sulphuric acid. – Rf = 0.11 (CH2Cl2/10% 
MeOH). – 1H NMR (CD3OD, 300 MHz):  = 
4.72 (d, 
3
J = 1.5 Hz, 1H, 1'-H), 3.81-3.39 (m, 9H, 1,1', 2',3',4',5',6'-H), 1.56 (m, 2H, 
2-H2), 1.41 (m, 2H, 3-H2), 0.93 (t, 
3
J = 7.3 Hz, 3H, 4-H3). – 
13
C NMR (CD3OD, 125 
MHz):  = 101.5 (CH-1'), 74.5 (CH-2'), 72.6 (CH-3'), 72.3 (CH-4'), 68.6 (CH-5'), 
68.2 (CH2-1), 62.9 (CH2-6'), 32.7 (CH2-2), 20.5 (CH2-3), 14.3 (CH3-4). – (+)-ESI 
MS: m/z (%) = 259.1 ([M+Na]
+
, 100), 495.2 ([2M+Na]+, 17). – (+)-HRESI MS: 
m/z = 259.11536 ([M+Na]
+
) (calc. 259.11521 for C10H20O6Na). 
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9.7 Terrestrial Streptomyces sp. Ank75 
The terrestrial Streptomyces sp. Ank75 was grown on M2 agar medium for 3 
days at 28 ºC, forming a white aerial mycelium. This culture was used for 1 L fer-
mentation in M2 medium at 28 ºC for three days on the round shaker. The crude ex-
tract of the strain presented activities against fungi Candida albicans and Mucor 
miehei (Tü 284) as shown in Table 8. The TLC exhibited several UV absorbing 
zones, which changed to red, and green with anisaldehyde/sulphuric acid. 
Table 8:  Antimicrobial activities of the crude extract of terrestrial Streptomyces 
sp. Ank75 
Tested microorganisms 
Inhibition zone  [mm] 
Bacillus subtilis  0 
Staphylococcus aureus 0 
Streptomyces viridochromogenes (Tü 57) 0 
Escherichia coli 0 
Candida albicans 15 
Mucor miehei (Tü 284) 25 
Chlorella vulgaris 33 
Chlorella sorokiniana 31 
Scenedesmus subspicatus 0 
9.7.1 Fermentation and Isolation 
The Ank75 strain was fermented in 25 L scale on M2 medium for 5 days at 28 
ºC. The culture broth was filtered over Celite and the water phase was adsorbed on 
resin Amberlite XAD-16 column and eluted with methanol after washing with de-
mineralised water prior to the elution with methanol. The biomass was exhaustively 
extracted with ethyl acetate and acetone. TLC of crude extract from each organic 
residues was identical, thus the three extracts (5.4 g) were combined together for 
further work-up procedure. 
The separation of crude extract (5.4 g) was performed by silica gel column 
chromatography (3  75 cm, 200 g) using aCH2Cl2/CH3OH gradient. Based on the 
spot pattern on the TLC, four fractions were selected for further purification. Frac-
tion II was subjected to Sephadex LH-20 column with methanol as the eluent to af-
ford benadrostin (88, 1.6 mg) and 2-O-methylpyrogallol (89, 1.1 mg). From fraction 
III, N-aminocarbonyl-2,3-dihydroxybenzamide (91, 1.2 mg), 2,3-dihydroxybenz-
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amide (92, 1.3 mg), and 2,3-dihydroxybenzoic acid (1.5 mg) were isolated via Se-
phadex LH-20 column using CH3OH/CH2Cl2 (6:4) as the solvent system. Bandamy-
cin (94, 1.2 mg) and 3-[(1Z)-1-hexenyl-ONN-azoxyl]-1,2-butanediol (93, 1.1 mg) 
were isolated from fraction IV after being subjected to Sephadex LH-20 (MeOH) and 
RP-18 (MeOH:H2O) columns. Finally, the fraction V delivered N
6
,N
6
-dimethyl-
adenosine (95, 2.3 mg). 
Benadrostin (88): Colourless solid. – Rf = 0.20 
(CH2Cl2/5% MeOH), strong UV absorbing band at 254 nm, 
orange with anisaldehyde/sulphuric acid. – 1H NMR (DMSO-
d6, 300 MHz ):  = 11.17 (br s, 1H, 3-H), 7.35 (dd, 
3
J = 7.5 Hz, 
4
J = 1.7 Hz, 1H, 5-H), 7.24 (dd, 
3
J = 7.9 Hz, 
4
J = 1.7 Hz, 1H, 
7-H), 7.18 (t, 
3
J = 7.7 Hz, 1H, 6-H). – (–)-ESI MS: m/z (%) = 178 ([M-H]-, 100), 
356 ([2M-H]
-
, 80), 379 ([2M-H+Na])
-
. – (–)-HRESI MS: m/z = 178.01403 ([M-H]-), 
(calculated 178.01348 for C8H4NO4). 
2-O-Methylpyrogallol (89): Colorless oil, UV absorbing 
band at 254 nm and red with anisaldehyde/sulphuric acid. – Rf = 
0.23 (CH2Cl2/5% MeOH). – 
1
H NMR (acetone-d6, 300 MHz ):  
= 6.72 (t, 
3
J = 8.1 Hz, 1H, 5-H), 6.37 (d, 
3
J = 8.1 Hz, 2H, 4,6-H), 
3.77 (s, 3H, 7-H3). – 
13
C NMR (acetone-d6, 125 MHz ):  = 151.5 (C-1,2,3), 124.6 
(CH-5), 108.3 (CH-4,6), 60.5 (CH3-7). – (+)-EI MS (70 eV) m/z (%) = 142 
([M+2H]
+
, 12), 140 ([M]
+
, 92), 125 (100), 97 (36), 79 (8), 51 (12). – (+)-HRESI 
MS: m/z = 140.04730 ([M]
+
), (calculated 140.04730 for C7H8O3). 
N-Aminocarbonyl-2,3-dihydroxybenzamide (91): Brown 
solid. – Rf = 0.17 (CH2Cl2/5% MeOH), strong UV absorbing band 
at 254 nm, pink with anisaldehyde/sulphuric acid. – 1H NMR 
(CD3OD, 300 MHz ):  = 7.45 (dd, 
3
J = 8.1 Hz, 
4
J = 1.5 Hz, 1H, 6-
H), 7.00 (dd, 
3
J = 7.8 Hz, 
4
J = 1.5 Hz, 1H, 4-H), 6.79 (t, 
3
J = 7.9 
Hz, 1H, 5-H). – (+)-ESI MS: m/z (%) = 197 ([M+H]+, 68), 219 
([M+Na]
+
, 100). – (+)-HRESI MS: m/z = 197.05573 ([M+H]+), (calculated 
197.05568 for C8H9N2O4). 
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2,3-Dihydroxybenzamide (92): Strong UV absorbing band at 
254 nm and no colour reaction with anisaldehyde/sulphuric acid. – 
Rf = 0.26 (CH2Cl2/5% MeOH). – UV/VIS (MeOH): max (log ) = 
214 (4.06), 319 (3.29) nm. – 1H NMR (CD3OD, 300 MHz ):  = 
7.33 (dd, 
3
J = 7.9 Hz, 
4
J = 1.5 Hz, 1H, 6-H), 6.89 (dd, 
3
J = 7.9 Hz, 
4
J = 1.5 Hz, 1H, 4-H), 6.64 (t, 
3
J = 7.9 Hz, 1H, 5-H). – 13C NMR (CD3OD, 125 
MHz ):  = 174.8 (C-1'), 151.6 (C-2), 146.8 (C-3), 122.0 (CH-6), 120.7 (CH-4), 
119.2 (CH-5), 116.0 (C-1). – (–)-ESI MS: m/z (%) = 152 ([M-H]-, 50). – (–)-HRESI 
MS: m/z = 152.03535 ([M-H]
-
), (calculated 152.03532 for C7H6NO3). 
3-[(1Z)-1-Hexenyl-ONN-azoxyl]-
1,2-butanediol (93): Colourless oil, UV 
absorbing band at 254 nm, yellow-green 
with anisaldehyde/sulphuric acid. – Rf = 
0.19 (CH2Cl2/5% MeOH). – 
1
H NMR (CD3OD, 300 MHz ):  = 6.78 (d, 1H, 
3
J = 
9.1 Hz, 1'-H), 5.78 (m, 1H, 2'-H), 4.16 (m, 1H, 3-H), 3.76 (m, 1H, 2-H), 3.56 (m, 2H, 
1-H), 2.60 (m, 2H, 3'-H), 1.49-29 (m, 4H, 4',5'-H), 1.17 (d, 3H, 
3
J = 6.6 Hz, 4-H), 
0.92 (t, 3H, 
3
J = 7.1 H, 6'-H). – (+)-ESI MS: m/z (%) = 239 ([M+Na]+, 90.6), 455 
([2M+Na]
+
, 100). – (+)-HRESI MS: m/z = 239.13680 ([M+Na]+), (calculated 
239.1366 for C10H20N2O3Na). 
Bandamycin (94): Colourless oil, UV 
absorbing band at 254 nm, green with 
anisaldehyde/sulphuric acid. – Rf = 0.16 
(CH2Cl2/5% MeOH). – UV/VIS (MeOH): 
max (log ) = 222 (3.64) nm. – IR (KBr): v = 3420, 2937, 1710, 1505, 1457, 1376, 
1316, 1119, 1065 cm
-1
. – 1H NMR (DMSO-d6, 300 MHz ):  = 4.73 (br s, 1H, OH), 
4.48 (br s, 1H, OH), 4.10 (t, 
3
J = 6.9 Hz, 2H, 1'-H2), 3.94 (quint, 
3
J = 6.5 Hz, 1H, 3-
H), 3.55 (m, 1H, 2-H), 3.34 (m, 2H, 1-H2), 2.49 (m, 2H, 3'-H2, overlapped by 
DMSO), 2.41 (q, 
3
J = 7.38 Hz, 2H, 5'-H2), 2.00 (quintet, 
3
J = 6.98 Hz, 2H, 2'-H2), 
1.01 (d, 
3
J = 6.5 Hz, 3H, 4-H3), 0.92 (t, 
3
J = 7.3 Hz, 3H, 6'-H3). – 
13
C NMR (DMSO-
d6, 125 MHz ):  = 209.7 (C-4'), 73.0 (CH-2), 68.6 (CH2-1'), 63.3 (CH2-1), 56.5 
(CH-3), 37.6 (CH2-3'), 34.9 (CH2-5'), 21.5 (CH2-2'), 11.6 (CH3-4), 7.5 (CH3-6'). – 
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(+)-ESI MS: m/z (%) = 255 ([M+Na]
+
, 100), 487 ([2M+Na]
+
, 6). – (+)-HRESI MS: 
m/z = 255.13159 ([M+Na]
+
) (calc. 255.13153 for C10H20N2O4Na). 
N
6
,N
6
-Dimethyl-adenosine (95): Pale yellow oil.  Rf = 
0.12 (CH2Cl2/5% MeOH), UV absorbing band at 254 nm, 
greenish yellow with anisaldehyde/sulphuric acid. – 1H NMR 
(CD3OD, 300 MHz ):  = 8.18 (s, 1H, 8-H), 8.15 (s, 1H, 2-H), 
5.94 (d, 
3
J = 6.5 Hz, 1'-H), 4.74 (m, 1H, 2'-H), 4.31 (dd, 
3
J = 
5.1, 2.5 Hz, 1H, 3'-H), 4.16 (q, 
3
J = 2.5 Hz, 1H, 4'-H), 3.87 (m, 
2H, 5'-H), 3.47 (br s, 3H, N-CH3), 3.34 (s, 3H, N-CH3). – (+)-
ESIMS m/z = 296 ([M+H]
+
, 100). – (+)-EIMS (70 eV) m/z (%) = 295 ([M]+, 16), 
206 (24), 192 (50), 163 (52), 148 (28), 134 (100).  
9.8 Marine Streptomyces sp. B5798 
In the biological screening, the crude extract B5798 demonstrated 90% activity 
against Artemia salina, but it did not show any activities against bacteria, fungi and 
algae. 
9.8.1 Fermentation and isolation 
The well-grown agar plates were inoculated into 25 L shaker culture of M2
+
 me-
dium and grown at 28 ºC for 5 days on linear shaker. After 5 days, the culture broth 
was harvested and mixed with Celite to separate mycelium and the water phase with 
the aid of filter press. The mycelium was extracted with ethyl acetate and acetone, 
while the water phase was passed through XAD-16 resin column and eluted with 
methanol. Due to the similar compositions of each crude extracts on the TLC, they 
were combined and the constituents were isolated using different chromatographic 
techniques. 
The crude extract (6.4 g) was subjected to silica gel chromatography column (3 
 75 cm, 150 g) using gradient of CH2Cl2/MeOH solvent systems (1.5 L CH2Cl2, 1.0 
L CH2Cl2/2% MeOH), 1.0 L CH2Cl2/3% MeOH, 1.0 L CH2Cl2/5% MeOH, 0.5 L 
CH2Cl2/10% MeOH, CH2Cl2/20% MeOH, 0.5 L CH2Cl2/50% MeOH, and 0.5 L 
MeOH). Fractions II and III were purified separately with Sephadex LH-20 column 
and methanol as the eluent to isolate p-hydroxyphenylacetic acid (96, 1.4 mg), in-
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dole-3-carboxylic acid and indole-3-acetic acid, respectively. Finally, fraction IV 
was subjected to Sephadex LH-20 and RP-18 columns to obtain macrolactin-A (97, 
2.46 mg) as oily compound. 
p-Hydroxyphenylacetic acid (96): Colourless solid, 
UV absorbing band at 254 nm, red with anisalde-
hyde/sulphuric acid. – Rf = 0.49 (CH2Cl2/5% MeOH). – 
1
H 
NMR (CD3OD, 300 MHz):  = 7.08 (d, J = 8.6 Hz, 2H, 2,6-H), 6.73 (d, J = 8.6 Hz, 
2H, 3,5-H), 3.47 (s, 2H, 2'-H). 
Macrolactin A (97): Reddish oil, UV ab-
sorbing band at 254 nm, black with anisalde-
hyde/sulphuric acid. – Rf = 0.25 (CH2Cl2/10% 
MeOH). – 1H NMR (CDCl3, 300 MHz):  = 
7.16 (dd, 
3
J = 14.9, 11.7 Hz, 1H, 4-H), 6.56 (dd, 
3
J = 11.4, 10.9 Hz, 2H, 3,9-H), 6.09 (m, 4H, 
18,17,10,5-H), 5.75 (dd, 
3
J = 15.1, 5.1 Hz, 1H, 8-H), 5.65-5.34 (m, 4H, 19,16,11,2-
H), 5.01 (m, 1H, 23-H), 4.48 (m, 1H, 15-H), 4.32 (m, 1H, 7-H), 4.17 (br s, 3H, 
15,13,7-OH), 3.95 (m, 1H, 13-H), 2.43 (m, 4H, 12,6-H), 2.02 (m, 2H, 20-H), 1.62 
(m, 4H, 22,14-H), 1.50 (m, 2H, 21-H), 1.26 (d, 
3
J = 6.3 Hz, 3H, 24-H). – 13C NMR 
(CDCl3/CD3OD, 125 MHz):  = 167.6 (C-1), 144.4 (CH-3), 141.5 (CH-5), 136.8 
(CH-8), 134.6 (CH-16), 134.2 (CH-19), 131.0 (CH-18), 130.9 (CH-17), 130.6 (CH-
10), 129.6 (CH-4), 127.8 (CH-11), 125.3 (CH-9), 117.6 (CH-2), 71.9 (CH-23), 71.7 
(CH-7), 69.5 (CH-15), 68.9 (CH-13), 42.4 (CH2-14), 42.2 (CH2-6), 35.8 (CH2-12), 
35.5 (CH2-22), 32.5 (CH2-20), 25.1 (CH2-21), 20.1 (CH3, C-24). – (+)-ESIMS: m/z 
(%) = 425 ([M+Na]
+
, 100), 827 ([2M+Na]
+
, 86). – (+)-HRESIMS: m/z 425.22980 
[M+Na]
+
, (calcd. 425.22970 for C24H34O5Na). 
9.9 Terrestrial Streptomyces sp. GT-2005/049 
The culture of the terrestrial Streptomyces sp. GT-2005/049 exhibited white my-
celium on M2 agar medium after incubation at 28 ºC for four days. Fermentation of 
the strain in 1 L scale of M2 at 28 ºC and 95 rpm for 5 days afforded a brown culture. 
After extraction of the filtrate and biomass with ethyl acetate, a brown crude extract 
was obtained. 
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The crude extract was then tested antimicrobially and the activity result was pre-
sented in Table 9. 
Table 9:  Antimicrobial activities of the crude extract of terrestrial Streptomyces 
sp. GT-2005/049 
Tested microorganisms 
Inhibition zone  [mm] 
Bacillus subtilis  15 
Staphylococcus aureus 22 
Streptomyces viridochromogenes (Tü 57) 17 
Escherichia coli 16 
Candida albicans 0 
Mucor miehei (Tü 284) 26 
Chlorella vulgaris 0 
Chlorella sorokiniana 0 
Scenedesmus subspicatus 0 
9.9.1 Fermentation and isolation 
The well-grown agar plate of the terrestrial Streptomyces sp. GT-2005/049 was 
inoculated into 100 of 1 L Erlenmeyer flasks containing 300 ml of M2 medium (pH 
7.8 before sterilisation) in each flask. The culture was incubated on linear shaker 
culture at 28 ºC for 6 days. The culture was harvested after 6 days and the resulting 
brown culture broth was filtered over Celite using a filter press. The filtrate and the 
mycelial cake were separately extracted by ethyl acetate and acetone. The combined 
extracts, prior to monitoring on TLC, were evaporated to dryness under reduced 
pressure to afford a brown crude extract (4.1 g). 
The separation of the crude extract was performed on silica gel column chroma-
tography (3  60 cm, 150 g) by gradient solvent systems (1.5 L CH2Cl2, 1.0 L 
CH2Cl2/2% MeOH), 1.0 L CH2Cl2/3% MeOH, 1.0 L CH2Cl2/5% MeOH, 0.5 L 
CH2Cl2/10% MeOH, CH2Cl2/20% MeOH, 0.5 L CH2Cl2/50% MeOH, and 0.5 L 
MeOH). According to the spot pattern on TLC, three fractions were selected for fur-
ther investigation. 
Lumichrome (98, 3.8 mg) and were isolated from fraction II by purification 
steps with Sephadex LH-20 (in MeOH system) and RP-18 column (using 
MeOH:H2O eluent system). From fraction III, 1-acetyl--carboline (84) and indole-
3-carboxylic acid were obtained via Sephadex LH-20 column using methanol as the 
Terrestrial Streptomyces sp. GW 4723  181 
  
  
solvent. Finally, the purification of fraction IV with Sephadex LH-20 column 
(MeOH as the mobile phase) resulted in uracil, thymine and 1-methyluracil. 
Lumichrome (98): Pale yellow solid, yellow 
with anisaldehyde/sulphuric acid, UV absorbing band 
at 254 nm. – Rf = 0.37 (CH2Cl2/10% MeOH). – 
1
H 
NMR (pyridin-d5, 300 MHz):  = 8.03 (s, 1H, 6-H), 
7.85 (s, 1H, 9-H), 2.33 (s, 3H, 8-CH3), 2.27 (s, 3H, 7-CH3). – 
13
C NMR (pyridin-d5, 
125 MHz):  = 161.9 (C-4), 151.7 (C-2), 147.6 (C-10a), 144.8 (C-8), 143.0 (C-9a), 
139.9 (C-7), 139.1 (C-5a), 130.9 (C-4a), 129.8 (CH-6), 127.2 (CH-9), 20.4 (CH3-8), 
19.8 (CH3-7). – (+)-ESI MS: m/z (%) = 265 ([M+Na]
+
, 28), 507 ([2M+Na]
+
, 100). – 
(–)-ESI MS: m/z (%) = 241 ([M-H]-, 100), 505 ([2M-H]-, 7). – (+)-HRESI MS: m/z 
= 265.07014 ([M+Na]
+
), (calculated 265.06970 for C12H10N4O2Na). 
9.10 Terrestrial Streptomyces sp. GW 4723 
The crude extract of Streptomyces sp. GW 4723 had been reported to show anti-
bacterial, anti-algal and anti-fungal activities against Bacillus subtilis, Staphylococ-
cus aureus, Escherichia coli, activity, Chlorella vulgaris, Chlorella sorokiniana and 
Scenedesmus subspicatus, Mucor miehei and Candida albicans.
[148]
 
9.10.1 Fermentation and isolation 
Well-grown agar subcultures of terrestrial Streptomyces sp. GW 4723 were used 
to inoculate a 50 L shaker culture for ten days at 28 ºC on E medium. The culture 
broth was harvested after 10 days and mixed with Celite. The mixture was then 
filtered with the aid of filter press to separate water phase and biomass. The biomass 
was extracted with ethyl acetate and acetone. The TLC of ethyl acetate extract, in 
addition to fats, exhibited two yellow bands, where one of them turned violet with 
dilute sodium hydroxide while the other remained unchanged. The ethyl acetate 
extract (2.4 g) was then fractionated on silica gel column chromatography (1.5  40 
cm, 20 g) using a CH2Cl2/MeOH gradient (CH2Cl2, 1 L; 3% MeOH, 0.5 L; 5% 
MeOH, 0.5 L; 7% MeOH, 0.5 L; 10% MeOH, 0.5 L; 15% MeOH, 0.5 L; 20% 
MeOH, 0.5 L; 50% MeOH, 0.5 L; 100% MeOH, 1 L). Under TLC control, four 
fractions were obtained. The PTLC (10  20 cm, CH2Cl2/4% MeOH) of fraction III 
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delivered celastramycin B (103) and acetyl--carboline. Fraction IV was subjected to 
Sephadex LH-20 column using methanol to obtain tyrosol, uracil and adenosine. 
Celastramycin B (103, 1.4 mg): Yellow 
solid, UV absorbing, violet with NaOH 2N. – Rf 
= 0.65 (CH2Cl2/5% MeOH). – 
1
H NMR and 
13
C 
NMR, see table Table 1. 
 
10 Metabolites from selected endophytic fungi 
10.1 Endophytic fungus LAF20 
10.1.1 Fermentation and isolation 
The endophytic fungus LAF20 was cultivated on sterilized rice medium in 20 P-
flasks and incubated for one month at 28 ºC. The resulting fermented rice was ex-
tracted with ethyl acetate (5 times) and was then concentrated to dryness under vacu-
um. The ethyl acetate extract (10.7 g) was chromatographed on silica gel (column 3 
 60 cm, 150 g) using gradient solvent systems of CH2Cl2/MeOH to deliver four 
fractions. Fraction I contained fats and was not further worked up. Fraction II was 
subjected to Sephadex LH-20 column and methanol as eluent to give a mixture of 
stigmasterol and -sitosterol. Isoclerone (104, 1.1 mg) was isolated from fraction III 
using Sephadex LH-20 (MeOH as solvent system). Finally, fraction IV delivered 
poly-(hydroxybutyric acid) (PHB) (86, 7.3 mg) and 4,6,8-trihydroxy-1-tetralone 
(105, 2.1 mg) after purification steps via silica gel and Sephadex LH-20 chromatog-
raphy columns. 
Isosclerone (104): White solid, grey with anisaldehyde/ sul-
phuric acid, UV absorbing band at 254 nm. – Rf = 0.41 (CH2Cl2/5% 
MeOH). – 1H NMR (CDCl3, 300 MHz):  = 12.40 (s, 1H, 8-OH), 
7.48 (dd, 1H, 
3
J = 7.7 and 8.2 Hz, 6-H), 7.00 (d, 1H, 
3
J = 7.5 Hz, 5-
H), 6.91 (d, 1H, 
3
J = 8.4 Hz, 7-H), 4.90 (dd, 1H, J = 7.3 and 3.9 Hz, 4-H) , 2.96-2.64 
(m, 2H, 2-H), 2.32-2.17 (m, 2H, 3-H). – 13C NMR (CDCl3, 125 MHz):  = 204,1 
(C-1), 162.6 (C-8), 145.7 (C-4a), 136.9 (CH-6), 117.7 (CH-5), 117.3 (CH-7), 115.2 
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(C-8a), 67.7 (CH-4), 34.6 (CH2-2), 31.3 (CH2-3). – EIMS (70 eV) m/z = 178 ([M]
+
, 
100), 160 ([M-H2O]
+
, 15), 150 ([M-C2H4]
+
, 45). 
4,6,8-Trihydroxy-1-tetralone (105): Brown solid, grey 
with anisaldehyde/sulphuric acid, UV active at 254 nm. – Rf = 
0.35 (CH2Cl2/5% MeOH). – 
1
H NMR (300 MHz, CD3OD):  
= 6.52 (d, 1H, 
4
J = 2.3 Hz, 5-H), 6.15 (d, 1H, 
4
J = 2.3 Hz, 7-H), 
4.70 (m, 1H, 4-H), 2.75-2.58 (m, 2H, 2-H), 2.23-2.03 (m, 2H, 
3-H). ─ 13C NMR (CD3OD, 125 MHz):  = 203.5 (C-1), 167.3 (C-6), 166.7 (C-8), 
150.9 (C-4a), 110.0 (C-8a), 107.6 (CH-5), 102.5 (CH-7), 68.5 (CH-4), 35.7 (CH2-2), 
32.6 (CH2-3). – (–)-ESI MS: m/z (%) = 193 ([M-H]
+
, 60), 387 ([2M-H]
+
, 100). – (–)-
HRESI MS: m/z = 193.05008 ([M-H]
+
) (calculated 193.04953 for C10H10O4). 
10.2 Endophytic fungus NP32-A 
Well-grown culture on agar plate of endophytic fungus NP32-A was inoculated 
in 1 L of M2 medium and incubated on a rotary shaker at 28 ºC for 5 days. The cul-
ture broth was extracted with ethyl acetate and the crude extract was used for the 
biological assay. 
On the agar diffusion test, the crude extract of endophytic fungus NP32-A ex-
hibited promising biological activities against Bacillus subtilis, Escherichia coli, 
Candida albicans, Mucor miehei (Tü 284), Rhizoctonia solani and Artemia salina. 
Table 10:  Antimicrobial activities of the crude extract of endophytic fungus 
NP32-A 
Tested microorganisms 
Inhibition zone  [mm] 
Bacillus subtilis  15 
Escherichia coli 12 
Candida albicans 11 
Mucor miehei (Tü 284) 14 
Rhizoctonia solani 15 
Artemia salina 100% 
10.2.1 Fermentation and isolation 
The endophytic fungus NP32-A was cultivated and fermented on 10 L of M2 
medium in 10 P-flasks. Then, the culture was incubated at 28 ºC for one month. The 
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mycelium was extracted with ethyl acetate and the water phase was passed through 
XAD-16 resin column and followed by elution with methanol. Then, both these or-
ganic phases were evaporated to dryness under reduced pressure. Based on the TLC, 
both organic extracts were combined to afford 3.7 g of crude extract. This crude ex-
tract was then subjected to silica gel column (3  60 cm, 150 g) with dichloro-
methane and methanol as solvent system (gradient condition) to give five fractions. 
Fraction I contained fats and was not further investigated. Fraction II was purified on 
Sephadex LH-20 column using MeOH as the eluent to isolate cerevisterol (106). 
Fraction III and IV were also subjected to Sephadex LH-20 column (MeOH as mo-
bile phase) to obtain fusaproliferin (107, 6.1 mg) and beauvericin (108) as white sol-
ids. Finally, fraction V was purified on silica gel column and followed by Sephadex 
LH-20 column (methanol as the solvent system) to afford trichosetin (109) and cere-
broside B (110), respectively. 
Cerevisterol (106): White solid, red 
with anisaldehyde/sulphuric acid. – Rf = 
0.25 (CH2Cl2/7% MeOH). – 
1
H NMR 
(DMSO-d6, 300 MHz ):  = 5.23-5.08 (m, 
3H, 7,22,23-H), 4.44 (d, 
3
J = 5.3 Hz, 1H, 
6-H), 3.78 (m, 1H, 3-H), 3.37 (m, 2H, 4-
H), 2.02-1.22 (m, 18H, 1,2,9,11,12,14,15,16,17,20,24,25-H), 1.0 (d, 
3
J = 6.6 Hz, 3H, 
21-H), 0.89 (d, 
3
J = 6.8 Hz, 3H, 28-H), 0.91 (s, 3H, 19-H), 0.82 (d, 
3
J = 6.7 Hz, 3H, 
27-H), 0.80 (d, 
3
J = 6.8 Hz, 3H, 26-H), 0.55 (s, 3H, 18-H). – 13C NMR (DMSO-d6, 
125 MHz):  = 139.6 (Cq-8), 135.3 (CH-23), 131.3 (CH-22), 119.4 (CH-7), 74.4 
(Cq-5), 72.1 (CH-6), 65.9 (CH-3), 55.3 (CH-17), 54.1 (CH-14), 42.9 (Cq-13), 42.2 
(CH-9), 41.9 (CH-24), 39.8 (CH-20), 39.6 (CH2-4), 38.9 (CH2-12), 36.6 (Cq-10), 
32.4 (CH2-1), 32.4 (CH-25), 31.1 (CH2-2), 27.6 (CH2-16), 22.5 (CH2-15), 21.3 (CH2-
11), 20.9 (CH3-27), 19.7 (CH3-26), 19.4 (CH3-21), 17.6 (CH3-19), 17.2 (CH3-28), 
11.9 (CH3-18). – (+)-ESI MS: m/z (%) = 471 ([M+Na+H2O]
+
, 100), 883 ([2M+Na]
+
, 
62). – (+)-HRESI MS: m/z = 471.34560 ([M+Na+H2O]
+
), (calculated 471.34580 for 
C28H48O4Na). 
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Fusaproliferin (107): White solid, UV 
absorbing at 254 nm, red with anisalde-
hyde/sulphuric acid. – Rf = 0.30 
(CH2Cl2/7% MeOH). – 
1
H NMR (CD3OD, 
300 MHz ):  = 5.38 (m, 1H, 12-H), 5.29 
(m, 1H, 2-H), 5.16 (m, 1H, 6-H), 4.27 (m, 2H, 24-H), 3.96 (m, 1H, 10-H), 3.77 (t, 
1H, 14-H), 2.77 (m, 1H, 19-H), 2.45-2.04 (m, 8H, 4,5,8,9-H), 1.99 (s, 3H, 27-H), 
1.79-1.71 (m, 4H, 1,13-H), 1.64 (s, 6H, 20,21-H), 1.28 (d, 3H, 25-H), 1.55 (s, 3H, 
22-H), 0.96 (s, 3H, 23-H). – 13C NMR (CD3OD, 125 MHz):  = 209.9 (C-16), 172.7 
(C-26), 149.9 (C-17), 149.5 (C-18), 138.9 (C-3), 137.4 (C-11), 133.8 (C-7), 130.2 
(CH-12), 125.3 (CH-6), 123.0 (CH-2), 77.1 (CH-10), 67.7 (CH2-24), 50.7 (CH-14), 
50.2 (Cq-15), 41.4 (CH2-4), 40.4 (CH2-1), 35.9 (CH2-8), 35.2 (CH-19), 30.8 (CH2-9), 
30.1 (CH2-13), 24.8 (CH2-5), 20.8 (CH3-27), 16.9 (CH3-23), 15.7 (CH3-20), 15.5 
(CH3-21), 14.7 (CH3-25), 10.4 (CH3-22). – (+)-ESI MS: m/z (%) = 467 ([M+Na]
+
, 
100), 911 ([2M+Na]+, 87). – (+)-HRESI MS: m/z = 467.27680 ([M+Na]+), (calcu-
lated 467.27550 for C27H40O5Na). 
Beauvericin (108): White solid, UV ab-
sorbing band at 254 nm, blue with chlo-
rine/dianisidine reagent. – Rf = 0.57 
(CH2Cl2/5% MeOH). – 
1
H NMR (CD3OD, 300 
MHz ):  = 7.25 (m, 5H, 5',6',7',8',9'-H), 5.79 
(dd, 
3
J = 12.7 and 4.6 Hz, 1H, 2-H), 4.85 (m, 
1H, 2'-H), 3.41-3.36 (d, 
3
J = 4.6 Hz, 2H, 3'-H), 
3.14 (s, 3H, N-CH3), 1.78 (m, 1H, 3-H), 0.84 (d, 
3
J = 6.6 Hz, 3H, 4-H), 0.24 (d, 
3
J = 6.8 Hz, 3H, 5-H). – 13C NMR (CD3OD, 125 
MHz):  = 173.1 (C-1), 170.9 (C-1'), 138.1 (C-4'), 129. 8 (CH-5', 9'), 129.7 (CH-
6',8'), 127.9 (CH-7'), 77.2 (CH-2), 57.8 (CH-2'), 35.4 (CH2-3'), 32.2 (CH3-N), 31.2 
(CH-3), 19.1 (CH3-4), 17.2 (CH3-5). – (+)-ESI MS: m/z (%) = 806 ([M+Na]
+
, 100), 
1590 ([2M+Na+H], 9.4). – (+)-HRESI MS: m/z = 806.39831 ([M+Na]+), (calculated 
806.39870 for C45H57N3O9Na).  
Trichosetin (109): White solid, UV absorbing 
band at 254 nm, yellow with anisaldehyde/sulphuric 
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acid. – Rf = 0.34 (CH2Cl2/10% MeOH). – 
1
H NMR (CD3OD, 300 MHz ):  = 5.36 
(dd, 
4
J = 2.4 Hz, 
3
J = 5.0 Hz , 1H, 4-H), 5.26-5.18 (m, 3H, 13, 14, 5-H), 4.0 (m, 1H, 
3-H), 3.81-3.52 (dd, 
4
J = 2.6 Hz, 
3
J = 10.0 Hz, 2H, 6'-H), 3.56 (d, 
3
J = 2.6 Hz, 1H, 5'-
H), 1.98-1.94 (m, 2H, 6, 8-H), 1.69-1.08 (m, 6H, 7, 9, 10, 11-H), 1.49 (d, 
3
J = 5.3 
Hz, 3H, 15-H), 1.34 (s, 3H, 12-H), 1.19 (d, 
3
J = 7.2 Hz, 3H, 16-H). – 13C NMR 
(CD3OD, 125 MHz):  = 203.6 (C-1), 192.7 (C-4'), 180.3 (C-2'), 134.9 (CH-13), 
131.1 (CH-5), 129.7 (CH-4), 125.6 (CH-14), 104.9 (C-3'), 65.0 (CH2-6'), 62.7 (CH-
5'), 52.7 (C-2), 44.9 (CH-3), 43.2 (CH-11), 41.1 (CH2-7), 33.9 (CH2-9), 33.7 (CH-6), 
29.4 (CH-8), 23.3 (CH2-10), 19.2 (CH3-16), 18.2 (CH3-15), 15.4 (CH3-12). – (+)-ESI 
MS: m/z (%) = 382 ([M+Na]
+
, 100), 741 ([2M+Na]
+
, 50). – (+)-HRESI MS: m/z = 
382.19890 ([M+Na]
+
), (calculated 382.19880 for C21H29NO4Na). 
Cerebroside B 
(110): White solid, not 
UV absorbing, violet 
with anisaldehyde/sul-
phuric acid. – Rf = 
0.15 (CH2Cl2/10% MeOH). – 
1
H NMR (CD3OD/CDCl3, 300 MHz ):  = 7.31 (d, 
3
J 
= 7.6 Hz, NH), 5.72 (m, 1H, 5-H), 5.45 (dd, 
3
J = 7.3, 15.4 Hz, 1H, 4-H), 5.10 (m, 
1H, 8-H), 4.25 (d, 
3
J = 7.8 Hz, 1H, 1''-H), 4.12-4.05 (m, 2H, 2'',3-H), 3.97 (m, 1H, 2-
H), 3.85 (dd, 
3
J = 12.6 Hz, 1H, 1-HB), 3.65 (dd, 
3
J = 4.7 Hz, 1H, 1-HA), 3.38-3.19 
(m, 5H, 3'',4'',5'',6''-H), 1.56 (s, 3H, 19-H), 2.04 (m, 4H, 6,7-H), 1.93 (t, 
3
J = 7.1 Hz, 
2H, 10-H), 1.25 (s, 38H, 3'-17-H), 0.86 (t, 
3
J = 7.0 Hz, 6H, 16',18-H). – 13C NMR 
(CD3OD/CDCl3, 125 MHz):  = 176.7 (C-1'), 136.5 (C-9), 134.6 (CH-5), 130.3 
(CH-4), 124.3 (CH-8), 104.1 (CH-1''), 77.4 (CH-3'',5''), 74.4 (CH-2'), 72.8 (CH-3), 
72.6 (CH-2''), 71.0 (CH-4''), 69.2 (CH2-1), 62.2 (CH2-6''), 54.1 (CH-2), 40.4 (CH2-
10), 35.4 (CH2-3'), 33.3 (CH2-6), 32.7-30.0 (CH2 of aliphatic chains), 28.7 (CH2-7), 
28.3 (CH2-11), 25.8 (CH2-4'), 23.4 (CH2-15',17), 16.2 (CH3-19), 14.4 (CH3-16',18). – 
(+)-ESI MS: m/z (%) = 750 ([M+Na]
+
, 100), 1478 ([2M+Na]
+
, 7). – (+)-HRESI 
MS: m/z = 750.55030 ([M+Na]
+
) (calculated 750.54910 for C41H77NO9Na).  
10.3 Endophytic fungus FT44 
The endophytic fungus FT44 was isolated by Ferdinand Talontsi from the Cam-
eroonian plant Endodesmia calophylloides (Clusiaceae). According to morphological 
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characteristics, it was identified as Penicillium sp. at IRAD (Institute of Agricultural 
Research for Development), Yaoundé, Cameroon. A culture of this fungus was de-
posited in our group. 
10.3.1 Fermentation and isolation 
The Penicillium sp. FT44 was cultivated on sterilized rice medium in 10 P-
flasks and incubated for one month at room temperature. The fermented rice was 
extracted with ethyl acetate (5 times) and was then concentrated to dryness under 
vacuum. The ethyl acetate extract (12.16 g) was chromatographed on silica gel (col-
umn 3  75 cm, 200 g) with a CH2Cl2/MeOH gradient to deliver four fractions. Frac-
tions III and IV were subjected to Sephadex LH-20 column separately with methanol 
as the eluent to isolate 1233-A (111, 3.4 mg) and ergosterol peroxide (112, 5.8 mg), 
respectively. 
1233-A (111): Colourless oil, 
UV absorbing band at 254 nm, red 
with anisaldehyde/sulphuric acid. – 
Rf = 0.54 (CH2Cl2/5% MeOH). – 
1
H NMR (CDCl3, 300 MHz):  = 5.73 (br s, 1H, 11-H), 5.68 (br s, 1 H, 13-H), 4.59 
(m, 1H, 3-H), 4.05 (dd, 
3
J = 4.9 Hz, 
2
J = 11.7 Hz, 1H, 18-HA), 3.88 (dd, 
3
J = 4.0 Hz, 
2
J = 11.7 Hz, 1H, 18-HB), 3.41 (quartet, 
3
J = 4.0 and 4.9 Hz, 1H, 2-H), 2.24 (s, 3H, 
15-H), 2.09 (dd, 
3
J = 6.2 Hz, 
2
J = 13.2 Hz, 2H, 9-H), 1.88 (m, 2H, 4-H), 1.81 (s, 3H, 
16-H), 1.62 (m, 1H, 8-H), 1.39-1.14 (m, 6H, 5,6,7-H), 0.84 (d, 
3
J = 6.6 Hz, 3H, 17-
H). – 13C NMR (CDCl3, 125 MHz):  = 171.6 (C-14), 169.9 (C-1), 156.8 (C-12), 
141.9 (C-10), 129.4 (CH-11), 116.7 (CH-13), 75.0 (CH-3), 58.6 (CH-2), 57.9 (CH2-
18), 49.0 (CH2-9), 36.6 (CH2-7), 34.0 (CH2-4), 30.9 (CH-8), 26.6 (CH2-5), 25.2 
(CH2-6), 20.0 (CH3-15), 19.5 (CH3-17), 18.6 (CH3-16). – (-)-ESI MS: m/z (%) = 323 
([M-H]
-
, 73). – (-)-HRESI MS: m/z = 323.18584 [M-H]- (calc. 323.18529 for 
C18H27O5). – DCI MS (NH3): m/z (%) = 342 ([M+NH3]
+
, 48), 298 ([M-CO2]
+
, 100), 
251 (48), 230 (16), 144 (16), 101 (15). 
Ergosterol peroxide (112): White 
solid, blue with anisaldehyde/sulphuric 
acid. – Rf = 0.43 (CH2Cl2/5% MeOH). – 
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1
H NMR (CDCl3, 300 MHz):  = 6.50 (d, 
3
J = 8.5 Hz, 1H, 6-H), 6.24 (d, 
3
J = 8.5 
Hz, 1H, 7-H), 5.23 (dd, 
3
J = 7.1, 15.2 Hz, 1H, 22-H), 5.14 (dd, 
3
J = 7.8, 15.2 Hz, 1H, 
23-H), 3.97 (m, 1H, 3-H), 0.99 (d, 
3
J = 6.6 Hz, 3H, 28-H), 0.91 (d, 
3
J = 6.6 Hz, 3H, 
21-H), 0.88 (s, 3H, 19-H), 0.82 (m, 9H, 18,26,27-H). – 13C NMR (CDCl3, 125 
MHz):  = 135.3 (CH-6), 135.1 (CH-22), 132.2 (CH-23), 130.6 (CH-7), 82.1 (C-5), 
79.4 (C-8), 66.5 (CH-3), 56.2 (CH-17), 51.7 (CH-14), 51.1 (CH-9), 44.6 (Cq-13), 
42.8 (CH-24), 39.8 (CH-20), 39.4 (C-12), 37.0 (C-10), 36.9 (CH2-4), 34.7 (CH2-1), 
33.1 (CH-25), 30.1 (CH2-2), 28.7 (CH2-16), 23.5 (CH2-11), 20.9 (CH3-21), 20.7 
(CH2-15), 20.0 (CH3-27), 19.7 (CH3-26), 18.2 (CH3-19), 17.6 (CH3-28), 12.95 (CH3-
18). – (+)-ESI MS: m/z (%) = 451 ([M+Na]+, 100), 879 ([2M+Na]+, 31). – (+)-
HRESI MS: m/z = 451.31830 ([M+Na
+
]) (calc. 451.31630 for C28H44O3Na). 
10.4 Endophytic fungus FTM1 
The endophytic fungus FTM1 was isolated by Ferdinand Talontsi from the 
Cameroonian plant Endodesmia calophylloides (Clusiaceae). According to 
morphological characteristics, it was identified as Alternaria sp. at IRAD (Institute of 
Agricultural Research for Development), Yaoundé, Cameroon. A culture of this 
fungus was deposited at our Institute. 
10.4.1 Fermentation and isolation 
The endophytic fungus Alternaria sp. FTM1 was cultivated on sterilized rice 
medium in 10 P-flasks and incubated for one month at room temperature. The 
fermented rice was then extracted with ethyl acetate (5 times) and was then 
concentrated to dryness under vacuum. The ethyl acetate extract (10.06 g) was 
chromatographed on silica gel (column 3  75 cm, 200 g) with a CH2Cl2/MeOH 
gradient to deliver four fractions. Fractions III was subjected to PTLC with 
CH2Cl2/1% MeOH to give 8-hydroxy-6,7-dimethoxy-3-methylisocoumarin (113, 1.5 
mg) and 5-methylochracin (114, 2.1 mg). Fraction IV was subjected to Sephadex 
LH-20 column (methanol) to obtain alternariol-monomethylether (115, 1.7 mg). 
8-Hydroxy-6,7-dimethoxy-3-methylisocou-
marin (113): White solid, grey with anisalde-
hyde/sulphuric acid, UV absorbing band at 254 nm. O
OH
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– Rf = 0.86 (CHCl3/MeOH; 95:5). – 
1
H NMR (CDCl3, 300 MHz ):  = 11.07 (brs, 
8-OH), 6.33 (s, 1H, 5-H), 6.19 (s, 1H, 4-H), 3.95 (s, 3H, 12-H), 3.91 (s, 3H, 13-H), 
2.27 (s, 3H, 11-H). – 13C NMR (CDCl3, 125 MHz):  = 166.3 (C-1), 159.9 (C-6), 
154.6 (C-8), 153.4 (C-3), 135.1 (C-7), 134.4 (C-10), 104.3 (CH-5), 100.8 (C-9), 97.9 
(CH-4), 60.8 (CH3-12), 56.2 (CH3-13), 19.4 (CH3-11). – (+)-ESI MS: m/z (%) = 259 
([M+Na]
+
, 16), 495 ([2M+Na]
+
, 100). – (+)-HRESI MS: m/z = 259.05780 
([M+Na]
+
) (calculated 259.05770 for C12H12O5Na). 
5-Methylochracin (114): White solid, grey with 
anisaldehyde/sulphuric acid, UV absorbing band at 254 nm. 
– Rf = 0.78 (CHCl3/MeOH; 95:5). – 
1
H NMR (CDCl3, 300 
MHz ):  = 10.96 (brs, 8-OH), 7.24 (d, 1H, 
3
J = 8.5 Hz, 6-
H), 6.76 (d, 1H, 
3
J = 8.5 Hz, 7-H), 4.64 (m, 1H, 3-H), 2.91 
(dd, 1H, J = 16.7, 3.4 Hz, 4-Ha), 2.67 (dd, 1H, J = 16.7, 11.6 Hz, 4-Hb), 2.16 (s, 3H, 
12-H), 1.51 (d, 3H, 
3
J = 6.3 Hz, 11-H). – 13C NMR (CDCl3, 125 MHz):  = 170.1 
(C-1), 160.3 (Cq-8), 137.8 (C-10), 136.9 (CH-6), 124.8 (C-5), 115.5 (C-7), 107.9 (C-
9), 75.4 (CH-3), 31.9 (CH2-4), 20.9 (CH3-11), 18.1 (CH3-12). – (+)-ESI MS: m/z 
(%) = 215 ([M+Na]
+
, 46), 407 ([2M+Na]
+
, 100). – (+)-HRESI MS: m/z = 215.2010 
([M+Na]
+
) (calculated 215.20045 for C11H12O3Na). 
Alternariol-monomethyl ether (115): Reddish-
white solid, UV absorbing band at 254 nm, violet with 
anisaldehyde/sulphuric acid. – Rf = 0.68 (CHCl3/ 
MeOH; 95:5). – 1H NMR (DMSO-d6, 300 MHz ):  = 
11.80 (s, 3-OH), 10.35 (s, 4’-OH), 7.19 (d, 1H, 4J = 
2.0 Hz, 6-H), 6.72 (d, 1H, 
4
J = 2.5 Hz, 5’-H), 6.63 (d, 1H, 4J = 2.5 Hz, 3’-H), 6.59 (d, 
1H, 
4
J = 2.1 Hz, 4-H), 3.90 (s, 3H, 8-H), 2.72 (s, 3H, 7’-H). – 13C NMR (DMSO-d6, 
75 MHz):  = 166.1 (C-5), 164.5 (C-7), 164.0 (C-3), 158.5 (C-4’), 152.5 (C-2’), 
138.3 (C-6’), 137.8 (C-1), 117.5 (CH-5’), 108.7 (C-1’), 103.2 (CH-6), 101.5 (CH-3’), 
99.1 (CH-4), 98.4 (C-2), 55.7 (CH3-8), 24.8 (CH3-7’). – (-)-ESI MS: m/z (%) = 271 
([M-H]
-
, 67), 543 ([2M-H]
-
, 100). – (-)-HRESI MS: m/z = 271.06120 ([M-H]-) (cal-
culated 271.06040 for C15H11O5). 
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11 Plant metabolites 
Garcinon D (116): Yellow solid, 10.1 
mg. – 1H NMR (DMSO-d6, 300 MHz ):  = 
6. 78 (s, 1H, 5-H), 6. 34 (s, 1H, 4-H), 5.18 
(t, 1H,
 3
J = 7.1 Hz, 11-H), 3.75 (s, 3H, CH3-
O), 3.32 (m, 2H, 16-CH2), 3.21 (d, 2H, 
3
J = 
7.1 Hz, 10-CH2), 1.73 (s, 3H, 14-CH3), 1.62 
(s, 3H, 13-CH3), 1.57 (m, 2H, 15-CH2), 1.22 (s, 6H, 18, 19-CH3). – 
13
C NMR 
(DMSO-d6, 125 MHz):  = 181.9 (C-9), 161.9 (C-3), 159.6 (C-1), 156.5 (C-5a), 
154.3 (C-6), 153.8 (C-4a), 143.1 (C-7), 138.4 (C-8), 130.1 (C-12), 122.2 (CH-11), 
109.8 (C-8a), 109.3 (C-2), 101.7 (C-9a), 101.3 (CH-5), 92.0 (CH-4), 69.0 (C-17), 
60.3 (7-OCH3), 44.7 (CH2-16), 28.7 (CH3-18,19), 25.4 (CH3-13), 22.1 (CH2-15), 
20.9 (CH2-10), 17.6 (CH3-14). – (+)-ESI MS: m/z = 451 ([M+Na]
+
). – (+)-HRESI 
MS: m/z = 451.17276 ([M+Na]
+
), (calculated 451.17272 for C24H28O7Na). 
Rubraxanthone (117): Yellow solid, 9.8 mg. 
− 1H NMR (CD3OD, 300 MHz ):  = 6.60 (s, 1H, 
5-H), 6.09 (d, 1H, 
4
J = 2.2 Hz, 4-H), 6.03 (d, 1H, 
4
J 
= 2.2 Hz, 2-H), 5. 17 (m, 1H, 15-H), 4.97 (m, 1H, 
11-H), 4.00 (d, 2H, 
3
J = 6.3 Hz, 10-H), 3.73 (s, 3H, 
CH3-O), 1.99 (m, 2H, 13-H), 1.95 (m, 2H, 14-H), 
1.78 (s, 3H, 19-H), 1.52 (s, 3H, 18-H), 1.49 (s, 3H, 
17-H). − 13C NMR (CD3OD, 125 MHz):  = 182.8 
(C-9), 165.7 (C-3), 164.6 (C-1), 158.2 (C-5a), 157.9 (C-4a), 156.6 (C-6), 144.7 (C-
7), 138.5 (C-12), 135.3 (C-8), 131.8 (C-16), 125.3 (CH-11), 125.1 (CH-15), 112.1 
(C-8a), 103.8 (C-9a), 102.8 (CH-5), 98.7 (CH-2), 93.9 (CH-4), 61.3 (7-OCH3), 40.8 
(CH2-13), 27.6 (CH2-14), 27.0 (CH2-10), 25.8 (CH3-18), 17.7 (CH3-17), 16.6 (CH3-
19). – (+)-ESI MS: m/z = 433 ([M+Na]+). – (+)-HRESI MS: m/z = 433.162196 
([M+Na]
+
), (calculated 433.162159 for C24H26O6Na). 
Acetyl aleuritolic acid (118): White sol-
id, 11.6 mg. – 1H NMR (CDCl3, 300 MHz ): 
 = 5.20 (1H, m,15-H), 4.50 (1H, m, 3-H), 
O
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2.80 (2H, m, 16-CH2), 1.90 (3H, s, COOCH3), 1.10 (3H, s, 26-CH3), 0.92 (3H, s, 30-
CH3), 0.90 (3H, s, 29-CH3), 0.88 (3H, s, 23-CH3), 0.84 (3H, s, 24-CH3), 0,82 (3H, s, 
27-CH3), 0.70 (3H, s, 25-CH3). – 
13
C NMR (CDCl3, 125 MHz):  = 184.12 (C-28, 
COOH), 170.86 (Cq, COOCH3), 143.47 (C-14), 122.44 (CH-15), 80.84 (CH-3), 
55.29 (CH-5), 47.57 (C-17), 46.57 (CH-9), 45.85 (CH-18), 41.56 (CH2-7), 40.92 (C-
8), 39.31 (C-4), 38.09 (C-10), 37.72 (CH2-1), 37.02 (C-13), 33.82 (CH2-19), 33.10 
(CH2-12), 32.55 (CH2-21), 32.48 (CH3-29), 30.71 (CH2-16), 28.09 (CH2-22), 27.71 
(C-20), 25.96 (CH3-30), 23.64 (CH3-23), 23.58 (CH3-26), 23.44 (CH2-2), 22.91 
(CH3-27), 21.36 (COOCH3), 18.23 (CH2-6), 17.25 (CH2-11), 16.72 (CH3-24), 15.45 
(CH3-25). – (+)-ESI MS: m/z = 521 ([M+Na]
+
). – (+)-HRESI MS: m/z = 521.36066 
([M+Na]
+
), (calculated 521.36032 for C32H50O4Na). 
Betulinic acid (119): White needles, 10.03 
mg. – 1H NMR (DMSO-d6, 300 MHz):  = 
12.0 (bs, 1H, 28-OH), 4.70 (s, 1H, 29-Ha), 4.56 
(s, 1H, 29-Hb), 4.20 (bs, 1H, 3-OH), 2.98 (m, 
1H, 3-H), 2.22 (dt, J = 14.1, 3.6 Hz, 1H, 19-H), 
1.80 (m, 2H, 16-H), 1.65 (s, 3H, 30-CH3), 0.65-
1.85 (m, 1,2,6,7,11,12,15,21,22-CH2, 5,9-H), 
0.93 (s, 3H, 23-CH3), 0.87 (s, 6H, 26,27-CH3), 0.77 (s, 3H, 24-CH3), 0.65 (s, 3H, 25-
CH3). – 
13
C NMR (DMSO-d6, 125 MHz):  = 176.9 (C-28), 150.1 (C-20), 109.4 
(CH2-29), 76.7 (CH-3), 55.3 (C-17), 54.8 (CH-5), 49.9 (CH-9), 48.5 (CH-18), 46.5 
(CH-19), 41.9 (C-14), 40.2 (C-8), 39.0 (C-4), 38.4 (CH2-1), 38.2 (CH-13), 37.6 
(CH2-7), 36.7 (C-10), 36.3 (CH2-22), 31.7 (CH2-6), 30.1 (CH2-21), 29.2 (CH2-15), 
28.0 (CH3-23), 27.1 (CH2-2), 25.1 (CH2-12), 20.4 (CH2-11), 18.9 (CH3-30), 17.9 
(CH2-6), 15.9 (CH3-26), 15.74 (CH3-25), 15.71 (CH3-24), 14.4 (CH3-27). – (–)-ESI 
MS: m/z = 455 ([M-H]
-
). – (–)-HRESI MS: m/z = 455.35309 ([M-H]-), (calculated 
455.353069 for C30H48O3). 
5,7-Dimethoxyapigenin (121): White 
solid, 10.3 mg. – 1H NMR (DMSO-d6, 300 
MHz):  = 7.87 (d, 2H, 3J = 8.8 Hz, 2', 6'-H), 
6.90 (d, 2H, 
3
J = 8.8 Hz, 3', 5'-H), 6.82 (d, 1H, 
4
J = 2.3 Hz, 8-H), 6.56 (s, 1H, 3-H), 6.49 (d, 
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1H, 
4
J = 2.3 Hz, 6-H), 3.89 (s, 3H, CH3-O), 3.83 (s, 3H, CH3-O). – 
13
C NMR 
(DMSO-d6, 125 MHz):  = 175.3 (C-4), 163.3 (C-7), 160.1 (C-4'), 160.0 (C-5), 
159.8 (C-2), 158.8 (C-8a), 127.6 (CH-2', 6'), 121.0 (C-1'), 115.6 (CH-3', 5'), 108.1 
(C-4a), 105.8 (CH-3), 96.0 (CH-6), 93.2 (CH-8), 55.9 (5-OCH3), 55.8 (7-OCH3). – 
(+)-ESI MS: m/z = 297 ([M-H]
+
). – (+)-HRESI MS: m/z = 299.09153 ([M+H]+), 
(calculated 299.09140 for C17H15O5). 
Ganschisandrine (122): White sol-
id, 9.71 mg. – 1H NMR (CDCl3, 300 
MHz ):  = 6.83 (d, 1H, 
3
J = 8.2 Hz, 5-
H), 6.94 (d, 1H, 
4
J = 1.9 Hz, 2-H), 6.95 
(dd, 1H, 
3
J = 8.2, 
4
J = 1.9 Hz, 6-H), 4.51 
(d, 1H, 
3
J = 6.4 Hz, 7-H), 3.86, 3.85 (2 s, 6H, 3,4-OMe), 2.31 (m, 1H, 8-H), 1.02 (d, 
3H,
 3
J = 6.7 Hz, 8-CH3). – 
13
C NMR (CDCl3, 125 MHz):  = 148.8 (C-3), 148.3 (C-
4), 134.7 (C-1), 118.5 (CH-6), 110.8 (CH-5), 109.7 (CH-2), 87.2 (CH-7), 55.9 (4-
OMe), 55.8 (3-OMe), 44.4 (CH-8), 13.0 (CH3-8). – (+)-ESI MS: m/z = 395 
([M+Na]
+
). – (+)-HRESI MS: m/z = 395.18289 ([M+Na]+), (calculated 395.18283 
for C22H28O5Na). 
Stigmasterol glucoside 
(123): White solid, 11.1 mg. – 
1
H NMR (DMSO-d6, 300 
MHz ):  = 5.32 (br s, 6-H), 5.4 
(m, 22-H), 5.01 (m, 23-H), 4.80 
(m, 1’-H), 4.34 (t, 3J = 7.6 Hz, 
6b’-H), 4.22 (d, 3J = 5.6Hz, 
6a’-H), 3.64 (m, 3, 3’-H), 3.44 
(m, 4’-H), 3.08 (m, 5’-H), 2.91 (m, 2’-H), 2.36 (m, 4-H), 2.15-0.65 (m, 1, 2, 7, 8, 9, 
11, 12, 14, 15, 16, 17, 20, 21, 24, 25, 26, 27, 28, 29-H). – 13C NMR (DMSO-d6, 125 
MHz ):  = 36.8 (CH2-1), 29.2 (CH2-2), 70.0 (CH-3), 41.7 (CH2-4), 140.2 (C-5), 
120.9 (CH-6), 31.3 (CH2-7), 31.4 (CH-8), 49.5 (CH-9), 36.2 (C-10), 22.6 (CH2-11), 
38.1 (CH2-12), 41.8 (C-13), 56.1 (CH-14), 23.8 (CH2-15), 28.7 (CH2-16), 55.4 (CH-
17), 11.7 (CH3-18), 19.6 (CH3-19), 38.3 (CH-20), 20.8 (CH3-21), 137.7 (CH-22), 
128.6 (CH-23), 50.5 (CH-24), 33.3 (CH-25), 19.0 (CH3-26), 20.5 (CH3-27), 25.5 
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(CH2-28), 12.0 (CH3-29), 100.7 (CH-1'), 76.6 (CH-2'), 76.7 (CH-3'), 73.3 (CH-4'), 
76.8 (CH-5'), 61.0 (CH2-6'). – (+)-ESI MS: m/z = 597 ([M+Na]
+
). – (+)-HRESI 
MS: m/z = 597.41256 ([M+Na]
+
), (calculated 597.41244 for C35H58O6Na).  
Oleanolic acid (124): Pale yellow solid, 
10.0 mg. – 1H NMR (CDCl3, 300 MHz):  = 
5.23 (t, 1H, 
3
J = 3.5 Hz, 12-H), 3.14 (dd, 1H, 
3
J = 10.7, 6.1 Hz, 3-H), 2.82 (dd, 1H, 
3
J = 
13.1 and 4.4 Hz, 18-H), 2.01-1.28 (1, 2, 5, 6, 
7, 11, 15, 16, 19, 21, 22-H), 1.15-0.77 (23, 24, 
25, 26, 27, 29, 30-Me). – (+)-ESI MS: m/z = 
479 ([M+Na]
+
). – (+)-HRESI MS: m/z = 479.34961 ([M+Na]+), (calculated 
479.34956 for C30H48O3Na). 
Betulin (120): White solid, 8.9 mg. – 1H 
NMR (CDCl3, 300 MHz):  = 4.66, 4.56 (2d, 
2H, 29-H), 3.78, 3.53 (2xd, 2H, 
2
J = 10.8 Hz, 
28-H), 3.21 (m, 1H, 3-H), 2.37 (m, 1H, 19-H), 
1.67 (s, 3H, 30-CH3). – (+)-ESI MS: m/z = 465 
([M+Na]
+
). – (+)-HRESI MS: m/z = 465.37043 
([M+Na]
+
), (calculated 465.37030 for 
C30H50O2Na). 
2-Methylanthraquinone (125): Yellow solid, 9.6 mg. 
– 1H NMR (CDCl3, 300 MHz):  = 8.28 (m, 2H, 5-H and 
8-H), 8.18 (d, 
3
J = 7.9 Hz, 1H, 4-H), 8.08 (d, 
4
J = 1.1 Hz, 
1H, 1-H), 7.77 (m, 2H, 6-H and 7-H), 7.58 (dd, 1H, 
3
J = 
7.9 Hz, 
4
J = 1.1 Hz, 3-H), 2.52 (s, 3H, 2-CH3). – (+)-ESI MS: m/z = 245 ([M+Na]
+
). 
– (+)-HRESI MS: m/z = 245.05735 ([M+Na]+), (calculated 245.05730 for 
C15H10O2Na). 
Scopoletin (126): Yellow solid, 9.0 mg. – 1H NMR 
(CDCl3, 300 MHz):  = 7.58 (d, 1H, 
3
J = 9.5 Hz, 4-H), 
6.89 (s, 1H, 5-H), 6.82 (s, 1H, 8-H), 6.25 (d, 1H, 
3
J = 9.5 
Hz, 3-H), 3.93 (s, 3H, OMe). – (+)-ESI MS: m/z = 215 ([M+Na]+). – (+)-HRESI 
MS: m/z = 215.03148 ([M+Na]
+
), (calculated 215.03147 for C10H8O4Na). 
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13 Spectra
 
Figure 111: H, H COSY spectrum (DMSO-d6, 600 MHz) of bandamycin (94) 
 
Figure 112: COSY spectrum (DMSO-d6, 300 MHz) of garcinon D (116) 
  
  
  
 
Figure 113: HMBC spectrum (DMSO-d6, 300 MHz) of garcinon D (116) 
 
Figure 114: 
13
C NMR spectrum (DMSO-d6, 125 MHz) of 5,7-dimethoxyapigenin 
(121) 
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Figure 115: HMBC spectrum (CDCl3, 300 MHz) of ganschisandrine (122) 
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